JP6795753B2 - Resin material for forming a cured film, method for forming a cured film, cured film, semiconductor element and display element - Google Patents
Resin material for forming a cured film, method for forming a cured film, cured film, semiconductor element and display element Download PDFInfo
- Publication number
- JP6795753B2 JP6795753B2 JP2015214790A JP2015214790A JP6795753B2 JP 6795753 B2 JP6795753 B2 JP 6795753B2 JP 2015214790 A JP2015214790 A JP 2015214790A JP 2015214790 A JP2015214790 A JP 2015214790A JP 6795753 B2 JP6795753 B2 JP 6795753B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- cured film
- structural unit
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 title claims description 127
- 239000011347 resin Substances 0.000 title claims description 127
- 229920005989 resin Polymers 0.000 title claims description 127
- 238000000034 method Methods 0.000 title claims description 49
- 239000004065 semiconductor Substances 0.000 title claims description 16
- 229920000642 polymer Polymers 0.000 claims description 116
- -1 methylol group Chemical group 0.000 claims description 99
- 125000004432 carbon atom Chemical group C* 0.000 claims description 84
- 150000001875 compounds Chemical class 0.000 claims description 72
- 238000000576 coating method Methods 0.000 claims description 52
- 239000011248 coating agent Substances 0.000 claims description 47
- 125000000217 alkyl group Chemical group 0.000 claims description 46
- 230000005855 radiation Effects 0.000 claims description 46
- 239000000758 substrate Substances 0.000 claims description 44
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 40
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 35
- 125000003545 alkoxy group Chemical group 0.000 claims description 32
- 125000005843 halogen group Chemical group 0.000 claims description 25
- 238000010438 heat treatment Methods 0.000 claims description 24
- 239000003963 antioxidant agent Substances 0.000 claims description 22
- 230000003078 antioxidant effect Effects 0.000 claims description 22
- 239000003505 polymerization initiator Substances 0.000 claims description 22
- 230000002378 acidificating effect Effects 0.000 claims description 18
- 229910052731 fluorine Inorganic materials 0.000 claims description 17
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 229920001577 copolymer Polymers 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 9
- 125000001153 fluoro group Chemical group F* 0.000 claims description 8
- 125000004429 atom Chemical group 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 150000002367 halogens Chemical class 0.000 claims description 6
- 125000003566 oxetanyl group Chemical group 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 239000010408 film Substances 0.000 description 223
- 239000002904 solvent Substances 0.000 description 39
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 37
- 239000000178 monomer Substances 0.000 description 32
- 239000000126 substance Substances 0.000 description 27
- 239000000243 solution Substances 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 238000006116 polymerization reaction Methods 0.000 description 17
- 238000003860 storage Methods 0.000 description 17
- 239000004094 surface-active agent Substances 0.000 description 17
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 11
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 11
- 150000002430 hydrocarbons Chemical group 0.000 description 11
- 238000002834 transmittance Methods 0.000 description 11
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 239000003999 initiator Substances 0.000 description 10
- 229910052710 silicon Inorganic materials 0.000 description 10
- 239000010703 silicon Substances 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 238000011161 development Methods 0.000 description 9
- 230000018109 developmental process Effects 0.000 description 9
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 9
- 239000011737 fluorine Substances 0.000 description 9
- 238000005227 gel permeation chromatography Methods 0.000 description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 8
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 7
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 7
- 125000002723 alicyclic group Chemical group 0.000 description 7
- 239000011229 interlayer Substances 0.000 description 7
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 7
- 229910052753 mercury Inorganic materials 0.000 description 7
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 7
- 239000011342 resin composition Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- BGYHLZZASRKEJE-UHFFFAOYSA-N [3-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]-2,2-bis[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxymethyl]propyl] 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)OCC(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 BGYHLZZASRKEJE-UHFFFAOYSA-N 0.000 description 6
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 125000003700 epoxy group Chemical group 0.000 description 6
- OTTZHAVKAVGASB-UHFFFAOYSA-N hept-2-ene Chemical compound CCCCC=CC OTTZHAVKAVGASB-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 5
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 5
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 230000006866 deterioration Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000004973 liquid crystal related substance Substances 0.000 description 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- BQTPKSBXMONSJI-UHFFFAOYSA-N 1-cyclohexylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1CCCCC1 BQTPKSBXMONSJI-UHFFFAOYSA-N 0.000 description 4
- UAJRSHJHFRVGMG-UHFFFAOYSA-N 1-ethenyl-4-methoxybenzene Chemical compound COC1=CC=C(C=C)C=C1 UAJRSHJHFRVGMG-UHFFFAOYSA-N 0.000 description 4
- CNJRPYFBORAQAU-UHFFFAOYSA-N 1-ethoxy-2-(2-methoxyethoxy)ethane Chemical compound CCOCCOCCOC CNJRPYFBORAQAU-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- LWRBVKNFOYUCNP-UHFFFAOYSA-N 2-methyl-1-(4-methylsulfanylphenyl)-2-morpholin-4-ylpropan-1-one Chemical compound C1=CC(SC)=CC=C1C(=O)C(C)(C)N1CCOCC1 LWRBVKNFOYUCNP-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 4
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000005456 alcohol based solvent Substances 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 125000000962 organic group Chemical group 0.000 description 4
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000001226 reprecipitation Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 3
- VSAWBBYYMBQKIK-UHFFFAOYSA-N 4-[[3,5-bis[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-2,4,6-trimethylphenyl]methyl]-2,6-ditert-butylphenol Chemical compound CC1=C(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)C(C)=C(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)C(C)=C1CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 VSAWBBYYMBQKIK-UHFFFAOYSA-N 0.000 description 3
- JAGRUUPXPPLSRX-UHFFFAOYSA-N 4-prop-1-en-2-ylphenol Chemical compound CC(=C)C1=CC=C(O)C=C1 JAGRUUPXPPLSRX-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical group C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 125000005233 alkylalcohol group Chemical group 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 150000001491 aromatic compounds Chemical class 0.000 description 3
- 239000007810 chemical reaction solvent Substances 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical group 0.000 description 3
- 239000004210 ether based solvent Substances 0.000 description 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 3
- 125000003709 fluoroalkyl group Chemical group 0.000 description 3
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 3
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 3
- 125000004957 naphthylene group Chemical group 0.000 description 3
- 230000001590 oxidative effect Effects 0.000 description 3
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 3
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 150000003376 silicon Chemical class 0.000 description 3
- 229920001187 thermosetting polymer Polymers 0.000 description 3
- 230000004580 weight loss Effects 0.000 description 3
- SSLASPHAKUVIRG-UHFFFAOYSA-N (2-methylcyclohexyl) prop-2-enoate Chemical compound CC1CCCCC1OC(=O)C=C SSLASPHAKUVIRG-UHFFFAOYSA-N 0.000 description 2
- MWMWRSCIFDZZGW-UHFFFAOYSA-N (2-oxooxolan-3-yl) prop-2-enoate Chemical compound C=CC(=O)OC1CCOC1=O MWMWRSCIFDZZGW-UHFFFAOYSA-N 0.000 description 2
- FYGHSUNMUKGBRK-UHFFFAOYSA-N 1,2,3-trimethylbenzene Chemical compound CC1=CC=CC(C)=C1C FYGHSUNMUKGBRK-UHFFFAOYSA-N 0.000 description 2
- KVNYFPKFSJIPBJ-UHFFFAOYSA-N 1,2-diethylbenzene Chemical compound CCC1=CC=CC=C1CC KVNYFPKFSJIPBJ-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 125000001989 1,3-phenylene group Chemical group [H]C1=C([H])C([*:1])=C([H])C([*:2])=C1[H] 0.000 description 2
- PMBXCGGQNSVESQ-UHFFFAOYSA-N 1-Hexanethiol Chemical compound CCCCCCS PMBXCGGQNSVESQ-UHFFFAOYSA-N 0.000 description 2
- HIDBROSJWZYGSZ-UHFFFAOYSA-N 1-phenylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=CC=CC=C1 HIDBROSJWZYGSZ-UHFFFAOYSA-N 0.000 description 2
- SDJHPPZKZZWAKF-UHFFFAOYSA-N 2,3-dimethylbuta-1,3-diene Chemical compound CC(=C)C(C)=C SDJHPPZKZZWAKF-UHFFFAOYSA-N 0.000 description 2
- OJVAMHKKJGICOG-UHFFFAOYSA-N 2,5-hexanedione Chemical compound CC(=O)CCC(C)=O OJVAMHKKJGICOG-UHFFFAOYSA-N 0.000 description 2
- JKQRNTIBBOTABS-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-[2-(2,4-dichlorophenyl)-4,5-diphenylimidazol-2-yl]-4,5-diphenylimidazole Chemical compound ClC1=CC(Cl)=CC=C1C(N1C2(N=C(C(=N2)C=2C=CC=CC=2)C=2C=CC=CC=2)C=2C(=CC(Cl)=CC=2)Cl)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 JKQRNTIBBOTABS-UHFFFAOYSA-N 0.000 description 2
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 2
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 2
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 2
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 2
- QPRQEDXDYOZYLA-UHFFFAOYSA-N 2-methylbutan-1-ol Chemical compound CCC(C)CO QPRQEDXDYOZYLA-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- RZKSECIXORKHQS-UHFFFAOYSA-N Heptan-3-ol Chemical compound CCCCC(O)CC RZKSECIXORKHQS-UHFFFAOYSA-N 0.000 description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 description 2
- FZTQMMOUZOKRBC-UHFFFAOYSA-N OC1=CC=C(C=C1)C=C(C(=O)O)C.C(C(=C)C)(=O)OC1=CC=C(C=C1)O Chemical compound OC1=CC=C(C=C1)C=C(C(=O)O)C.C(C(=C)C)(=O)OC1=CC=C(C=C1)O FZTQMMOUZOKRBC-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 239000006087 Silane Coupling Agent Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000004115 Sodium Silicate Substances 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- LCXXNKZQVOXMEH-UHFFFAOYSA-N Tetrahydrofurfuryl methacrylate Chemical compound CC(=C)C(=O)OCC1CCCO1 LCXXNKZQVOXMEH-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- DAKWPKUUDNSNPN-UHFFFAOYSA-N Trimethylolpropane triacrylate Chemical compound C=CC(=O)OCC(CC)(COC(=O)C=C)COC(=O)C=C DAKWPKUUDNSNPN-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- HVVWZTWDBSEWIH-UHFFFAOYSA-N [2-(hydroxymethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical class C=CC(=O)OCC(CO)(COC(=O)C=C)COC(=O)C=C HVVWZTWDBSEWIH-UHFFFAOYSA-N 0.000 description 2
- MPIAGWXWVAHQBB-UHFFFAOYSA-N [3-prop-2-enoyloxy-2-[[3-prop-2-enoyloxy-2,2-bis(prop-2-enoyloxymethyl)propoxy]methyl]-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate Chemical compound C=CC(=O)OCC(COC(=O)C=C)(COC(=O)C=C)COCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C MPIAGWXWVAHQBB-UHFFFAOYSA-N 0.000 description 2
- 229940022663 acetate Drugs 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 2
- 238000007611 bar coating method Methods 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- 150000005676 cyclic carbonates Chemical group 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- 238000007607 die coating method Methods 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N ethylene glycol monomethyl ether acetate Natural products COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- NGAZZOYFWWSOGK-UHFFFAOYSA-N heptan-3-one Chemical compound CCCCC(=O)CC NGAZZOYFWWSOGK-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- GJRQTCIYDGXPES-UHFFFAOYSA-N isobutyl acetate Chemical compound CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropyl acetate Chemical compound CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 2
- 239000005453 ketone based solvent Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- GJQIMXVRFNLMTB-UHFFFAOYSA-N nonyl acetate Chemical compound CCCCCCCCCOC(C)=O GJQIMXVRFNLMTB-UHFFFAOYSA-N 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical group O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 238000001955 polymer synthesis method Methods 0.000 description 2
- 229920000056 polyoxyethylene ether Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- YKYONYBAUNKHLG-UHFFFAOYSA-N propyl acetate Chemical compound CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- ODLMAHJVESYWTB-UHFFFAOYSA-N propylbenzene Chemical compound CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 2
- 229910052911 sodium silicate Inorganic materials 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- SJMYWORNLPSJQO-UHFFFAOYSA-N tert-butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)(C)C SJMYWORNLPSJQO-UHFFFAOYSA-N 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KIJJAQMJSXOBIE-UHFFFAOYSA-N (2-methylcyclohexyl) 2-methylprop-2-enoate Chemical compound CC1CCCCC1OC(=O)C(C)=C KIJJAQMJSXOBIE-UHFFFAOYSA-N 0.000 description 1
- RYNQKSJRFHJZTK-UHFFFAOYSA-N (3-methoxy-3-methylbutyl) acetate Chemical compound COC(C)(C)CCOC(C)=O RYNQKSJRFHJZTK-UHFFFAOYSA-N 0.000 description 1
- WNHHRXSVKWWRJY-UHFFFAOYSA-N (5-methyl-5-bicyclo[2.2.1]hept-2-enyl)methanol Chemical compound C1C2C(C)(CO)CC1C=C2 WNHHRXSVKWWRJY-UHFFFAOYSA-N 0.000 description 1
- HAHASQAKYSVXBE-AATRIKPKSA-N (e)-2,3-diethylbut-2-enedioic acid Chemical compound CC\C(C(O)=O)=C(\CC)C(O)=O HAHASQAKYSVXBE-AATRIKPKSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- CFCRODHVHXGTPC-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,12-pentacosafluorododecane-1-sulfonic acid Chemical compound OS(=O)(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F CFCRODHVHXGTPC-UHFFFAOYSA-N 0.000 description 1
- NHMQIIWXKSTTCZ-UHFFFAOYSA-N 1,1,2,2,8,8,9,9,10,10-decafluorododecane Chemical compound CCC(F)(F)C(F)(F)C(F)(F)CCCCCC(F)(F)C(F)F NHMQIIWXKSTTCZ-UHFFFAOYSA-N 0.000 description 1
- IJURQEZAWYGJDB-UHFFFAOYSA-N 1,1,2,2-tetrafluoro-1-(1,1,2,2-tetrafluorobutoxy)butane Chemical compound CCC(F)(F)C(F)(F)OC(F)(F)C(F)(F)CC IJURQEZAWYGJDB-UHFFFAOYSA-N 0.000 description 1
- GCCPAVALGCCVQZ-UHFFFAOYSA-N 1,1,2,2-tetrafluoro-1-[2-[2-[2-[2-[2-[2-[2-[2-(1,1,2,2-tetrafluorobutoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]butane Chemical compound CCC(F)(F)C(F)(F)OCCOCCOCCOCCOCCOCCOCCOCCOC(F)(F)C(F)(F)CC GCCPAVALGCCVQZ-UHFFFAOYSA-N 0.000 description 1
- RIZMPBJZAHNFGY-UHFFFAOYSA-N 1,1,2,2-tetrafluoro-1-hexoxyoctane Chemical compound CCCCCCOC(F)(F)C(F)(F)CCCCCC RIZMPBJZAHNFGY-UHFFFAOYSA-N 0.000 description 1
- VIDOPANCAUPXNH-UHFFFAOYSA-N 1,2,3-triethylbenzene Chemical compound CCC1=CC=CC(CC)=C1CC VIDOPANCAUPXNH-UHFFFAOYSA-N 0.000 description 1
- ZXHDVRATSGZISC-UHFFFAOYSA-N 1,2-bis(ethenoxy)ethane Chemical compound C=COCCOC=C ZXHDVRATSGZISC-UHFFFAOYSA-N 0.000 description 1
- BPXVHIRIPLPOPT-UHFFFAOYSA-N 1,3,5-tris(2-hydroxyethyl)-1,3,5-triazinane-2,4,6-trione Chemical compound OCCN1C(=O)N(CCO)C(=O)N(CCO)C1=O BPXVHIRIPLPOPT-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- 125000005657 1,3-cyclobutylene group Chemical group [H]C1([H])C([H])([*:1])C([H])([H])C1([H])[*:2] 0.000 description 1
- 125000005838 1,3-cyclopentylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:2])C([H])([H])C1([H])[*:1] 0.000 description 1
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 description 1
- ALVZNPYWJMLXKV-UHFFFAOYSA-N 1,9-Nonanediol Chemical compound OCCCCCCCCCO ALVZNPYWJMLXKV-UHFFFAOYSA-N 0.000 description 1
- COLYDFXUNAQRBZ-UHFFFAOYSA-N 1-(1-ethoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCOCC(C)OCC(C)OC(C)=O COLYDFXUNAQRBZ-UHFFFAOYSA-N 0.000 description 1
- ZWPUOFSQNASCII-UHFFFAOYSA-N 1-(2-ethoxyethoxy)butane Chemical compound CCCCOCCOCC ZWPUOFSQNASCII-UHFFFAOYSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- BLLFPKZTBLMEFG-UHFFFAOYSA-N 1-(4-hydroxyphenyl)pyrrole-2,5-dione Chemical compound C1=CC(O)=CC=C1N1C(=O)C=CC1=O BLLFPKZTBLMEFG-UHFFFAOYSA-N 0.000 description 1
- USRJNCZFXRJTNN-UHFFFAOYSA-N 1-(furan-2-yl)propan-2-yl prop-2-enoate Chemical compound C=CC(=O)OC(C)CC1=CC=CO1 USRJNCZFXRJTNN-UHFFFAOYSA-N 0.000 description 1
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
- XTWPKMFMPBGNKR-UHFFFAOYSA-N 1-[(4-hydroxyphenyl)methyl]pyrrole-2,5-dione Chemical compound C1=CC(O)=CC=C1CN1C(=O)C=CC1=O XTWPKMFMPBGNKR-UHFFFAOYSA-N 0.000 description 1
- ZDQNWDNMNKSMHI-UHFFFAOYSA-N 1-[2-(2-prop-2-enoyloxypropoxy)propoxy]propan-2-yl prop-2-enoate Chemical compound C=CC(=O)OC(C)COC(C)COCC(C)OC(=O)C=C ZDQNWDNMNKSMHI-UHFFFAOYSA-N 0.000 description 1
- NCFIKBMPEOEIED-UHFFFAOYSA-N 1-acridin-9-ylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1C1=C(C=CC=C2)C2=NC2=CC=CC=C12 NCFIKBMPEOEIED-UHFFFAOYSA-N 0.000 description 1
- MKRBAPNEJMFMHU-UHFFFAOYSA-N 1-benzylpyrrole-2,5-dione Chemical compound O=C1C=CC(=O)N1CC1=CC=CC=C1 MKRBAPNEJMFMHU-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 1
- LIPRQQHINVWJCH-UHFFFAOYSA-N 1-ethoxypropan-2-yl acetate Chemical compound CCOCC(C)OC(C)=O LIPRQQHINVWJCH-UHFFFAOYSA-N 0.000 description 1
- HYFLWBNQFMXCPA-UHFFFAOYSA-N 1-ethyl-2-methylbenzene Chemical compound CCC1=CC=CC=C1C HYFLWBNQFMXCPA-UHFFFAOYSA-N 0.000 description 1
- LMAUULKNZLEMGN-UHFFFAOYSA-N 1-ethyl-3,5-dimethylbenzene Chemical compound CCC1=CC(C)=CC(C)=C1 LMAUULKNZLEMGN-UHFFFAOYSA-N 0.000 description 1
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- YAJYJWXEWKRTPO-UHFFFAOYSA-N 2,3,3,4,4,5-hexamethylhexane-2-thiol Chemical compound CC(C)C(C)(C)C(C)(C)C(C)(C)S YAJYJWXEWKRTPO-UHFFFAOYSA-N 0.000 description 1
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 1
- VBSNQEZPXZKHGV-UHFFFAOYSA-N 2,3-diethoxybicyclo[2.2.1]hept-5-ene Chemical compound C1C2C=CC1C(OCC)C2OCC VBSNQEZPXZKHGV-UHFFFAOYSA-N 0.000 description 1
- VTFXHGBOGGGYDO-UHFFFAOYSA-N 2,4-bis(dodecylsulfanylmethyl)-6-methylphenol Chemical compound CCCCCCCCCCCCSCC1=CC(C)=C(O)C(CSCCCCCCCCCCCC)=C1 VTFXHGBOGGGYDO-UHFFFAOYSA-N 0.000 description 1
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 description 1
- LZHUBCULTHIFNO-UHFFFAOYSA-N 2,4-dihydroxy-1,5-bis[4-(2-hydroxyethoxy)phenyl]-2,4-dimethylpentan-3-one Chemical compound C=1C=C(OCCO)C=CC=1CC(C)(O)C(=O)C(O)(C)CC1=CC=C(OCCO)C=C1 LZHUBCULTHIFNO-UHFFFAOYSA-N 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- MHDULSOPQSUKBQ-UHFFFAOYSA-N 2-(2-chlorophenyl)-1-[2-(2-chlorophenyl)-4,5-diphenylimidazol-2-yl]-4,5-diphenylimidazole Chemical compound ClC1=CC=CC=C1C(N1C2(N=C(C(=N2)C=2C=CC=CC=2)C=2C=CC=CC=2)C=2C(=CC=CC=2)Cl)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 MHDULSOPQSUKBQ-UHFFFAOYSA-N 0.000 description 1
- FPZWZCWUIYYYBU-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl acetate Chemical compound CCOCCOCCOC(C)=O FPZWZCWUIYYYBU-UHFFFAOYSA-N 0.000 description 1
- GZMAAYIALGURDQ-UHFFFAOYSA-N 2-(2-hexoxyethoxy)ethanol Chemical compound CCCCCCOCCOCCO GZMAAYIALGURDQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- BJINVQNEBGOMCR-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethyl acetate Chemical compound COCCOCCOC(C)=O BJINVQNEBGOMCR-UHFFFAOYSA-N 0.000 description 1
- DRLRGHZJOQGQEC-UHFFFAOYSA-N 2-(2-methoxypropoxy)propyl acetate Chemical compound COC(C)COC(C)COC(C)=O DRLRGHZJOQGQEC-UHFFFAOYSA-N 0.000 description 1
- DJCYDDALXPHSHR-UHFFFAOYSA-N 2-(2-propoxyethoxy)ethanol Chemical compound CCCOCCOCCO DJCYDDALXPHSHR-UHFFFAOYSA-N 0.000 description 1
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- PUBNJSZGANKUGX-UHFFFAOYSA-N 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-(4-morpholin-4-ylphenyl)butan-1-one Chemical compound C=1C=C(N2CCOCC2)C=CC=1C(=O)C(CC)(N(C)C)CC1=CC=C(C)C=C1 PUBNJSZGANKUGX-UHFFFAOYSA-N 0.000 description 1
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 description 1
- HQLKZWRSOHTERR-UHFFFAOYSA-N 2-Ethylbutyl acetate Chemical compound CCC(CC)COC(C)=O HQLKZWRSOHTERR-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- GQKZRWSUJHVIPE-UHFFFAOYSA-N 2-Pentanol acetate Chemical compound CCCC(C)OC(C)=O GQKZRWSUJHVIPE-UHFFFAOYSA-N 0.000 description 1
- PFHOSZAOXCYAGJ-UHFFFAOYSA-N 2-[(2-cyano-4-methoxy-4-methylpentan-2-yl)diazenyl]-4-methoxy-2,4-dimethylpentanenitrile Chemical compound COC(C)(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)(C)OC PFHOSZAOXCYAGJ-UHFFFAOYSA-N 0.000 description 1
- ZIAGYKQVFTXUQH-UHFFFAOYSA-N 2-[(4-methylphenyl)methyl]-1-(4-morpholin-4-ylphenyl)butan-1-one Chemical compound C=1C=C(N2CCOCC2)C=CC=1C(=O)C(CC)CC1=CC=C(C)C=C1 ZIAGYKQVFTXUQH-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- SDHQGBWMLCBNSM-UHFFFAOYSA-N 2-[2-(2-methoxyethoxy)ethoxy]ethyl acetate Chemical compound COCCOCCOCCOC(C)=O SDHQGBWMLCBNSM-UHFFFAOYSA-N 0.000 description 1
- UDOJNGPPRYJMKR-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-hydroxypropoxy)propoxy]propoxy]propoxy]propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)COC(C)COC(C)COC(C)CO UDOJNGPPRYJMKR-UHFFFAOYSA-N 0.000 description 1
- ZZEANNAZZVVPKU-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-(2-hydroxypropoxy)propoxy]propoxy]propoxy]propoxy]propoxy]propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)COC(C)COC(C)COC(C)COC(C)COC(C)CO ZZEANNAZZVVPKU-UHFFFAOYSA-N 0.000 description 1
- DJNMUNZDHCXGMC-UHFFFAOYSA-N 2-[3-(2-hydroxyethyl)-2-bicyclo[2.2.1]hept-5-enyl]ethanol Chemical compound C1C2C=CC1C(CCO)C2CCO DJNMUNZDHCXGMC-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- UHFFVFAKEGKNAQ-UHFFFAOYSA-N 2-benzyl-2-(dimethylamino)-1-(4-morpholin-4-ylphenyl)butan-1-one Chemical compound C=1C=C(N2CCOCC2)C=CC=1C(=O)C(CC)(N(C)C)CC1=CC=CC=C1 UHFFVFAKEGKNAQ-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- TZYRSLHNPKPEFV-UHFFFAOYSA-N 2-ethyl-1-butanol Chemical compound CCC(CC)CO TZYRSLHNPKPEFV-UHFFFAOYSA-N 0.000 description 1
- WDQMWEYDKDCEHT-UHFFFAOYSA-N 2-ethylhexyl 2-methylprop-2-enoate Chemical compound CCCCC(CC)COC(=O)C(C)=C WDQMWEYDKDCEHT-UHFFFAOYSA-N 0.000 description 1
- WOYWLLHHWAMFCB-UHFFFAOYSA-N 2-ethylhexyl acetate Chemical compound CCCCC(CC)COC(C)=O WOYWLLHHWAMFCB-UHFFFAOYSA-N 0.000 description 1
- CETWDUZRCINIHU-UHFFFAOYSA-N 2-heptanol Chemical compound CCCCCC(C)O CETWDUZRCINIHU-UHFFFAOYSA-N 0.000 description 1
- UPGSWASWQBLSKZ-UHFFFAOYSA-N 2-hexoxyethanol Chemical compound CCCCCCOCCO UPGSWASWQBLSKZ-UHFFFAOYSA-N 0.000 description 1
- VOGSBOVWPQXXAH-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-(4-propylphenyl)propan-1-one Chemical compound CCCC1=CC=C(C(=O)C(C)(C)O)C=C1 VOGSBOVWPQXXAH-UHFFFAOYSA-N 0.000 description 1
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- WNXTZVMMNCCZTP-UHFFFAOYSA-N 2-hydroxyethyl 2-methylprop-2-enoate 5-hydroxy-2-methylpent-2-enoic acid Chemical compound OCCC=C(C(=O)O)C.C(C(=C)C)(=O)OCCO WNXTZVMMNCCZTP-UHFFFAOYSA-N 0.000 description 1
- PFNHSEQQEPMLNI-UHFFFAOYSA-N 2-methyl-1-pentanol Chemical compound CCCC(C)CO PFNHSEQQEPMLNI-UHFFFAOYSA-N 0.000 description 1
- GAODDBNJCKQQDY-UHFFFAOYSA-N 2-methyl-4,6-bis(octylsulfanylmethyl)phenol Chemical compound CCCCCCCCSCC1=CC(C)=C(O)C(CSCCCCCCCC)=C1 GAODDBNJCKQQDY-UHFFFAOYSA-N 0.000 description 1
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- MWDGNKGKLOBESZ-UHFFFAOYSA-N 2-oxooctanal Chemical compound CCCCCCC(=O)C=O MWDGNKGKLOBESZ-UHFFFAOYSA-N 0.000 description 1
- NMUIIYJWWOPNIP-UHFFFAOYSA-N 2-pentan-3-ylidenebutanedioic acid Chemical compound CCC(CC)=C(C(O)=O)CC(O)=O NMUIIYJWWOPNIP-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- WYYQKWASBLTRIW-UHFFFAOYSA-N 2-trimethoxysilylbenzoic acid Chemical compound CO[Si](OC)(OC)C1=CC=CC=C1C(O)=O WYYQKWASBLTRIW-UHFFFAOYSA-N 0.000 description 1
- BRRVXFOKWJKTGG-UHFFFAOYSA-N 3,3,5-trimethylcyclohexanol Chemical compound CC1CC(O)CC(C)(C)C1 BRRVXFOKWJKTGG-UHFFFAOYSA-N 0.000 description 1
- PKNKULBDCRZSBT-UHFFFAOYSA-N 3,4,5-trimethylnonan-2-one Chemical compound CCCCC(C)C(C)C(C)C(C)=O PKNKULBDCRZSBT-UHFFFAOYSA-N 0.000 description 1
- JSGVZVOGOQILFM-UHFFFAOYSA-N 3-methoxy-1-butanol Chemical compound COC(C)CCO JSGVZVOGOQILFM-UHFFFAOYSA-N 0.000 description 1
- HZHPOJPIGFWDTD-UHFFFAOYSA-N 3-prop-2-enoyloxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCOC(=O)C=C HZHPOJPIGFWDTD-UHFFFAOYSA-N 0.000 description 1
- LDMRLRNXHLPZJN-UHFFFAOYSA-N 3-propoxypropan-1-ol Chemical compound CCCOCCCO LDMRLRNXHLPZJN-UHFFFAOYSA-N 0.000 description 1
- XDLMVUHYZWKMMD-UHFFFAOYSA-N 3-trimethoxysilylpropyl 2-methylprop-2-enoate Chemical compound CO[Si](OC)(OC)CCCOC(=O)C(C)=C XDLMVUHYZWKMMD-UHFFFAOYSA-N 0.000 description 1
- ZAAQJFLUOUQAOG-UHFFFAOYSA-N 4-benzyl-2,6-ditert-butylphenol Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CC=2C=CC=CC=2)=C1 ZAAQJFLUOUQAOG-UHFFFAOYSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- 125000006181 4-methyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])C([H])([H])* 0.000 description 1
- MQWCXKGKQLNYQG-UHFFFAOYSA-N 4-methylcyclohexan-1-ol Chemical compound CC1CCC(O)CC1 MQWCXKGKQLNYQG-UHFFFAOYSA-N 0.000 description 1
- VGVHNLRUAMRIEW-UHFFFAOYSA-N 4-methylcyclohexan-1-one Chemical compound CC1CCC(=O)CC1 VGVHNLRUAMRIEW-UHFFFAOYSA-N 0.000 description 1
- LLNJETIYJIMHAV-UHFFFAOYSA-N 5-ethoxybicyclo[2.2.1]hept-2-ene Chemical compound C1C2C(OCC)CC1C=C2 LLNJETIYJIMHAV-UHFFFAOYSA-N 0.000 description 1
- JTAJIHHUWPIHCG-UHFFFAOYSA-N 5-ethylbicyclo[2.2.1]hept-2-en-1-ol Chemical compound OC12C=CC(C(C1)CC)C2 JTAJIHHUWPIHCG-UHFFFAOYSA-N 0.000 description 1
- RCDOWRWNYHNLLA-UHFFFAOYSA-N 5-methoxybicyclo[2.2.1]hept-2-ene Chemical compound C1C2C(OC)CC1C=C2 RCDOWRWNYHNLLA-UHFFFAOYSA-N 0.000 description 1
- ZAVRBAGOQPJLCD-UHFFFAOYSA-N 5-methylbicyclo[2.2.1]hept-2-en-5-ol Chemical compound C1C2C(C)(O)CC1C=C2 ZAVRBAGOQPJLCD-UHFFFAOYSA-N 0.000 description 1
- PCBPVYHMZBWMAZ-UHFFFAOYSA-N 5-methylbicyclo[2.2.1]hept-2-ene Chemical compound C1C2C(C)CC1C=C2 PCBPVYHMZBWMAZ-UHFFFAOYSA-N 0.000 description 1
- ZTUXPCHXGIBVJU-UHFFFAOYSA-N 6-(furan-2-yl)-2-methylhex-1-en-3-one Chemical compound CC(=C)C(=O)CCCC1=CC=CO1 ZTUXPCHXGIBVJU-UHFFFAOYSA-N 0.000 description 1
- IAEDLGNYFJXAQC-UHFFFAOYSA-N 6-(furan-2-yl)-6-methylhept-1-en-3-one Chemical compound C=CC(=O)CCC(C)(C)C1=CC=CO1 IAEDLGNYFJXAQC-UHFFFAOYSA-N 0.000 description 1
- ZVVFVKJZNVSANF-UHFFFAOYSA-N 6-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]hexyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)OCCCCCCOC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 ZVVFVKJZNVSANF-UHFFFAOYSA-N 0.000 description 1
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 1
- COCLLEMEIJQBAG-UHFFFAOYSA-N 8-methylnonyl 2-methylprop-2-enoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)=C COCLLEMEIJQBAG-UHFFFAOYSA-N 0.000 description 1
- LVGFPWDANALGOY-UHFFFAOYSA-N 8-methylnonyl prop-2-enoate Chemical compound CC(C)CCCCCCCOC(=O)C=C LVGFPWDANALGOY-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- 0 CCC(C)(C)C(C)(CC(C)(C)C)[N+]([O-])O* Chemical compound CCC(C)(C)C(C)(CC(C)(C)C)[N+]([O-])O* 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- YYLLIJHXUHJATK-UHFFFAOYSA-N Cyclohexyl acetate Chemical compound CC(=O)OC1CCCCC1 YYLLIJHXUHJATK-UHFFFAOYSA-N 0.000 description 1
- IEPRKVQEAMIZSS-UHFFFAOYSA-N Di-Et ester-Fumaric acid Natural products CCOC(=O)C=CC(=O)OCC IEPRKVQEAMIZSS-UHFFFAOYSA-N 0.000 description 1
- IEPRKVQEAMIZSS-WAYWQWQTSA-N Diethyl maleate Chemical compound CCOC(=O)\C=C/C(=O)OCC IEPRKVQEAMIZSS-WAYWQWQTSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- HXQPUEQDBSPXTE-UHFFFAOYSA-N Diisobutylcarbinol Chemical compound CC(C)CC(O)CC(C)C HXQPUEQDBSPXTE-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- OKOBUGCCXMIKDM-UHFFFAOYSA-N Irganox 1098 Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)NCCCCCCNC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 OKOBUGCCXMIKDM-UHFFFAOYSA-N 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- XUCQQLCBOJJVRF-UHFFFAOYSA-N Lepalone Chemical compound CC(=C)C(=O)CCC=1C=COC=1 XUCQQLCBOJJVRF-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Nc1ccccc1 Chemical compound Nc1ccccc1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- JKRZOJADNVOXPM-UHFFFAOYSA-N Oxalic acid dibutyl ester Chemical compound CCCCOC(=O)C(=O)OCCCC JKRZOJADNVOXPM-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- YCWINENYANGRAA-UHFFFAOYSA-N [1-oxo-1-(oxolan-2-ylmethoxy)propan-2-yl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)C(=O)OCC1CCCO1 YCWINENYANGRAA-UHFFFAOYSA-N 0.000 description 1
- IGHHPVIMEQGKNE-UHFFFAOYSA-N [3-(hydroxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]methanol Chemical compound C1C2C=CC1C(CO)C2CO IGHHPVIMEQGKNE-UHFFFAOYSA-N 0.000 description 1
- HTMMMSIQFWMMIJ-UHFFFAOYSA-N [3-[2,2-dimethyl-3-(6-prop-2-enoyloxyhexanoyloxy)propanoyl]oxy-2,2-dimethylpropyl] 6-prop-2-enoyloxyhexanoate Chemical compound C=CC(=O)OCCCCCC(=O)OCC(C)(C)COC(=O)C(C)(C)COC(=O)CCCCCOC(=O)C=C HTMMMSIQFWMMIJ-UHFFFAOYSA-N 0.000 description 1
- NOZAQBYNLKNDRT-UHFFFAOYSA-N [diacetyloxy(ethenyl)silyl] acetate Chemical compound CC(=O)O[Si](OC(C)=O)(OC(C)=O)C=C NOZAQBYNLKNDRT-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 125000005571 adamantylene group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N alpha-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940107816 ammonium iodide Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 150000008378 aryl ethers Chemical class 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- GCTPMLUUWLLESL-UHFFFAOYSA-N benzyl prop-2-enoate Chemical compound C=CC(=O)OCC1=CC=CC=C1 GCTPMLUUWLLESL-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- TZLWRLOYRRZECT-UHFFFAOYSA-N bicyclo[2.2.1]hept-5-ene-2,3-diol Chemical compound C1C2C(O)C(O)C1C=C2 TZLWRLOYRRZECT-UHFFFAOYSA-N 0.000 description 1
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- HJZGNWSIJASHMX-UHFFFAOYSA-N butyl acetate;ethane-1,2-diol Chemical compound OCCO.CCCCOC(C)=O HJZGNWSIJASHMX-UHFFFAOYSA-N 0.000 description 1
- HPQSTQJMBMYCLI-UHFFFAOYSA-N butyl acetate;propane-1,2-diol Chemical compound CC(O)CO.CCCCOC(C)=O HPQSTQJMBMYCLI-UHFFFAOYSA-N 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- BTMVHUNTONAYDX-UHFFFAOYSA-N butyl propionate Chemical compound CCCCOC(=O)CC BTMVHUNTONAYDX-UHFFFAOYSA-N 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N c(cc1)cc2c1cccc2 Chemical compound c(cc1)cc2c1cccc2 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 125000002993 cycloalkylene group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004976 cyclobutylene group Chemical group 0.000 description 1
- CGZZMOTZOONQIA-UHFFFAOYSA-N cycloheptanone Chemical compound O=C1CCCCCC1 CGZZMOTZOONQIA-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- OIWOHHBRDFKZNC-UHFFFAOYSA-N cyclohexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1CCCCC1 OIWOHHBRDFKZNC-UHFFFAOYSA-N 0.000 description 1
- MSPIWBYBMMBCEX-UHFFFAOYSA-N cyclohexyl bicyclo[2.2.1]hept-2-ene-5-carboxylate Chemical compound C1C(C=C2)CC2C1C(=O)OC1CCCCC1 MSPIWBYBMMBCEX-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- 125000004956 cyclohexylene group Chemical group 0.000 description 1
- IIRFCWANHMSDCG-UHFFFAOYSA-N cyclooctanone Chemical compound O=C1CCCCCCC1 IIRFCWANHMSDCG-UHFFFAOYSA-N 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004978 cyclooctylene group Chemical group 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004979 cyclopentylene group Chemical group 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- ATCZONOLUJITKL-UHFFFAOYSA-N dicyclohexyl bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate Chemical compound C1=CC2CC1C(C(=O)OC1CCCCC1)C2C(=O)OC1CCCCC1 ATCZONOLUJITKL-UHFFFAOYSA-N 0.000 description 1
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- 229940028356 diethylene glycol monobutyl ether Drugs 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 1
- 239000012972 dimethylethanolamine Substances 0.000 description 1
- 229960001826 dimethylphthalate Drugs 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- FYPWTNDNZOOPAO-UHFFFAOYSA-N ditert-butyl bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylate Chemical compound C1C2C=CC1C(C(=O)OC(C)(C)C)C2C(=O)OC(C)(C)C FYPWTNDNZOOPAO-UHFFFAOYSA-N 0.000 description 1
- WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- GLONGQUNMYDUKZ-UHFFFAOYSA-N ethane-1,2-diol;propyl acetate Chemical compound OCCO.CCCOC(C)=O GLONGQUNMYDUKZ-UHFFFAOYSA-N 0.000 description 1
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- LJUJMKJGPIXNAK-UHFFFAOYSA-N ethyl 4-[2-(2-chlorophenyl)-1-[2-(2-chlorophenyl)-4,5-bis(4-ethoxycarbonylphenyl)imidazol-2-yl]-5-(4-ethoxycarbonylphenyl)imidazol-4-yl]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1C1=NC(N2C(=C(N=C2C=2C(=CC=CC=2)Cl)C=2C=CC(=CC=2)C(=O)OCC)C=2C=CC(=CC=2)C(=O)OCC)(C=2C(=CC=CC=2)Cl)N=C1C1=CC=C(C(=O)OCC)C=C1 LJUJMKJGPIXNAK-UHFFFAOYSA-N 0.000 description 1
- FKIRSCKRJJUCNI-UHFFFAOYSA-N ethyl 7-bromo-1h-indole-2-carboxylate Chemical compound C1=CC(Br)=C2NC(C(=O)OCC)=CC2=C1 FKIRSCKRJJUCNI-UHFFFAOYSA-N 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- XVEOUOTUJBYHNL-UHFFFAOYSA-N heptane-2,4-diol Chemical compound CCCC(O)CC(C)O XVEOUOTUJBYHNL-UHFFFAOYSA-N 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- QNVRIHYSUZMSGM-UHFFFAOYSA-N hexan-2-ol Chemical compound CCCCC(C)O QNVRIHYSUZMSGM-UHFFFAOYSA-N 0.000 description 1
- RXTNIJMLAQNTEG-UHFFFAOYSA-N hexan-2-yl acetate Chemical compound CCCCC(C)OC(C)=O RXTNIJMLAQNTEG-UHFFFAOYSA-N 0.000 description 1
- OHMBHFSEKCCCBW-UHFFFAOYSA-N hexane-2,5-diol Chemical compound CC(O)CCC(C)O OHMBHFSEKCCCBW-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- QWTDNUCVQCZILF-UHFFFAOYSA-N iso-pentane Natural products CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
- KXUHSQYYJYAXGZ-UHFFFAOYSA-N isobutylbenzene Chemical compound CC(C)CC1=CC=CC=C1 KXUHSQYYJYAXGZ-UHFFFAOYSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- IMXBRVLCKXGWSS-UHFFFAOYSA-N methyl 2-cyclohexylacetate Chemical compound COC(=O)CC1CCCCC1 IMXBRVLCKXGWSS-UHFFFAOYSA-N 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- GYNNXHKOJHMOHS-UHFFFAOYSA-N methyl-cycloheptane Natural products CC1CCCCCC1 GYNNXHKOJHMOHS-UHFFFAOYSA-N 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- QYZFTMMPKCOTAN-UHFFFAOYSA-N n-[2-(2-hydroxyethylamino)ethyl]-2-[[1-[2-(2-hydroxyethylamino)ethylamino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCNCCO QYZFTMMPKCOTAN-UHFFFAOYSA-N 0.000 description 1
- 229940017144 n-butyl lactate Drugs 0.000 description 1
- QJQAMHYHNCADNR-UHFFFAOYSA-N n-methylpropanamide Chemical compound CCC(=O)NC QJQAMHYHNCADNR-UHFFFAOYSA-N 0.000 description 1
- 125000003506 n-propoxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- WSGCRAOTEDLMFQ-UHFFFAOYSA-N nonan-5-one Chemical compound CCCCC(=O)CCCC WSGCRAOTEDLMFQ-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 125000003518 norbornenyl group Chemical group C12(C=CC(CC1)C2)* 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- ZWWQICJTBOCQLA-UHFFFAOYSA-N o-propan-2-yl (propan-2-yloxycarbothioyldisulfanyl)methanethioate Chemical compound CC(C)OC(=S)SSC(=S)OC(C)C ZWWQICJTBOCQLA-UHFFFAOYSA-N 0.000 description 1
- SSDSCDGVMJFTEQ-UHFFFAOYSA-N octadecyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 SSDSCDGVMJFTEQ-UHFFFAOYSA-N 0.000 description 1
- SJWFXCIHNDVPSH-UHFFFAOYSA-N octan-2-ol Chemical compound CCCCCCC(C)O SJWFXCIHNDVPSH-UHFFFAOYSA-N 0.000 description 1
- KZCOBXFFBQJQHH-UHFFFAOYSA-N octane-1-thiol Chemical compound CCCCCCCCS KZCOBXFFBQJQHH-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- ZDHCZVWCTKTBRY-UHFFFAOYSA-N omega-Hydroxydodecanoic acid Natural products OCCCCCCCCCCCC(O)=O ZDHCZVWCTKTBRY-UHFFFAOYSA-N 0.000 description 1
- 125000005375 organosiloxane group Chemical group 0.000 description 1
- FOKLVOHHYNATHU-UHFFFAOYSA-N oxan-2-ylmethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1CCCCO1 FOKLVOHHYNATHU-UHFFFAOYSA-N 0.000 description 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 description 1
- JCGNDDUYTRNOFT-UHFFFAOYSA-N oxolane-2,4-dione Chemical compound O=C1COC(=O)C1 JCGNDDUYTRNOFT-UHFFFAOYSA-N 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- JYVLIDXNZAXMDK-UHFFFAOYSA-N pentan-2-ol Chemical compound CCCC(C)O JYVLIDXNZAXMDK-UHFFFAOYSA-N 0.000 description 1
- GTCCGKPBSJZVRZ-UHFFFAOYSA-N pentane-2,4-diol Chemical compound CC(O)CC(C)O GTCCGKPBSJZVRZ-UHFFFAOYSA-N 0.000 description 1
- GXOHBWLPQHTYPF-UHFFFAOYSA-N pentyl 2-hydroxypropanoate Chemical compound CCCCCOC(=O)C(C)O GXOHBWLPQHTYPF-UHFFFAOYSA-N 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 125000005003 perfluorobutyl group Chemical group FC(F)(F)C(F)(F)C(F)(F)C(F)(F)* 0.000 description 1
- 125000005004 perfluoroethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 125000005009 perfluoropropyl group Chemical group FC(C(C(F)(F)F)(F)F)(F)* 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- QIWKUEJZZCOPFV-UHFFFAOYSA-N phenyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1=CC=CC=C1 QIWKUEJZZCOPFV-UHFFFAOYSA-N 0.000 description 1
- WLVPQQDEYVVXJF-UHFFFAOYSA-N phenyl bicyclo[2.2.1]hept-2-ene-5-carboxylate Chemical compound C1C(C=C2)CC2C1C(=O)OC1=CC=CC=C1 WLVPQQDEYVVXJF-UHFFFAOYSA-N 0.000 description 1
- WRAQQYDMVSCOTE-UHFFFAOYSA-N phenyl prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1 WRAQQYDMVSCOTE-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229940051841 polyoxyethylene ether Drugs 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- FZYCEURIEDTWNS-UHFFFAOYSA-N prop-1-en-2-ylbenzene Chemical compound CC(=C)C1=CC=CC=C1.CC(=C)C1=CC=CC=C1 FZYCEURIEDTWNS-UHFFFAOYSA-N 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- CVCYODHOXFGRCE-UHFFFAOYSA-N propane-1,2-diol;propyl acetate Chemical compound CC(O)CO.CCCOC(C)=O CVCYODHOXFGRCE-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000000637 radiosensitizating effect Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000007261 regionalization Effects 0.000 description 1
- 230000006335 response to radiation Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000565 sulfonamide group Chemical group 0.000 description 1
- 230000005469 synchrotron radiation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- MUTNCGKQJGXKEM-UHFFFAOYSA-N tamibarotene Chemical compound C=1C=C2C(C)(C)CCC(C)(C)C2=CC=1NC(=O)C1=CC=C(C(O)=O)C=C1 MUTNCGKQJGXKEM-UHFFFAOYSA-N 0.000 description 1
- BZBMBZJUNPMEBD-UHFFFAOYSA-N tert-butyl bicyclo[2.2.1]hept-2-ene-5-carboxylate Chemical compound C1C2C(C(=O)OC(C)(C)C)CC1C=C2 BZBMBZJUNPMEBD-UHFFFAOYSA-N 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BRGJIIMZXMWMCC-UHFFFAOYSA-N tetradecan-2-ol Chemical compound CCCCCCCCCCCCC(C)O BRGJIIMZXMWMCC-UHFFFAOYSA-N 0.000 description 1
- 229940073455 tetraethylammonium hydroxide Drugs 0.000 description 1
- LRGJRHZIDJQFCL-UHFFFAOYSA-M tetraethylazanium;hydroxide Chemical compound [OH-].CC[N+](CC)(CC)CC LRGJRHZIDJQFCL-UHFFFAOYSA-M 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000007736 thin film deposition technique Methods 0.000 description 1
- 150000003568 thioethers Chemical group 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- KEROTHRUZYBWCY-UHFFFAOYSA-N tridecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCOC(=O)C(C)=C KEROTHRUZYBWCY-UHFFFAOYSA-N 0.000 description 1
- XOALFFJGWSCQEO-UHFFFAOYSA-N tridecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCOC(=O)C=C XOALFFJGWSCQEO-UHFFFAOYSA-N 0.000 description 1
- FRGPKMWIYVTFIQ-UHFFFAOYSA-N triethoxy(3-isocyanatopropyl)silane Chemical compound CCO[Si](OCC)(OCC)CCCN=C=O FRGPKMWIYVTFIQ-UHFFFAOYSA-N 0.000 description 1
- HQYALQRYBUJWDH-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical compound CCC[Si](OC)(OC)OC HQYALQRYBUJWDH-UHFFFAOYSA-N 0.000 description 1
- DQZNLOXENNXVAD-UHFFFAOYSA-N trimethoxy-[2-(7-oxabicyclo[4.1.0]heptan-4-yl)ethyl]silane Chemical compound C1C(CC[Si](OC)(OC)OC)CCC2OC21 DQZNLOXENNXVAD-UHFFFAOYSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- XMUJIPOFTAHSOK-UHFFFAOYSA-N undecan-2-ol Chemical compound CCCCCCCCCC(C)O XMUJIPOFTAHSOK-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229940042596 viscoat Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2/00—Processes of polymerisation
- C08F2/46—Polymerisation initiated by wave energy or particle radiation
- C08F2/48—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
- C08F2/50—Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/10—Esters; Ether-esters
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
- G03F7/027—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
- G03F7/027—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
- G03F7/028—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with photosensitivity-increasing substances, e.g. photoinitiators
- G03F7/031—Organic compounds not covered by group G03F7/029
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/004—Photosensitive materials
- G03F7/027—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
- G03F7/032—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with binders
- G03F7/033—Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with binders the binders being polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. vinyl polymers
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
- H01L21/027—Making masks on semiconductor bodies for further photolithographic processing not provided for in group H01L21/18 or H01L21/34
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
- H01L21/70—Manufacture or treatment of devices consisting of a plurality of solid state components formed in or on a common substrate or of parts thereof; Manufacture of integrated circuit devices or of parts thereof
- H01L21/71—Manufacture of specific parts of devices defined in group H01L21/70
- H01L21/768—Applying interconnections to be used for carrying current between separate components within a device comprising conductors and dielectrics
Landscapes
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Power Engineering (AREA)
- Computer Hardware Design (AREA)
- Manufacturing & Machinery (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Exposure And Positioning Against Photoresist Photosensitive Materials (AREA)
- Materials For Photolithography (AREA)
Description
本発明は、硬化膜形成用樹脂材料、硬化膜の形成方法、硬化膜、半導体素子及び表示素子に関する。 The present invention relates to a resin material for forming a cured film, a method for forming a cured film, a cured film, a semiconductor element, and a display element.
近年、電子ペーパー等のフレキシブルディスプレイが注目され、フレキシブルディスプレイの基板として、ポリエチレンテレフタレート等を用いたプラスチック製の基板が検討されている。この基板は加熱時に伸張又は収縮を起こすため、製造プロセスの低温化が検討されている。中でも、製造プロセス上最も高温となる層間絶縁膜等の硬化膜の形成工程における焼成温度の低温化が求められている。 In recent years, flexible displays such as electronic paper have attracted attention, and as a substrate for flexible displays, a plastic substrate using polyethylene terephthalate or the like has been studied. Since this substrate expands or contracts when heated, lowering the temperature of the manufacturing process is being studied. Above all, it is required to lower the firing temperature in the step of forming a cured film such as an interlayer insulating film, which has the highest temperature in the manufacturing process.
このような焼成温度の低温化が可能な硬化膜の材料として、パターン形成時の工程数が少なく、かつ高い表面硬度が得られる感放射線性樹脂組成物が用いられ、例えばカルボキシ基及びエポキシ基を含む共重合体を含有する感放射線性樹脂組成物が知られている(特開2001−354822号公報参照)。このような感放射線性樹脂組成物においては、カルボキシ基とエポキシ基とが反応することで硬化膜としての表面硬度が得られるように構成されている。しかしながら、上述の共重合体を含有する感放射線性樹脂組成物にあっては、感放射線性樹脂組成物の保存の際にもカルボキシ基とエポキシ基が反応してしまい増粘するという、保存安定性の低下を引き起こすおそれがある。 As a material for a cured film capable of lowering the firing temperature, a radiation-sensitive resin composition capable of obtaining a high surface hardness with a small number of steps during pattern formation is used, and for example, a carboxy group and an epoxy group can be used. A radiation-sensitive resin composition containing a copolymer containing the same is known (see JP-A-2001-354822). In such a radiation-sensitive resin composition, the surface hardness as a cured film is obtained by reacting the carboxy group and the epoxy group. However, in the radiation-sensitive resin composition containing the above-mentioned copolymer, the carboxy group and the epoxy group react with each other during storage of the radiation-sensitive resin composition to increase the viscosity. May cause deterioration of sex.
そこで、優れた表面硬度を有すると共に耐薬品性、耐熱性、透明性(光の透過率が高いこと)及び低誘電性(比誘電率が低いこと)等の一般的特性を十分満足可能な硬化膜を形成でき、かつ保存安定性に優れる硬化膜形成用樹脂組成物が求められている。このような材料としては、フッ素化アルキルアルコール構造と架橋性基とを含む共重合体を含有する硬化膜形成用組成物が知られている(特開2014−152192号公報参照)。このような硬化膜形成用組成物においては、上記フッ素化アルキルアルコール構造とエポキシ基のような架橋性基とが反応することで硬化するように構成されている。しかしながら、この硬化膜形成用組成物にあっては、上記フッ素化アルキルアルコール構造とエポキシ基との反応性が、カルボキシ基とエポキシ基との反応性に比べてやや劣るため、得られる硬化膜の耐熱性や耐薬品性の低下を引き起こすおそれがある。 Therefore, curing that has excellent surface hardness and can sufficiently satisfy general properties such as chemical resistance, heat resistance, transparency (high light transmittance) and low dielectric constant (low relative permittivity). There is a demand for a resin composition for forming a cured film that can form a film and has excellent storage stability. As such a material, a composition for forming a cured film containing a copolymer containing a fluorinated alkyl alcohol structure and a crosslinkable group is known (see JP-A-2014-152192). Such a cured film-forming composition is configured to be cured by reacting the fluorinated alkyl alcohol structure with a crosslinkable group such as an epoxy group. However, in this cured film-forming composition, the reactivity of the fluorinated alkyl alcohol structure with the epoxy group is slightly inferior to that of the carboxy group and the epoxy group, so that the cured film can be obtained. It may cause deterioration of heat resistance and chemical resistance.
本発明は、以上のような事情に基づいてなされたものであり、その目的は、優れた表面硬度を有すると共に耐薬品性、耐熱性、透明性及び低誘電性等の一般的特性を十分満足可能な硬化膜を形成でき、かつ保存安定性に優れる硬化膜形成用樹脂材料、並びにこれを用いた硬化膜の形成方法、硬化膜、半導体素子及び表示素子を提供することである。 The present invention has been made based on the above circumstances, and an object of the present invention is to have excellent surface hardness and sufficiently satisfy general properties such as chemical resistance, heat resistance, transparency and low dielectric property. It is an object of the present invention to provide a resin material for forming a cured film which can form a possible cured film and has excellent storage stability, a method for forming a cured film using the resin material, a cured film, a semiconductor element and a display element.
上記課題を解決するためになされた発明は、酸性基を有する構造単位(以下、「構造単位(I)ともいう。))、並びに下記式(1−1)で表される基及び下記式(1−2)で表される基から選ばれる少なくとも1種の基を有する構造単位(以下、「構造単位(II)ともいう。)を含む重合体(以下、「[A]重合体」ともいう。)を含有する硬化膜形成用樹脂材料である。
上記式(1−2)中、R1、R2及びR3は、上記式(1−1)と同義である。A2は、ハロゲン原子、ヒドロキシ基、炭素数1〜6のアルコキシ基又は炭素数1〜6のアルキル基である。A2が複数の場合、複数のA2はそれぞれ独立して上記定義を満たす。n2は、0〜6の整数である。*は結合位を示す。)
The invention made to solve the above problems includes a structural unit having an acidic group (hereinafter, also referred to as “structural unit (I))), a group represented by the following formula (1-1), and the following formula (hereinafter, also referred to as “structural unit (I))). A polymer containing a structural unit having at least one group selected from the groups represented by 1-2) (hereinafter, also referred to as “structural unit (II))” (hereinafter, also referred to as “[A] polymer”). ) Is a resin material for forming a cured film.
In the above formula (1-2), R 1 , R 2 and R 3 are synonymous with the above formula (1-1). A 2 is a halogen atom, a hydroxy group, an alkoxy group having 1 to 6 carbon atoms, or an alkyl group having 1 to 6 carbon atoms. If A 2 is plural, each independently plurality of A 2 satisfy the above definition. n2 is an integer from 0 to 6. * Indicates the binding site. )
上記課題を解決するためになされた別の発明は、上記硬化膜形成用樹脂材料を用い、基板上に塗膜を形成する工程、及び上記塗膜を加熱する工程を備える硬化膜の形成方法である。 Another invention made to solve the above problems is a method for forming a cured film, which comprises a step of forming a coating film on a substrate using the resin material for forming a cured film and a step of heating the coating film. is there.
上記課題を解決するためになされたさらに別の発明は、上記硬化膜形成用樹脂材料を用い、基板上に塗膜を形成する工程、上記塗膜の一部に放射線を照射する工程、上記放射線が照射された塗膜を現像する工程、及び上記現像された塗膜を加熱する工程を備える硬化膜の形成方法である。 Yet another invention made to solve the above problems is a step of forming a coating film on a substrate using the resin material for forming a cured film, a step of irradiating a part of the coating film with radiation, and the radiation. This is a method for forming a cured film, which comprises a step of developing a coating film irradiated with and a step of heating the developed coating film.
上記課題を解決するためになされたさらに別の発明は、上記硬化膜形成用樹脂材料から形成された硬化膜である。 Yet another invention made to solve the above problems is a cured film formed from the cured film forming resin material.
上記課題を解決するためになされたさらに別の発明は、上記硬化膜を備える半導体素子である。 Yet another invention made to solve the above problems is a semiconductor device provided with the above-mentioned cured film.
上記課題を解決するためになされたさらに別の発明は、上記半導体素子を備える表示素子である。 Yet another invention made to solve the above problems is a display element including the above semiconductor element.
本発明は、優れた表面硬度を有すると共に耐薬品性、耐熱性、透明性及び低誘電性等の一般的特性を十分満足可能な硬化膜を形成でき、かつ保存安定性に優れる硬化膜形成用樹脂材料、並びにこれを用いた硬化膜の形成方法、硬化膜、半導体素子及び表示素子を提供することができる。従って、本発明は、フレキシブルディスプレイなどの電子デバイス等の製造プロセスに好適に使用することができる。 The present invention is for forming a cured film having excellent surface hardness, capable of forming a cured film that can sufficiently satisfy general properties such as chemical resistance, heat resistance, transparency, and low dielectric property, and having excellent storage stability. It is possible to provide a resin material, a method for forming a cured film using the resin material, a cured film, a semiconductor element, and a display element. Therefore, the present invention can be suitably used in a manufacturing process of an electronic device such as a flexible display.
本発明の一実施形態に係る硬化膜形成用樹脂材料は、[A]重合体を含有する。[A]重合体は、後述するように、加熱による架橋により硬化する。このため、当該硬化膜形成用樹脂材料は、熱硬化性の硬化膜形成用樹脂材料(以下、「硬化膜形成用樹脂材料(1)ともいう」として用いることができる。この硬化膜形成用樹脂材料(1)は、通常、感放射線性を有さない。一方、当該硬化膜形成樹脂材料は、例えばエチレン性不飽和結合を有する重合性化合物(以下、「[B]重合性化合物」ともいう。)及び感放射線性重合開始剤(以下、「[C]感放射線性重合開始剤」ともいう。)をさらに含有する場合、感放射線性を有する硬化膜形成用樹脂材料(以下、「硬化膜形成用樹脂材料(2)」として用いることもできる。以下、硬化膜形成用樹脂材料(1)及び硬化膜形成用樹脂材料(2)のそれぞれについて説明する。 The resin material for forming a cured film according to an embodiment of the present invention contains the [A] polymer. The polymer [A] is cured by cross-linking by heating, as will be described later. Therefore, the cured film-forming resin material can be used as a thermosetting resin material for forming a cured film (hereinafter, also referred to as "resin material for forming a cured film (1)"). The material (1) usually does not have radiosensitivity. On the other hand, the cured film-forming resin material is also referred to as, for example, a polymerizable compound having an ethylenically unsaturated bond (hereinafter, also referred to as “[B] polymerizable compound”. ) And a radiation-sensitive polymerization initiator (hereinafter, also referred to as “[C] radiation-sensitive polymerization initiator”), a resin material for forming a cured film having radiation-sensitive properties (hereinafter, “cured film”). It can also be used as a "forming resin material (2)". Hereinafter, each of the cured film forming resin material (1) and the cured film forming resin material (2) will be described.
<硬化膜形成用樹脂材料(1)>
当該硬化膜形成用樹脂材料(1)は、[A]重合体を含有する。また、当該硬化膜形成用樹脂材料(1)は、[D]酸化防止剤を含有することが好ましく、さらに、本発明の効果を損なわない範囲でその他の成分を含有していてもよい。
<Resin material for forming a cured film (1)>
The cured film-forming resin material (1) contains the [A] polymer. Further, the resin material (1) for forming a cured film preferably contains [D] an antioxidant, and may further contain other components as long as the effects of the present invention are not impaired.
<[A]重合体>
[A]重合体は、酸性基を有する構造単位(I)、並びに下記式(1−1)で表される基及び下記式(1−2)で表される基から選ばれる少なくとも1種の基を有する構造単位(II)を含む。[A]重合体は、構造単位(I)及び構造単位(II)以外の構造単位をさらに含んでいてもよい。なお、[A]重合体としては、構造単位(I)と構造単位(II)とを有する共重合体であってもよいし、構造単位(I)を有する重合体と構造単位(II)を有する重合体の混合物であってもよい。[A]重合体において、構造単位(I)と構造単位(II)とは、加熱により、例えば以下の反応により架橋し、硬化すると考えられる。
<[A] Polymer>
The polymer [A] is at least one selected from the structural unit (I) having an acidic group, the group represented by the following formula (1-1) and the group represented by the following formula (1-2). Includes a structural unit (II) having a group. [A] The polymer may further contain structural units other than the structural unit (I) and the structural unit (II). The polymer [A] may be a copolymer having a structural unit (I) and a structural unit (II), or a polymer having a structural unit (I) and a structural unit (II). It may be a mixture of polymers having. In the polymer [A], the structural unit (I) and the structural unit (II) are considered to be crosslinked and cured by heating, for example, by the following reaction.
当該硬化膜形成用樹脂材料(1)によれば、優れた表面硬度を有すると共に耐薬品性、耐熱性、透明性及び低誘電性等の一般的特性を十分満足可能な硬化膜を形成することができる。特に、構造単位(II)によりシロキサン構造が導入されることにより、得られる硬化膜の耐熱性や透明性等を優れたものとすることができる。また、上記反応が常温では進行し難くい結果、当該硬化膜形成用樹脂材料(1)は、優れた保存安定性を有する。 According to the cured film-forming resin material (1), a cured film having excellent surface hardness and sufficiently satisfying general properties such as chemical resistance, heat resistance, transparency and low dielectric property is to be formed. Can be done. In particular, by introducing the siloxane structure by the structural unit (II), the heat resistance and transparency of the obtained cured film can be made excellent. Further, as a result of the above reaction being difficult to proceed at room temperature, the cured film-forming resin material (1) has excellent storage stability.
[構造単位(I)]
構造単位(I)は、酸性基を有する構造単位である。構造単位(I)は、複数種の構造単位から構成されていてもよい。
[Structural unit (I)]
The structural unit (I) is a structural unit having an acidic group. The structural unit (I) may be composed of a plurality of types of structural units.
上記酸性基としては、カルボキシ基、スルホ基、フェノール性水酸基、リン酸基、ホスホン酸基、ホスフィン酸基、スルホンアミド基、炭素原子に結合した水素原子が電子求引基に置換されたヒドロキシアルキル基等を挙げることができる。上記電子求引基としては、フッ素、塩素等のハロゲン原子、ニトロ基、シアノ基等が挙げられる。上記酸性基としては、カルボキシ基、スルホ基、フェノール性水酸基、フッ素含有アルコール性水酸基(ヒドロキシフッ素化アルキル基)、リン酸基、ホスホン酸基、ホスフィン酸基及びこれらの組み合わせが好ましく、フッ素含有アルコール性水酸基がより好ましい。このような酸性基により、本発明の効果をより効果的に発揮させることができる。 Examples of the acidic group include a carboxy group, a sulfo group, a phenolic hydroxyl group, a phosphoric acid group, a phosphonic acid group, a phosphinic acid group, a sulfonamide group, and a hydroxyalkyl in which a hydrogen atom bonded to a carbon atom is substituted with an electron-withdrawing group. The groups can be mentioned. Examples of the electron attracting group include halogen atoms such as fluorine and chlorine, nitro groups and cyano groups. As the acidic group, a carboxy group, a sulfo group, a phenolic hydroxyl group, a fluorine-containing alcoholic hydroxyl group (hydroxyfluorinated alkyl group), a phosphoric acid group, a phosphonic acid group, a phosphinic acid group and a combination thereof are preferable, and a fluorine-containing alcohol is preferable. The sex hydroxyl group is more preferable. With such an acidic group, the effect of the present invention can be exerted more effectively.
上記フッ素含有アルコール性水酸基としては、下記式(2)で表される基が好ましい。下記式(2)で表される基は、構造単位(II)の式(1−1)又は(1−2)で表される基とのより良好な架橋反応性等を発揮することなどができる。 As the fluorine-containing alcoholic hydroxyl group, a group represented by the following formula (2) is preferable. The group represented by the following formula (2) may exhibit better cross-linking reactivity with the group represented by the formula (1-1) or (1-2) of the structural unit (II). it can.
上記式(2)中、R4は、フッ素原子又は炭素数1〜4のフッ素化アルキル基である。R5は、水素原子、フッ素原子、炭素数1〜4のアルキル基又は炭素数1〜4のフッ素化アルキル基である。 In the above formula (2), R 4 is a fluorine atom or a fluorinated alkyl group having 1 to 4 carbon atoms. R 5 is a hydrogen atom, a fluorine atom, an alkyl group having 1 to 4 carbon atoms or a fluorinated alkyl group having 1 to 4 carbon atoms.
上記R4で表される炭素数1〜4のフッ素化アルキル基としては、ジフルオロメチル基、トリフルオロメチル基、2,2−ジフルオロエチル基、2,2,2−トリフルオロエチル基、パーフルオロエチル基、2,2,3,3−テトラフルオロプロピル基、パーフルオロエチルメチル基、パーフルオロプロピル基、2,2,3,3,4,4−ヘキサフルオロブチル基、パーフルオロブチル基等を挙げることができる。 Examples of the fluorinated alkyl group of 1 to 4 carbon atoms represented by R 4, difluoromethyl group, trifluoromethyl group, 2,2-difluoroethyl group, 2,2,2-trifluoroethyl group, perfluoro Ethyl group, 2,2,3,3-tetrafluoropropyl group, perfluoroethylmethyl group, perfluoropropyl group, 2,2,3,3,4,4-hexafluorobutyl group, perfluorobutyl group, etc. Can be mentioned.
上記R4としては、フッ素化アルキル基が好ましく、パーフルオロアルキル基がより好ましく、トリフルオロメチル基(パーフルオロメチル基)がさらに好ましい。 As the R 4, preferably a fluorinated alkyl group, more preferably a perfluoroalkyl group, a trifluoromethyl group (perfluoromethyl group) is more preferred.
上記R5で表される炭素数1〜4のアルキル基としては、メチル基、エチル基、n−プロピル基、i−プロピル基、n−ブチル基、i−ブチル基、sec−ブチル基、t−ブチル基等を挙げることができる。上記R5で表される炭素数1〜4のフッ素化アルキル基としては、R4の説明において例示したものを挙げることができる。 The alkyl group having 1 to 4 carbon atoms represented by R 5, a methyl group, an ethyl group, n- propyl group, i- propyl, n- butyl group, i- butyl group, sec- butyl group, t -Butyl group and the like can be mentioned. Examples of the fluorinated alkyl group having 1 to 4 carbon atoms represented by R 5 include those exemplified in the description of R 4 .
上記R5としては、水素原子、フッ素原子及びフッ素化アルキル基が好ましく、水素原子及びフッ素化アルキル基がより好ましく、パーフルオロアルキル基がさらに好ましく、トリフルオロメチル基が特に好ましい。 The above-mentioned R 5, a hydrogen atom, a fluorine atom and a fluorinated alkyl group, more preferably a hydrogen atom or a fluorinated alkyl group, more preferably a perfluoroalkyl group, a trifluoromethyl group is particularly preferred.
さらに、上記R4及びR5が共にフッ素化アルキル基であることが好ましく、共にパーフルオロアルキル基であることがより好ましく、共にトリフルオロメチル基であることがさらに好ましい。上記R4及びR5がこのような基である場合、好適な酸性基となるため良好な架橋反応が生じ、耐薬品性等の得られる硬化膜の諸特性をさらに高めることができる。 Further, it is preferable that both R 4 and R 5 are fluorinated alkyl groups, more preferably both are perfluoroalkyl groups, and further preferably both are trifluoromethyl groups. When the above R 4 and R 5 are such groups, they become suitable acidic groups, so that a good cross-linking reaction occurs, and various properties of the obtained cured film such as chemical resistance can be further enhanced.
構造単位(I)としては、下記式(3−1)で表される構造単位、下記式(3−2)で表される構造単位、下記式(4)で表される構造単位、(メタ)アクリル酸に由来する構造単位等を挙げることができる。 The structural unit (I) includes a structural unit represented by the following formula (3-1), a structural unit represented by the following formula (3-2), a structural unit represented by the following formula (4), and (meta). ) Structural units derived from acrylic acid can be mentioned.
上記式(3−1)及び(3−2)中、R4及びR5は、上記式(2)中のR4及びR5と同義である。R6及びR7は、それぞれ独立して、(n+1)価の有機基である。但し、R7においては、主鎖側末端がエステル構造(−COO−)であるものを除く。Rは、それぞれ独立して、水素原子、メチル基、ヒドロキシメチル基、シアノ基又はトリフルオロメチル基である。nは、それぞれ独立して、1〜5の整数である。nが2以上の場合、複数のR4及びR5は、それぞれ同一でも異なっていてもよい。 In the above formula (3-1) and (3-2), R 4 and R 5 have the same meanings as R 4 and R 5 in the formula (2). R 6 and R 7 are independently (n + 1) -valent organic groups. However, in R 7 , those having an ester structure (-COO-) at the end on the main chain side are excluded. R is independently a hydrogen atom, a methyl group, a hydroxymethyl group, a cyano group or a trifluoromethyl group. n is an integer of 1 to 5 independently of each other. When n is 2 or more, the plurality of R 4 and R 5 may be the same or different from each other.
上記R6及びR7で表される(n+1)価の有機基としては、例えば炭化水素基として、炭素数1〜20の(n+1)価の鎖状炭化水素基、炭素数3〜20の(n+1)価の脂環式炭化水素基、炭素数6〜20の(n+1)価の芳香族炭化水素基、又はこれらの基のうちの2種以上を組み合わせた(n+1)価の基等が挙げられる。但し、これらの基が有する水素原子の一部又は全部は置換されていてもよい。 Examples of the (n + 1) -valent organic group represented by R 6 and R 7 include, for example, a hydrocarbon group having a (n + 1) -valent chain hydrocarbon group having 1 to 20 carbon atoms and a (n + 1) -valent chain hydrocarbon group having 3 to 20 carbon atoms. Examples include n + 1) -valent alicyclic hydrocarbon groups, (n + 1) -valent aromatic hydrocarbon groups having 6 to 20 carbon atoms, or (n + 1) -valent groups in which two or more of these groups are combined. Be done. However, some or all of the hydrogen atoms contained in these groups may be substituted.
上記炭素数1〜20の(n+1)価の鎖状炭化水素基としては、炭素数1〜20の直鎖状又は分岐状のアルキル基から水素原子をn個除いた基等が挙げられる。上記炭素数1〜20の直鎖状又は分岐状のアルキル基としては、例えばメチル基、エチル基、n−プロピル基、i−プロピル基、n−ブチル基、2−メチルプロピル基、1−メチルプロピル基、t−ブチル基等が挙げられる。 Examples of the (n + 1) -valent chain hydrocarbon group having 1 to 20 carbon atoms include a linear or branched alkyl group having 1 to 20 carbon atoms from which n hydrogen atoms have been removed. Examples of the linear or branched alkyl group having 1 to 20 carbon atoms include a methyl group, an ethyl group, an n-propyl group, an i-propyl group, an n-butyl group, a 2-methylpropyl group and a 1-methyl group. Examples thereof include a propyl group and a t-butyl group.
上記炭素数3〜20の(n+1)価の脂環式炭化水素基としては、炭素数3〜20の1価の脂環式炭化水素基から水素原子をn個除いた基等が挙げられる。上記炭素数3〜20の1価の脂環式炭化水素基としては、例えばシクロプロピル基、シクロブチル基、シクロペンチル基、シクロヘキシル基、シクロオクチル基、ノルボルニル基、アダマンチル基等が挙げられる。 Examples of the (n + 1) -valent alicyclic hydrocarbon group having 3 to 20 carbon atoms include a group obtained by removing n hydrogen atoms from a monovalent alicyclic hydrocarbon group having 3 to 20 carbon atoms. Examples of the monovalent alicyclic hydrocarbon group having 3 to 20 carbon atoms include a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a cyclohexyl group, a cyclooctyl group, a norbornyl group and an adamantyl group.
上記炭素数6〜20の(n+1)価の芳香族炭化水素基としては、炭素数6〜20の1価の芳香族炭化水素基から水素原子をn個除いた基等が挙げられる。上記炭素数6〜20の1価の芳香族炭化水素基としては、例えばフェニル基、トリル基、ナフチル基等が挙げられる。 Examples of the (n + 1) -valent aromatic hydrocarbon group having 6 to 20 carbon atoms include a monovalent aromatic hydrocarbon group having 6 to 20 carbon atoms from which n hydrogen atoms have been removed. Examples of the monovalent aromatic hydrocarbon group having 6 to 20 carbon atoms include a phenyl group, a tolyl group, and a naphthyl group.
上記R6及びR7としては、
メチレン基、エチレン基、プロピレン基(1,3−プロピレン基、1,2−プロピレン基等)、テトラメチレン基、ペンタメチレン基、ヘキサメチレン基、ヘプタメチレン基、オクタメチレン基、ノナメチレン基、デカメチレン基、ウンデカメチレン基、ドデカメチレン基、トリデカメチレン基、テトラデカメチレン基、ペンタデカメチレン基、ヘキサデカメチレン基、ヘプタデカメチレン基、オクタデカメチレン基、ノナデカメチレン基、インサレン基、1−メチル−1,3−プロピレン基、2−メチル−1,3−プロピレン基、2−メチル−1,2−プロピレン基、1−メチル−1,4−ブチレン基、2−メチル−1,4−ブチレン基、メチリデン基、エチリデン基、プロピリデン基、2−プロピリデン基等の飽和鎖状炭化水素基;
1,3−シクロブチレン基等のシクロブチレン基、1,3−シクロペンチレン基等のシクロペンチレン基、1,4−シクロヘキシレン基等のシクロヘキシレン基、1,5−シクロオクチレン基等のシクロオクチレン基などのシクロアルキレン基などの単環式炭化水素環基;
ノルボルニレン基(1,4−ノルボルニレン基、2,5−ノルボルニレン基等)、アダマンチレン基(1,5−アダマンチレン基、2,6−アダマンチレン基等)、シクロヘキサントリイル基(1,3,5−シクロヘキサントリイル基等)等の多環式炭化水素基;
1,3−フェニレン基、1,4−フェニレン基等の芳香族炭化水素基;
及びこれらを組み合わせた基が好ましい。
The above R 6 and R 7 include
Methylene group, ethylene group, propylene group (1,3-propylene group, 1,2-propylene group, etc.), tetramethylene group, pentamethylene group, hexamethylene group, heptamethylene group, octamethylene group, nonamethylene group, decamethylene group , Undecamethylene group, dodecamethylene group, tridecamethylene group, tetradecamethylene group, pentadecamethylene group, hexadecamethylene group, heptadecamethylene group, octadecamethylene group, nonadecamethylene group, insalen group, 1- Methylene-1,3-propylene group, 2-methyl-1,3-propylene group, 2-methyl-1,2-propylene group, 1-methyl-1,4-butylene group, 2-methyl-1,4- Saturated chain hydrocarbon groups such as butylene group, methylene group, etylidene group, propylidene group, 2-propylidene group;
Cyclobutylene group such as 1,3-cyclobutylene group, cyclopentylene group such as 1,3-cyclopentylene group, cyclohexylene group such as 1,4-cyclohexylene group, 1,5-cyclooctylene group, etc. Monocyclic hydrocarbon ring groups such as cycloalkylene groups such as cyclooctylene groups in
Norbornene group (1,4-norbornene group, 2,5-norbornene group, etc.), adamantylene group (1,5-adamantylene group, 2,6-adamantylene group, etc.), cyclohexanetriyl group (1,3, Polycyclic hydrocarbon group such as 5-cyclohexanetriyl group;
Aromatic hydrocarbon groups such as 1,3-phenylene group and 1,4-phenylene group;
And a group combining these are preferable.
上記R6としては、メチレン基、エチレン基、1,2−プロピレン基、2,5−ノルボルニレン基、1,4−フェニレン基及び1,3,5−シクロヘキサントリイル基がより好ましい。上記R6としては、(n+1)価の芳香族炭化水素基もより好ましい。上記R6が芳香族炭化水素基である場合、耐熱性等をより高めることができる。 Examples of the R 6, methylene group, ethylene group, 1,2-propylene group, 2,5-norbornylene group, a 1,4-phenylene group, and 1,3,5-cyclohexanetricarboxylic-yl group is more preferable. As the R 6, (n + 1) -valent aromatic hydrocarbon group is more preferable. When the above R 6 is an aromatic hydrocarbon group, heat resistance and the like can be further improved.
また、上記R7としては、1,3−フェニレン基、1,4−フェニレン基等の(n+1)価の芳香族炭化水素基がより好ましく、1,4−フェニレン基がさらに好ましい。上記R7が芳香族炭化水素基である場合、耐熱性等をより高めることができる。 Further, as the R 7 , a (n + 1) -valent aromatic hydrocarbon group such as a 1,3-phenylene group or a 1,4-phenylene group is more preferable, and a 1,4-phenylene group is even more preferable. When the above R 7 is an aromatic hydrocarbon group, heat resistance and the like can be further improved.
上記Rとしては、水素原子及びメチル基が好ましい。 As the R, a hydrogen atom and a methyl group are preferable.
上記nとしては、1及び2が好ましい。 As the above n, 1 and 2 are preferable.
上記式(3−1)で表される構造単位としては、下記式(3−1−1)〜(3−1−6)でそれぞれ表される構造単位を挙げることができる。また、上記式(3−2)で表される構造単位としては、下記式(3−2−1)〜(3−2−2)でそれぞれ表される構造単位を挙げることができる。 Examples of the structural unit represented by the above formula (3-1) include structural units represented by the following formulas (3-1-1) to (3-1-6), respectively. Further, as the structural unit represented by the above formula (3-2), structural units represented by the following formulas (3-2-1) to (3-2-2) can be mentioned.
上記式中、Rは、上記式(3−1)及び(3−2)中のRと同義である。これらの中でも、式(3−1−3)、(3−2−1)及び(3−2−2)で表される芳香族炭化水素基を含む構造単位が好ましく、式(3−1−3)及び(3−2−1)で表される、芳香族炭化水素基に酸性基として−C(CF3)2OHで表される基が置換された構造単位がより好ましい。 In the above formula, R is synonymous with R in the above formulas (3-1) and (3-2). Among these, structural units containing aromatic hydrocarbon groups represented by the formulas (3-1-3), (3-2-1) and (3-2-2) are preferable, and the formula (3-1-1) is preferable. A structural unit in which an aromatic hydrocarbon group represented by 3) and (3-2-1) is substituted with a group represented by -C (CF 3 ) 2 OH as an acidic group is more preferable.
上記式(4)中、R’は、水素原子、メチル基又はトリフルオロメチル基である。RL1〜RL5は、それぞれ独立して、水素原子、ヒドロキシ基又は炭素数1〜4のアルキル基である。Yは、単結合、−COO−又は−CONH−である。pは、0〜3の整数である。但し、RL1〜RL5のうちの少なくとも1つは、ヒドロキシ基である。 In the above formula (4), R'is a hydrogen atom, a methyl group or a trifluoromethyl group. R L1 to R L5 are each independently a hydrogen atom, a hydroxy group or an alkyl group having 1 to 4 carbon atoms. Y is a single bond, -COO- or -CONH-. p is an integer from 0 to 3. Provided that at least one of R L1 to R L5 is a hydroxy group.
上記RL1〜RL5で表される炭素数1〜4のアルキル基としては、上記R5で表される炭素数1〜4のアルキル基として例示した基を挙げることができる。 The alkyl group having 1 to 4 carbon atoms represented by R L1 to R L5, mention may be made of the group exemplified as the alkyl group having 1 to 4 carbon atoms represented by the R 5.
上記式(4)で表される構造単位としては、下記式(4−1)〜(4−8)で表される構造単位を挙げることができる。 Examples of the structural unit represented by the above formula (4) include structural units represented by the following formulas (4-1) to (4-8).
上記式中、R’及びpは、上記式(4)中のR’及びpとそれぞれ同義である。これらの中でも、式(4−1)及び(4−7)でそれぞれ表される構造単位が好ましい。 In the above formula, R'and p are synonymous with R'and p in the above formula (4), respectively. Among these, structural units represented by the formulas (4-1) and (4-7) are preferable.
上記構造単位(I)としては、これらの中でも、上記式(3−1)で表される構造単位及び上記式(3−2)で表される構造単位が好ましい。さらに、上記構造単位(I)としては、上記式(3−1)で表される構造単位又は上記式(3−2)で表される構造単位と、(メタ)アクリル酸に由来する構造単位等のカルボキシ基を有する構造単位とを併用することが好ましい。構造単位(I)をこのような構成とすることにより、得られる硬化膜の耐薬品性等の諸特性をより高めることができる。 Among these, as the structural unit (I), the structural unit represented by the above formula (3-1) and the structural unit represented by the above formula (3-2) are preferable. Further, the structural unit (I) includes a structural unit represented by the above formula (3-1) or a structural unit represented by the above formula (3-2), and a structural unit derived from (meth) acrylic acid. It is preferable to use in combination with a structural unit having a carboxy group such as. By setting the structural unit (I) to such a structure, various properties such as chemical resistance of the obtained cured film can be further enhanced.
上記構造単位(I)の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、10質量%が好ましく、20質量%がより好ましく、30質量%がさらに好ましく、40質量%が特に好ましい。一方、構造単位(I)の含有割合の上限としては、80質量%が好ましく、70質量%がより好ましく、60質量%がさらに好ましい。構造単位(I)の含有割合を上記範囲とすることにより、保存安定性や、得られる硬化膜の諸特性等をより高めることができる。なお、各重合体における各構造単位の含有割合は、[A]重合体の合成の際の各構造単位に対応する単量体の仕込比(配合比)と同様とみなすことができる。 The lower limit of the content ratio of the structural unit (I) is preferably 10% by mass, more preferably 20% by mass, further preferably 30% by mass, and 40% by mass, based on all the structural units constituting the polymer [A]. Mass% is particularly preferred. On the other hand, as the upper limit of the content ratio of the structural unit (I), 80% by mass is preferable, 70% by mass is more preferable, and 60% by mass is further preferable. By setting the content ratio of the structural unit (I) in the above range, the storage stability and various properties of the obtained cured film can be further improved. The content ratio of each structural unit in each polymer can be regarded as the same as the charging ratio (blending ratio) of the monomers corresponding to each structural unit in the synthesis of the [A] polymer.
上記構造単位(I)の中でも、上記式(3−1)及び式(3−2)で表される構造単位等の、フッ素含有アルコール性水酸基を有する構造単位の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、10質量%が好ましく、20質量%がより好ましくい。一方、この上限としては、60質量%が好ましく、50質量%がより好ましく、40質量%がさらに好ましい。 Among the structural units (I), the lower limit of the content ratio of the structural units having a fluorine-containing alcoholic hydroxyl group, such as the structural units represented by the formulas (3-1) and (3-2), is [ A] 10% by mass is preferable, and 20% by mass is more preferable, based on all the structural units constituting the polymer. On the other hand, as the upper limit, 60% by mass is preferable, 50% by mass is more preferable, and 40% by mass is further preferable.
上記構造単位(I)の中でも、(メタ)アクリル酸に由来する構造単位等、カルボキシ基を有する構造単位の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、5質量%が好ましく、10質量%がより好ましく、15質量%がさらに好ましく、20質量%が特に好ましい。一方、この上限としては、50質量%が好ましく、30質量%がより好ましい。 Among the above structural units (I), the lower limit of the content ratio of the structural unit having a carboxy group such as the structural unit derived from (meth) acrylic acid is set with respect to all the structural units constituting the polymer [A]. 5% by mass is preferable, 10% by mass is more preferable, 15% by mass is further preferable, and 20% by mass is particularly preferable. On the other hand, as the upper limit, 50% by mass is preferable, and 30% by mass is more preferable.
[構造単位(II)]
構造単位(II)は、下記式(1−1)で表される基及び下記式(1−2)で表される基から選ばれる少なくとも1種の基を有する構造単位である。構造単位(II)は、複数種の構造単位から構成されていてもよい。
[Structural unit (II)]
The structural unit (II) is a structural unit having at least one group selected from the groups represented by the following formula (1-1) and the groups represented by the following formula (1-2). The structural unit (II) may be composed of a plurality of types of structural units.
上記式(1−1)中、R1は、水素原子、ハロゲン原子、ヒドロキシ基又は炭素数1〜6のアルコキシ基である。R2及びR3は、それぞれ独立して、水素原子、ハロゲン原子、ヒドロキシ基、炭素数1〜6のアルコキシ基、炭素数1〜6のアルキル基又はフェニル基である。A1は、ハロゲン原子、ヒドロキシ基、炭素数1〜6のアルコキシ基又は炭素数1〜6のアルキル基である。A1が複数の場合、複数のA1はそれぞれ独立して上記定義を満たす。n1は、0〜4の整数である。*は、結合部位を示す。 In the above formula (1-1), R 1 is a hydrogen atom, a halogen atom, a hydroxy group, or an alkoxy group having 1 to 6 carbon atoms. R 2 and R 3 are independently hydrogen atoms, halogen atoms, hydroxy groups, alkoxy groups having 1 to 6 carbon atoms, and alkyl groups or phenyl groups having 1 to 6 carbon atoms. A 1 is a halogen atom, a hydroxy group, an alkoxy group having 1 to 6 carbon atoms, or an alkyl group having 1 to 6 carbon atoms. If A 1 is plural, each independently plurality of A 1 may satisfy the above definition. n1 is an integer from 0 to 4. * Indicates the binding site.
上記式(1−2)中、R1、R2及びR3は、上記式(1−1)と同義である。A2は、ハロゲン原子、ヒドロキシ基、炭素数1〜6のアルコキシ基又は炭素数1〜6のアルキル基である。A2が複数の場合、複数のA2はそれぞれ独立して上記定義を満たす。n2は、0〜6の整数である。*は結合位を示す。 In the above formula (1-2), R 1 , R 2 and R 3 are synonymous with the above formula (1-1). A 2 is a halogen atom, a hydroxy group, an alkoxy group having 1 to 6 carbon atoms, or an alkyl group having 1 to 6 carbon atoms. If A 2 is plural, each independently plurality of A 2 satisfy the above definition. n2 is an integer from 0 to 6. * Indicates the binding site.
上記R1〜R3で表されるハロゲン原子としては、フッ素原子、塩素原子、臭素原子等を挙げることができる。 Examples of the halogen atom represented by R 1 to R 3 include a fluorine atom, a chlorine atom, and a bromine atom.
上記R1〜R3で表される炭素数1〜6のアルコキシ基としては、メトキシ基、エトキシ基、n−プロポキシ基、i−プロポキシ基等を挙げることができる。 Examples of the alkoxy group having 1 to 6 carbon atoms represented by R 1 to R 3 include a methoxy group, an ethoxy group, an n-propoxy group, an i-propoxy group and the like.
上記R2及びR3で表される炭素数1〜6のアルキル基としては、上記R5の説明において例示した炭素数1〜4のアルキル基等を挙げることができる。 Examples of the alkyl group having 1 to 6 carbon atoms represented by R 2 and R 3 include an alkyl group having 1 to 4 carbon atoms exemplified in the explanation of R 5 above.
上記R1としては、炭素数1〜6のアルコキシ基が好ましく、メトキシ基及びエトキシ基がより好ましく、メトキシ基がさらに好ましい。 As the R 1, preferably an alkoxy group having 1 to 6 carbon atoms, more preferably a methoxy group and an ethoxy group, a methoxy group is more preferred.
上記R2及びR3としては、炭素数1〜6のアルコキシ基が好ましく、メトキシ基及びエトキシ基がより好ましく、メトキシ基がさらに好ましい。 As the R 2 and R 3 , an alkoxy group having 1 to 6 carbon atoms is preferable, a methoxy group and an ethoxy group are more preferable, and a methoxy group is further preferable.
上記A1及びA2で表されるハロゲン原子、炭素数1〜6のアルコキシ基及び炭素数1〜6のアルキル基としては、上記R1〜R3として例示したものをそれぞれ挙げることができる。 Examples of the halogen atom represented by A 1 and A 2 , the alkoxy group having 1 to 6 carbon atoms and the alkyl group having 1 to 6 carbon atoms include those exemplified as R 1 to R 3 above, respectively.
上記n1としては、0が好ましい。また、上記n2としては、0が好ましい。 The n1 is preferably 0. Further, the n2 is preferably 0.
上記構造単位(II)としては、下記式(5−1)で表される構造単位及び下記式(5−2)で表される構造単位を挙げることができる。これらの中でも、耐熱性等の観点から、下記式(5−2)で表される構造単位が好ましい。 Examples of the structural unit (II) include a structural unit represented by the following formula (5-1) and a structural unit represented by the following formula (5-2). Among these, the structural unit represented by the following formula (5-2) is preferable from the viewpoint of heat resistance and the like.
上記式(5−1)及び(5−2)中、R1〜R3は、上記式(1−1)及び(1−2)中のR1〜R3と同義である。R8及びR9は、それぞれ独立して、Siと連結するベンゼン環又はナフタレン環を有する2価の有機基である。但し、R9においては、主鎖側末端がエステル構造(−COO−)であるものを除く。RAは、それぞれ独立して、水素原子、メチル基、ヒドロキシメチル基、シアノ基又はトリフルオロメチル基である。 In the above formula (5-1) and (5-2), R 1 to R 3 have the same meanings as R 1 to R 3 in the formula (1-1) and (1-2). R 8 and R 9 are divalent organic groups each independently having a benzene ring or a naphthalene ring linked to Si. However, in R 9 , those having an ester structure (-COO-) at the end on the main chain side are excluded. Each R A is independently, a hydrogen atom, a methyl group, a hydroxymethyl group, a cyano group or a trifluoromethyl group.
上記R8及びR9で表される2価の基としては、例えばフェニレン基、ナフチレン基の他、フェニレン基又はナフチレン基が、鎖状炭化水素基、脂環式炭化水素基及びその他の連結基と連結した基が挙げられる。但し、これらの基が有する水素原子の一部又は全部は置換基により置換されていてもよい。上記置換基としては、上記A1及びA2で表される基等を挙げることができる。上記鎖状炭化水素基及び脂環式炭化水素基としては、上記式(3−1)及び(3−2)中のR6及びR7で表される(n+1)価の有機基の例として挙げたもののうちの、2価の基を挙げることができる。 Examples of the divalent group represented by R 8 and R 9 include a phenylene group and a naphthylene group, as well as a phenylene group or a naphthylene group, a chain hydrocarbon group, an alicyclic hydrocarbon group and other linking groups. The group linked with is mentioned. However, some or all of the hydrogen atoms contained in these groups may be substituted with substituents. Examples of the substituent include the groups represented by the above A 1 and A 2 . The chain hydrocarbon group and the alicyclic hydrocarbon group are examples of (n + 1) valent organic groups represented by R 6 and R 7 in the above formulas (3-1) and (3-2). Among the listed ones, a divalent group can be mentioned.
上記R8及びR9としては、フェニレン基及びナフチレン基がより好ましく、p−フェニレン基がさらに好ましい。すなわち、式(5−1)中のSi(R1R2R3)−R8−及びSi(R1R2R3)−R9−は、上記式(1−1)又は(1−2)で表される基であることが好ましい。 As the R 8 and R 9 , a phenylene group and a naphthylene group are more preferable, and a p-phenylene group is further preferable. That, Si in the formula (5-1) (R 1 R 2 R 3) -R 8 - and Si (R 1 R 2 R 3 ) -R 9 - is the formula (1-1) or (1- It is preferably a group represented by 2).
上記RAとしては、水素原子及びメチル基が好ましい。 As the RA , a hydrogen atom and a methyl group are preferable.
上記式(5−1)で表される構造単位としては、下記式(5−1−1)〜(5−1−2)で表される構造単位等を挙げることができる。上記式(5−2)で表される構造単位としては、下記式(5−2−1)〜(5−2−2)で表される構造単位等を挙げることができる。 Examples of the structural unit represented by the above formula (5-1) include structural units represented by the following formulas (5-1-1) to (5-1-2). Examples of the structural unit represented by the above formula (5-2) include structural units represented by the following formulas (5-2-1) to (5-2-2).
上記式中、RAは、上記式(5−1)及び(5−2)中のRAと同義である。 In the above formula, R A has the same meaning as R A in the above formula (5-1) and (5-2).
上記構造単位(II)の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、10質量%が好ましく、20質量%がより好ましい。一方、この上限としては、70質量%が好ましく、50質量%がより好ましい。構造単位(II)の含有割合を上記範囲とすることで、得られる硬化膜の諸特性や、保存安定性等をより高めることができる。 The lower limit of the content ratio of the structural unit (II) is preferably 10% by mass, more preferably 20% by mass, based on all the structural units constituting the polymer [A]. On the other hand, as the upper limit, 70% by mass is preferable, and 50% by mass is more preferable. By setting the content ratio of the structural unit (II) within the above range, various properties of the obtained cured film, storage stability, and the like can be further enhanced.
[構造単位(III)]
[A]重合体は、架橋性基を有する構造単位(以下、「構造単位(III)」ともいう。)をさらに有することが好ましい。[A]重合体が構造単位(III)を有することで、得られる硬化膜の表面硬度等をさらに高めることができる。
[Structural unit (III)]
The polymer [A] preferably further has a structural unit having a crosslinkable group (hereinafter, also referred to as “structural unit (III)”). [A] When the polymer has the structural unit (III), the surface hardness and the like of the obtained cured film can be further increased.
上記架橋性基とは、酸性基及び上記式(1−1)又は(1−2)で表される基以外の基であって、他の基等と共有結合することができる基をいう。上記架橋性基としては、例えばオキシラニル基(1,2−エポキシ構造)、オキセタニル基(1,3−エポキシ構造)、環状カーボネート基、メチロール基(ヒドロキシメチル構造)、(メタ)アクリロイル基等が挙げられる。 The crosslinkable group refers to a group other than an acidic group and a group represented by the above formula (1-1) or (1-2) and which can be covalently bonded to another group or the like. Examples of the crosslinkable group include an oxylanyl group (1,2-epoxy structure), an oxetanyl group (1,3-epoxy structure), a cyclic carbonate group, a methylol group (hydroxymethyl structure), a (meth) acryloyl group and the like. Be done.
オキシラニル基を含む構造単位(III)としては、例えば下記式(6−1)〜(6−5)で表される構造単位等が挙げられる。オキセタニル基を含む構造単位(III)としては、例えば下記式(6−6)〜(6−9)で表される構造単位等が挙げられる。環状カーボネート基を含む構造単位(III)としては、例えば下記式(6−10)〜(6−14)で表される構造単位等が挙げられる。メチロール基を含む構造単位(III)としては、例えば下記式(6−15)で表される構造単位等が挙げられる。 Examples of the structural unit (III) containing an oxylanyl group include structural units represented by the following formulas (6-1) to (6-5). Examples of the structural unit (III) containing an oxetanyl group include structural units represented by the following formulas (6-6) to (6-9). Examples of the structural unit (III) containing a cyclic carbonate group include structural units represented by the following formulas (6-10) to (6-14). Examples of the structural unit (III) containing a methylol group include a structural unit represented by the following formula (6-15).
上記式中、RBは、水素原子、メチル基又はトリフルオロメチル基である。 In the above formula, R B is a hydrogen atom, a methyl group or a trifluoromethyl group.
(メタ)アクリロイル基を含む構造単位(III)としては、例えば
エチレングリコールジ(メタ)アクリレート、ジエチレングリコールジ(メタ)アクリレート、トリエチレングリコールジ(メタ)アクリレート、プロピレングリコールジ(メタ)アクリレート、ジプロピレンジ(メタ)アクリレート、トリプロピレンジ(メタ)アクリレート、1,3−ブチレングリコールジ(メタ)アクリレート、1,4−ブタンジオールジ(メタ)アクリレート、1,6−ヘキサンジオールジ(メタ)アクリレート、ネオペンチルグリコールジ(メタ)アクリレート、トリプロピレングリコールジアクリレート等のジ(メタ)アクリレート化合物;
トリス(2−ヒドロキシエチル)イソシアヌレートトリ(メタ)アクリレート、トリメチロールプロパントリ(メタ)アクリレート、ペンタエリスリトールトリ(メタ)アクリレート等のトリ(メタ)アクリレート化合物;
ペンタエリスリトールテトラ(メタ)アクリレート等のテトラ(メタ)アクリレート化合物;
ジペンタエリスリトールペンタ(メタ)アクリレート等のペンタ(メタ)アクリレート化合物などの単量体化合物に由来の構造単位等が挙げられる。
Examples of the structural unit (III) containing the (meth) acryloyl group include ethylene glycol di (meth) acrylate, diethylene glycol di (meth) acrylate, triethylene glycol di (meth) acrylate, propylene glycol di (meth) acrylate, and dipropylene di (meth). Meta) acrylate, tripropylene di (meth) acrylate, 1,3-butylene glycol di (meth) acrylate, 1,4-butanediol di (meth) acrylate, 1,6-hexanediol di (meth) acrylate, neopentyl Di (meth) acrylate compounds such as glycol di (meth) acrylate and tripropylene glycol diacrylate;
Tri (meth) acrylate compounds such as tris (2-hydroxyethyl) isocyanurate tri (meth) acrylate, trimethylolpropane tri (meth) acrylate, pentaerythritol tri (meth) acrylate;
Tetra (meth) acrylate compounds such as pentaerythritol tetra (meth) acrylate;
Examples thereof include structural units derived from monomeric compounds such as penta (meth) acrylate compounds such as dipentaerythritol penta (meth) acrylate.
上記架橋性基としては、オキシラニル基、オキセタニル基、メチロール基及びこれらの組み合わせが好ましく、オキシラニル基、メチロール基及びこれらの組み合わせがより好ましく、オキシラニル基がさらに好ましい。このような架橋性基を有することで、形成される硬化膜の耐熱性や耐薬品性をより高めることができる。 As the crosslinkable group, an oxylanyl group, an oxetanyl group, a methylol group and a combination thereof are preferable, an oxylanyl group, a methylol group and a combination thereof are more preferable, and an oxylanyl group is further preferable. By having such a crosslinkable group, the heat resistance and chemical resistance of the formed cured film can be further enhanced.
上記構造単位(III)の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、1質量%が好ましく、5質量%がより好ましく、10質量%がさらに好ましい。一方、この上限としては、70質量%が好ましく、50質量%がより好ましく、30質量%がさらに好ましく、25質量%が特に好ましい。構造単位(III)の含有割合を上記範囲とすることで、高い保存安定性を維持したまま、得られる硬化膜の諸特性をより高めることなどができる。 The lower limit of the content ratio of the structural unit (III) is preferably 1% by mass, more preferably 5% by mass, still more preferably 10% by mass, based on all the structural units constituting the polymer [A]. On the other hand, as the upper limit, 70% by mass is preferable, 50% by mass is more preferable, 30% by mass is further preferable, and 25% by mass is particularly preferable. By setting the content ratio of the structural unit (III) in the above range, it is possible to further enhance various properties of the obtained cured film while maintaining high storage stability.
[構造単位(IV)]
[A]重合体は、構造単位(I)〜(III)以外の構造単位であって、ヒドロキシ基を有する(メタ)アクリル酸エステル由来の構造単位(以下、「構造単位(IV)」)を有することができる。
[Structural unit (IV)]
[A] The polymer is a structural unit other than the structural units (I) to (III), and is a structural unit derived from a (meth) acrylic acid ester having a hydroxy group (hereinafter, “structural unit (IV)”). Can have.
構造単位(IV)としては、例えば下記式(7−1)〜(7−3)でそれぞれ表される構造単位を挙げることができる。 Examples of the structural unit (IV) include structural units represented by the following formulas (7-1) to (7-3).
上記式中、RCは、水素原子、メチル基又はトリフルオロメチル基である。 In the above formula, RC is a hydrogen atom, a methyl group or a trifluoromethyl group.
上記構造単位(IV)の含有割合としては、例えば[A]重合体を構成する全構造単位に対して1質量%以上50質量%以下とすることができる。 The content ratio of the structural unit (IV) can be, for example, 1% by mass or more and 50% by mass or less with respect to all the structural units constituting the polymer [A].
[構造単位(V)]
[A]重合体は、構造単位(I)〜(IV)以外のその他の構造単位(以下、「構造単位(V)」ともいう。)を有していてもよい。[A]重合体が構造単位(V)を有することで、当該硬化膜形成用樹脂材料(1)は、樹脂のガラス転移温度を調整し、熱硬化時のメルトフロー性や得られる硬化膜の機械的強度、耐薬品性を向上させることができる。
[Structural unit (V)]
[A] The polymer may have other structural units (hereinafter, also referred to as “structural unit (V)”) other than the structural units (I) to (IV). [A] Since the polymer has a structural unit (V), the cured film-forming resin material (1) adjusts the glass transition temperature of the resin, and has a melt flow property during thermosetting and a cured film obtained. Mechanical strength and chemical resistance can be improved.
上記構造単位(V)としては、例えば下記式(8−1)〜(8−10)で表される構造単位等が挙げられる。 Examples of the structural unit (V) include structural units represented by the following formulas (8-1) to (8-10).
上記式中、RDは、水素原子、メチル基又はトリフルオロメチル基である。RMは、水素原子又はメチル基である。sは、1〜10の整数である。これらの中でも、構造単位(V)としては、式(8−1)、(8−6)〜(8−8)及び(8−10)で表される構造単位が好ましい。 In the above formula, RD is a hydrogen atom, a methyl group or a trifluoromethyl group. RM is a hydrogen atom or a methyl group. s is an integer from 1 to 10. Among these, as the structural unit (V), the structural units represented by the formulas (8-1), (8-6) to (8-8) and (8-10) are preferable.
構造単位(V)を与える単量体化合物としては、例えば(メタ)アクリル酸鎖状アルキルエステル、(メタ)アクリル酸環状アルキルエステル、(メタ)アクリル酸アリールエステル、不飽和ジカルボン酸ジエステル、ビシクロ不飽和化合物、マレイミド化合物、不飽和芳香族化合物及び共役ジエン化合物、並びにテトラヒドロフラン骨格、フラン骨格、テトラヒドロピラン骨格、ピラン骨格又は下記式(9)で表される骨格を有する不飽和化合物、その他の不飽和化合物等に由来の構造単位が挙げられる。 Examples of the monomer compound giving the structural unit (V) include (meth) acrylic acid chain alkyl ester, (meth) acrylic acid cyclic alkyl ester, (meth) acrylic acid aryl ester, unsaturated dicarboxylic acid diester, and uncyclonized. Saturated compounds, maleimide compounds, unsaturated aromatic compounds and conjugated diene compounds, unsaturated compounds having a tetrahydrofuran skeleton, furan skeleton, tetrahydropyran skeleton, pyran skeleton or a skeleton represented by the following formula (9), and other unsaturated compounds. Examples include structural units derived from compounds and the like.
上記式(9)中、RM及びsは、上記式(8−9)中のRM及びsと同義である。 In the above formula (9), R M and s have the same meanings as R M and s in the formula (8-9).
上記(メタ)アクリル酸鎖状アルキルエステルとしては、例えば
アクリル酸メチル、アクリル酸エチル、アクリル酸n−ブチル、アクリル酸sec−ブチル、アクリル酸t−ブチル、アクリル酸2−エチルヘキシル、アクリル酸イソデシル、アクリル酸n−ラウリル、アクリル酸トリデシル、アクリル酸n−ステアリル等のアクリル酸鎖状アルキルエステル;
メタクリル酸メチル、メタクリル酸エチル、メタクリル酸n−ブチル、メタクリル酸sec−ブチル、メタクリル酸t−ブチル、メタクリル酸2−エチルヘキシル、メタクリル酸イソデシル、メタクリル酸n−ラウリル、メタクリル酸トリデシル、メタクリル酸n−ステアリル等のメタクリル酸鎖状アルキルエステル等が挙げられる。
Examples of the (meth) acrylic acid chain alkyl ester include methyl acrylate, ethyl acrylate, n-butyl acrylate, sec-butyl acrylate, t-butyl acrylate, 2-ethylhexyl acrylate, and isodecyl acrylate. Acrylic acid chain alkyl esters such as n-lauryl acrylate, tridecyl acrylate, n-stearyl acrylate;
Methyl methacrylate, ethyl methacrylate, n-butyl methacrylate, sec-butyl methacrylate, t-butyl methacrylate, 2-ethylhexyl methacrylate, isodecyl methacrylate, n-lauryl methacrylate, tridecyl methacrylate, n-methacrylate Examples thereof include methacrylic acid chain alkyl esters such as stearyl.
上記(メタ)アクリル酸環状アルキルエステルとしては、例えば
アクリル酸シクロヘキシル、アクリル酸2−メチルシクロヘキシル、アクリル酸トリシクロ[5.2.1.02,6]デカン−8−イル、アクリル酸トリシクロ[5.2.1.02,6]デカン−8−イルオキシエチル、アクリル酸イソボロニル等のアクリル酸環状アルキルエステル;
メタクリル酸シクロヘキシル、メタクリル酸2−メチルシクロヘキシル、メタクリル酸トリシクロ[5.2.1.02,6]デカン−8−イル、メタクリル酸トリシクロ[5.2.1.02,6]デカン−8−イルオキシエチル、メタクリル酸イソボロニル等のメタクリル酸環状アルキルエステル等が挙げられる。
Examples of the (meth) acrylic acid cyclic alkyl ester include cyclohexyl acrylate, 2-methylcyclohexyl acrylate, tricyclo acrylate [5.2.1.0 2,6 ] decane-8-yl, and tricyclo acrylate [5]. 2.1.0 2,6 ] Acrylic acid cyclic alkyl esters such as decane-8-yloxyethyl and isobolonyl acrylate;
Cyclohexyl methacrylate, 2-methylcyclohexyl methacrylate, tricyclo methacrylate [5.2.1.0 2,6 ] decane-8-yl, tricyclo methacrylate [5.2.1.0 2,6 ] decane-8 − Methacrylic acid cyclic alkyl esters such as yloxyethyl and isobolonyl methacrylate can be mentioned.
上記(メタ)アクリル酸アリールエステルとしては、例えば
アクリル酸フェニル。アクリル酸ベンジル等のアクリル酸アリールエステル;
メタクリル酸フェニル、メタクリル酸ベンジル等のメタクリル酸アリールエステル等が挙げられる。
Examples of the (meth) acrylic acid aryl ester include phenyl acrylate. Acrylic acid aryl esters such as benzyl acrylate;
Examples thereof include methacrylic acid aryl esters such as phenyl methacrylate and benzyl methacrylate.
上記不飽和ジカルボン酸ジエステルとしては、例えばマレイン酸ジエチル、フマル酸ジエチル、イタコン酸ジエチル等が挙げられる。 Examples of the unsaturated dicarboxylic acid diester include diethyl maleate, diethyl fumaric acid, and diethyl itaconic acid.
上記ビシクロ不飽和化合物としては、例えばビシクロ[2.2.1]ヘプト−2−エン、5−メチルビシクロ[2.2.1]ヘプト−2−エン、5−エチルビシクロ[2.2.1]ヘプト−2−エン、5−メトキシビシクロ[2.2.1]ヘプト−2−エン、5−エトキシビシクロ[2.2.1]ヘプト−2−エン、5,6−ジメトキシビシクロ[2.2.1]ヘプト−2−エン、5,6−ジエトキシビシクロ[2.2.1]ヘプト−2−エン、5−t−ブトキシカルボニルビシクロ[2.2.1]ヘプト−2−エン、5−シクロヘキシルオキシカルボニルビシクロ[2.2.1]ヘプト−2−エン、5−フェノキシカルボニルビシクロ[2.2.1]ヘプト−2−エン、5,6−ジ(t−ブトキシカルボニル)ビシクロ[2.2.1]ヘプト−2−エン、5,6−ジ(シクロヘキシルオキシカルボニル)ビシクロ[2.2.1]ヘプト−2−エン、5−(2’−ヒドロキシエチル)ビシクロ[2.2.1]ヘプト−2−エン、5,6−ジヒドロキシビシクロ[2.2.1]ヘプト−2−エン、5,6−ジ(ヒドロキシメチル)ビシクロ[2.2.1]ヘプト−2−エン、5,6−ジ(2’−ヒドロキシエチル)ビシクロ[2.2.1]ヘプト−2−エン、5−ヒドロキシ−5−メチルビシクロ[2.2.1]ヘプト−2−エン、5−ヒドロキシ−5−エチルビシクロ[2.2.1]ヘプト−2−エン、5−ヒドロキシメチル−5−メチルビシクロ[2.2.1]ヘプト−2−エン等が挙げられる。 Examples of the bicyclounsaturated compound include bicyclo [2.2.1] hept-2-ene, 5-methylbicyclo [2.2.1] hept-2-ene, and 5-ethylbicyclo [2.2.1]. ] Hept-2-ene, 5-methoxybicyclo [2.2.1] hept-2-ene, 5-ethoxybicyclo [2.2.1] hept-2-ene, 5,6-dimethoxybicyclo [2. 2.1] hept-2-ene, 5,6-diethoxybicyclo [2.2.1] hept-2-ene, 5-t-butoxycarbonylbicyclo [2.2.1] hept-2-ene, 5-Cyclohexyloxycarbonylbicyclo [2.2.1] hept-2-ene, 5-phenoxycarbonylbicyclo [2.2.1] hept-2-ene, 5,6-di (t-butoxycarbonyl) bicyclo [ 2.2.1] Hept-2-ene, 5,6-di (cyclohexyloxycarbonyl) bicyclo [2.2.1] Hept-2-ene, 5- (2'-hydroxyethyl) bicyclo [2.2] .1] Hept-2-ene, 5,6-dihydroxybicyclo [2.2.1] hept-2-ene, 5,6-di (hydroxymethyl) bicyclo [2.2.1] hept-2-ene , 5,6-di (2'-hydroxyethyl) bicyclo [2.2.1] hept-2-ene, 5-hydroxy-5-methylbicyclo [2.2.1] hept-2-ene, 5- Examples thereof include hydroxy-5-ethylbicyclo [2.2.1] hept-2-ene and 5-hydroxymethyl-5-methylbicyclo [2.2.1] hept-2-ene.
上記マレイミド化合物としては、例えばN−フェニルマレイミド、N−シクロヘキシルマレイミド、N−ベンジルマレイミド、N−(4−ヒドロキシフェニル)マレイミド、N−(4−ヒドロキシベンジル)マレイミド、N−スクシンイミジル−3−マレイミドベンゾエート、N−スクシンイミジル−4−マレイミドブチレート、N−スクシンイミジル−6−マレイミドカプロエート、N−スクシンイミジル−3−マレイミドプロピオネート、N−(9−アクリジニル)マレイミド等が挙げられる。 Examples of the maleimide compound include N-phenylmaleimide, N-cyclohexylmaleimide, N-benzylmaleimide, N- (4-hydroxyphenyl) maleimide, N- (4-hydroxybenzyl) maleimide, and N-succinimidyl-3-maleimidebenzoate. , N-succinimidyl-4-maleimidebutyrate, N-succinimidyl-6-maleimide caproate, N-succinimidyl-3-maleimide propionate, N- (9-acridinyl) maleimide and the like.
上記不飽和芳香族化合物としては、例えばスチレン、α−メチルスチレン、ビニルトルエン、p−メトキシスチレン、α−メチル−p−ヒドロキシスチレン等が挙げられる。 Examples of the unsaturated aromatic compound include styrene, α-methylstyrene, vinyltoluene, p-methoxystyrene, α-methyl-p-hydroxystyrene and the like.
上記共役ジエン化合物としては、例えば1,3−ブタジエン、イソプレン、2,3−ジメチル−1,3−ブタジエン等が挙げられる。 Examples of the conjugated diene compound include 1,3-butadiene, isoprene, 2,3-dimethyl-1,3-butadiene and the like.
上記テトラヒドロフラン骨格を有する不飽和化合物としては、例えば2−メタクリロイルオキシ−プロピオン酸テトラヒドロフルフリルエステル、3−(メタ)アクリロイルオキシテトラヒドロフラン−2−オン、(メタ)アクリル酸テトラヒドロフルフリル等が挙げられる。 Examples of the unsaturated compound having a tetrahydrofuran skeleton include 2-methacryloyloxy-propionic acid tetrahydrofurfuryl ester, 3- (meth) acryloyloxy tetrahydrofuran-2-one, and (meth) acrylate tetrahydrofurfuryl.
上記フラン骨格を有する不飽和化合物としては、例えば2−メチル−5−(3−フリル)−1−ペンテン−3−オン、(メタ)アクリル酸フルフリル、1−フラン−2−ブチル−3−エン−2−オン、1−フラン−2−ブチル−3−メトキシ−3−エン−2−オン、6−(2−フリル)−2−メチル−1−ヘキセン−3−オン、6−フラン−2−イル−ヘキシ−1−エン−3−オン、アクリル酸−2−フラン−2−イル−1−メチル−エチルエステル、6−(2−フリル)−6−メチル−1−ヘプテン−3−オン等が挙げられる。 Examples of the unsaturated compound having a furan skeleton include 2-methyl-5- (3-furyl) -1-penten-3-one, furfuryl (meth) acrylate, and 1-furan-2-butyl-3-ene. -2-one, 1-furan-2-butyl-3-methoxy-3-en-2-one, 6- (2-furyl) -2-methyl-1-hexen-3-one, 6-furan-2 -Il-hex-1-en-3-one, acrylate-2-furan-2-yl-1-methyl-ethyl ester, 6- (2-furyl) -6-methyl-1-hepten-3-one And so on.
上記テトラヒドロピラン骨格を含有する不飽和化合物としては、例えば(テトラヒドロピラン−2−イル)メチルメタクリレート、2,6−ジメチル−8−(テトラヒドロピラン−2−イルオキシ)−オクト−1−エン−3−オン、2−メタクリル酸テトラヒドロピラン−2−イルエステル、1−(テトラヒドロピラン−2−オキシ)−ブチル−3−エン−2−オン等が挙げられる。 Examples of the unsaturated compound containing the tetrahydropyran skeleton include (tetrahydropyran-2-yl) methyl methacrylate and 2,6-dimethyl-8- (tetrahydropyran-2-yloxy) -oct-1-en-3-. On, 2-methacrylic acid tetrahydropyran-2-yl ester, 1- (tetrahydropyran-2-oxy) -butyl-3-en-2-one and the like can be mentioned.
上記ピラン骨格を有する不飽和化合物としては、例えば4−(1,4−ジオキサ−5−オキソ−6−ヘプテニル)−6−メチル−2−ピラン、4−(1,5−ジオキサ−6−オキソ−7−オクテニル)−6−メチル−2−ピラン等が挙げられる。 Examples of the unsaturated compound having a pyran skeleton include 4- (1,4-dioxa-5-oxo-6-heptenyl) -6-methyl-2-pyran and 4- (1,5-dioxa-6-oxo). -7-octenyl) -6-methyl-2-pyran and the like.
上記その他の不飽和化合物としては、例えば(メタ)アクリロニトリル、塩化ビニル、塩化ビニリデン、(メタ)アクリルアミド、酢酸ビニル等が挙げられる。 Examples of the other unsaturated compounds include (meth) acrylonitrile, vinyl chloride, vinylidene chloride, (meth) acrylamide, vinyl acetate and the like.
これらの中でも、上記構造単位(V)を与える単量体化合物としては、メタクリル酸鎖状アルキルエステル、メタクリル酸環状アルキルエステル、マレイミド化合物、テトラヒドロフラン骨格、フラン骨格、テトラヒドロピラン骨格、ピラン骨格、上記式(9)で表される骨格を有する不飽和化合物、不飽和芳香族化合物及びアクリル酸環状アルキルエステルが好ましく、共重合反応性等の点から、スチレン、メタクリル酸メチル、メタクリル酸t−ブチル、メタクリル酸n−ラウリル、メタクリル酸トリシクロ[5.2.1.02,6]デカン−8−イル、p−メトキシスチレン、アクリル酸2−メチルシクロヘキシル、N−フェニルマレイミド、N−シクロヘキシルマレイミド、(メタ)アクリル酸テトラヒドロフルフリル、ポリエチレングリコール(n=2〜10)モノ(メタ)アクリレート及び3−(メタ)アクリロイルオキシテトラヒドロフラン−2−オンがより好ましい。 Among these, examples of the monomer compound giving the structural unit (V) include a methacrylic acid chain alkyl ester, a cyclic alkyl methacrylate ester, a maleimide compound, a tetrahydrofuran skeleton, a furan skeleton, a tetrahydropyran skeleton, and a pyran skeleton. An unsaturated compound having a skeleton represented by (9), an unsaturated aromatic compound and an acrylic acid cyclic alkyl ester are preferable, and styrene, methyl methacrylate, t-butyl methacrylate and methacrylic acid are preferable from the viewpoint of copolymerization reactivity and the like. N-lauryl acid, tricyclomethacrylate [5.2.1.0 2,6 ] decane-8-yl, p-methoxystyrene, 2-methylcyclohexyl acrylate, N-phenylmaleimide, N-cyclohexylmaleimide, (meth) ) Tetrahydrofurfuryl acrylate, polyethylene glycol (n = 2-10) mono (meth) acrylate and 3- (meth) acryloyloxy tetrahydrofuran-2-one are more preferred.
上記構造単位(V)の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、1質量%が好ましく、3質量%がより好ましい。一方、この上限としては、50質量%が好ましく、30質量%がより好ましい。構造単位(V)の含有割合を上記範囲とすることで、耐薬品性等を効果的に向上させることができる。 The lower limit of the content ratio of the structural unit (V) is preferably 1% by mass, more preferably 3% by mass, based on all the structural units constituting the polymer [A]. On the other hand, as the upper limit, 50% by mass is preferable, and 30% by mass is more preferable. By setting the content ratio of the structural unit (V) within the above range, chemical resistance and the like can be effectively improved.
[A]重合体は、構造単位(I)〜(III)を有し、構造単位(I)が上記式(3−1)又は(3−2)で表される構造単位と、カルボキシ基を有する構造単位とを含み、構造単位(II)が上記式(5−2)で表される構造単位であり、構造単位(III)がオキシラニル基又はメチロール基を有する構造単位であることが好ましい。さらにこのとき、上記式(3−1)及び(3−2)中のR4及びR5がパーフルオロアルキル基であることが好ましい。また、このとき、[A]重合体におけるカルボキシ基を有する構造単位の含有割合が比較的高い(例えば15質量%以上50質量%以下)であることが好ましい。[A]重合体がこのような構造単位を有することで、得られる硬化膜の耐熱性、透明性、表面硬度、低誘電性等を特に高めることができる。 The polymer [A] has structural units (I) to (III), and the structural unit (I) has a structural unit represented by the above formula (3-1) or (3-2) and a carboxy group. It is preferable that the structural unit (II) is a structural unit represented by the above formula (5-2), and the structural unit (III) is a structural unit having an oxylanyl group or a polymeric group. Further, at this time, it is preferable that R 4 and R 5 in the above formulas (3-1) and (3-2) are perfluoroalkyl groups. Further, at this time, it is preferable that the content ratio of the structural unit having a carboxy group in the [A] polymer is relatively high (for example, 15% by mass or more and 50% by mass or less). [A] When the polymer has such a structural unit, the heat resistance, transparency, surface hardness, low dielectric property, etc. of the obtained cured film can be particularly improved.
<[A]重合体の合成方法>
[A]重合体は、例えば所定の各構造単位に対応する単量体を、ラジカル開始剤を使用し、適当な溶媒中で重合することにより製造できる。なお、通常、重合の際の各単量体の配合比は、得られる[A]重合体において、対応する構造単位の含有割合と一致する。具体的な合成方法としては、(1)単量体及びラジカル開始剤を含有する溶液を、反応溶媒又は単量体を含有する溶液に滴下して重合反応させる方法、(2)単量体を含有する溶液と、ラジカル開始剤を含有する溶液とを各別に、反応溶媒又は単量体を含有する溶液に滴下して重合反応させる方法、(3)各々の単量体を含有する複数種の溶液と、ラジカル開始剤を含有する溶液とを各別に、反応溶媒又は単量体を含有する溶液に滴下して重合反応させる方法等の方法で合成することが好ましい。
<[A] Polymer synthesis method>
The polymer [A] can be produced, for example, by polymerizing a monomer corresponding to each predetermined structural unit in an appropriate solvent using a radical initiator. In general, the compounding ratio of each monomer at the time of polymerization is the same as the content ratio of the corresponding structural unit in the obtained [A] polymer. Specific synthetic methods include (1) a method of dropping a solution containing a monomer and a radical initiator into a reaction solvent or a solution containing a monomer to carry out a polymerization reaction, and (2) a monomer. A method in which a solution containing a radical initiator and a solution containing a radical initiator are separately added dropwise to a solution containing a reaction solvent or a monomer to carry out a polymerization reaction, (3) a plurality of types containing each monomer. It is preferable to synthesize the solution and the solution containing the radical initiator separately by a method such as a method of dropping the solution into a solution containing a reaction solvent or a monomer and causing a polymerization reaction.
これらの方法における反応温度は開始剤種によって適宜決定すればよい。通常30℃〜180℃とすることができる。滴下時間は、反応温度、開始剤の種類、反応させる単量体等の条件によって異なるが、通常、30分〜8時間である。また、滴下時間を含む全反応時間も、滴下時間と同様に条件により異なるが、通常、30分〜8時間である。 The reaction temperature in these methods may be appropriately determined depending on the initiator type. It can usually be 30 ° C to 180 ° C. The dropping time varies depending on conditions such as the reaction temperature, the type of initiator, and the monomer to be reacted, but is usually 30 minutes to 8 hours. Further, the total reaction time including the dropping time also varies depending on the conditions like the dropping time, but is usually 30 minutes to 8 hours.
上記重合に使用されるラジカル開始剤としては、アゾビスイソブチロニトリル(AIBN)、2,2’−アゾビス(4−メトキシ−2,4−ジメチルバレロニトリル)、2,2’−アゾビス(2−シクロプロピルプロピオニトリル)、2,2’−アゾビス(2,4−ジメチルバレロニトリル)、2,2’−アゾビス(2−メチルプロピオニトリル)等が挙げられる。これらの開始剤は、単独で又は2種以上を組み合わせて用いてもよい。 Examples of the radical initiator used in the above polymerization include azobisisobutyronitrile (AIBN), 2,2'-azobis (4-methoxy-2,4-dimethylvaleronitrile), and 2,2'-azobis (2). -Cyclopropylpropionitrile), 2,2'-azobis (2,4-dimethylvaleronitrile), 2,2'-azobis (2-methylpropionitrile) and the like. These initiators may be used alone or in combination of two or more.
重合溶媒としては、重合を阻害する溶媒(重合禁止効果を有するニトロベンゼン、連鎖移動効果を有するメルカプト化合物等)以外の溶媒であって、その単量体を溶解可能な溶媒であれば限定されない。重合溶媒としては、例えばアルコール系溶媒、エーテル系溶媒、ケトン系溶媒、アミド系溶媒、エステル・ラクトン系溶媒、ニトリル系溶媒等が挙げられる。これらの溶媒は、単独で又は2種以上を組み合わせて用いてもよい。 The polymerization solvent is not limited as long as it is a solvent other than a solvent that inhibits polymerization (nitrobenzene having a polymerization prohibition effect, a mercapto compound having a chain transfer effect, etc.) and can dissolve the monomer. Examples of the polymerization solvent include alcohol solvents, ether solvents, ketone solvents, amide solvents, ester-lactone solvents, nitrile solvents and the like. These solvents may be used alone or in combination of two or more.
重合反応により得られた重合体は、再沈殿法により回収することができる。すなわち、重合反応終了後、重合体溶液を再沈溶媒に投入することにより、目的の重合体を粉体として回収する。再沈溶媒としては、アルコール類やアルカン類等を単独で又は2種以上を混合して使用することができる。再沈殿法の他に、分液操作やカラム操作、限外ろ過操作等により、単量体、オリゴマー等の低分子成分を除去して、重合体を回収することもできる。なお、重合溶媒が調製する硬化膜形成用樹脂材料(1)の溶媒と同じ場合、得られた重合体溶液をそのまま用いたり、得られた重合体溶液に溶媒を追加することで、硬化膜形成用樹脂材料(1)の調製に供してもよい。 The polymer obtained by the polymerization reaction can be recovered by the reprecipitation method. That is, after the polymerization reaction is completed, the target polymer is recovered as a powder by putting the polymer solution into the reprecipitation solvent. As the reprecipitation solvent, alcohols, alkanes and the like can be used alone or in combination of two or more. In addition to the reprecipitation method, the polymer can be recovered by removing low molecular weight components such as monomers and oligomers by a liquid separation operation, a column operation, an ultrafiltration operation, or the like. When the polymerization solvent is the same as the solvent of the resin material (1) for forming a cured film prepared, the obtained polymer solution can be used as it is, or a solvent can be added to the obtained polymer solution to form a cured film. It may be used for the preparation of the resin material (1) for use.
[A]重合体を製造するための重合反応においては、分子量を調整するために、分子量調整剤を使用できる。分子量調整剤としては、例えばクロロホルム、四臭化炭素等のハロゲン化炭化水素類;n−ヘキシルメルカプタン、n−オクチルメルカプタン、n−ドデシルメルカプタン、t−ドデシルメルカプタン、チオグリコール酸等のメルカプタン類;ジメチルキサントゲンスルフィド、ジイソプロピルキサントゲンジスルフィド等のキサントゲン類;ターピノーレン、α−メチルスチレンダイマー等が挙げられる。 [A] In the polymerization reaction for producing a polymer, a molecular weight adjusting agent can be used to adjust the molecular weight. Examples of the molecular weight modifier include halogenated hydrocarbons such as chloroform and carbon tetrabromide; mercaptans such as n-hexyl mercaptan, n-octyl mercaptan, n-dodecyl mercaptan, t-dodecyl mercaptan, and thioglycolic acid; dimethyl. Xanthogens such as xanthogen sulfide and diisopropyl xanthogen disulfide; turpinolene, α-methylstyrene dimer and the like can be mentioned.
[A]重合体のゲルパーミエーションクロマトグラフィ(GPC)によるポリスチレン換算重量平均分子量(Mw)としては、特に限定されないが、1,000以上30,000以下が好ましい。また、[A]重合体のMwとGPCによるポリスチレン換算数平均分子量(Mn)との比(Mw/Mn)としては、1以上3以下が好ましい。 The polystyrene-equivalent weight average molecular weight (Mw) of the polymer by gel permeation chromatography (GPC) is not particularly limited, but is preferably 1,000 or more and 30,000 or less. The ratio (Mw / Mn) of the Mw of the polymer [A] to the polystyrene-equivalent number average molecular weight (Mn) by GPC is preferably 1 or more and 3 or less.
当該硬化膜形成用樹脂材料(1)における[A]重合体の含有量としては特に限定されないが、全固形分に占める[A]重合体の含有量の下限としては、50質量%が好ましく、70質量%がより好ましく、90質量%がさらに好ましい。一方、この上限は、100質量%であってよい。当該硬化膜形成用樹脂材料(1)における[A]重合体の含有量を上記範囲とすることにより、得られる硬化膜の諸特性をより効果的に高めることなどができる。 The content of the [A] polymer in the resin material (1) for forming a cured film is not particularly limited, but the lower limit of the content of the [A] polymer in the total solid content is preferably 50% by mass. 70% by mass is more preferable, and 90% by mass is further preferable. On the other hand, this upper limit may be 100% by mass. By setting the content of the [A] polymer in the resin material (1) for forming a cured film within the above range, various properties of the obtained cured film can be more effectively enhanced.
<[D]酸化防止剤>
[D]酸化防止剤は、露光や加熱により発生したラジカル、又は酸化によって生成した過酸化物を分解し、重合体分子の結合の解裂を防止することができる成分である。その結果、得られる硬化膜は経時的な酸化劣化が防止され、例えば硬化膜の膜厚変化を抑制することができる。
<[D] Antioxidant>
[D] The antioxidant is a component capable of decomposing radicals generated by exposure or heating or peroxides generated by oxidation to prevent the bond of polymer molecules from breaking. As a result, the obtained cured film is prevented from being oxidatively deteriorated over time, and for example, a change in the film thickness of the cured film can be suppressed.
[D]酸化防止剤としては、例えばヒンダードフェノール構造を有する化合物、ヒンダードアミン構造を有する化合物、アルキルホスファイト構造を有する化合物、チオエーテル構造を有する化合物等が挙げられる。これらの中で、[D]酸化防止剤としては、ヒンダードフェノール構造を有する化合物が好ましい。 [D] Examples of the antioxidant include a compound having a hindered phenol structure, a compound having a hindered amine structure, a compound having an alkyl phosphite structure, a compound having a thioether structure, and the like. Among these, as the [D] antioxidant, a compound having a hindered phenol structure is preferable.
上記ヒンダードフェノール構造を有する化合物としては、例えばペンタエリスリトールテトラキス[3−(3,5−ジ−tert−ブチル−4−ヒドロキシフェニル)プロピオネート]、チオジエチレンビス[3−(3,5−ジ−tert−ブチル−4−ヒドロキシフェニル)プロピオネート]、オクタデシル−3−(3,5−ジ−tert−ブチル−4−ヒドロキシフェニル)プロピオネート、トリス−(3,5−ジ−t−ブチル−4−ヒドロキシベンジル)−イソシアヌレイト、1,3,5−トリメチル−2,4,6−トリス(3,5−ジ−tert−ブチル−4−ヒドロキシベンジル)ベンゼン、N,N’−ヘキサン−1,6−ジイルビス[3−(3,5−ジ−tert−ブチル−4−ヒドロキシフェニルプロピオンアミド)、3,3’,3’,5’,5’−ヘキサ−tert−ブチル−a,a’,a’−(メシチレン−2,4,6−トリイル)トリ−p−クレゾール、4,6−ビス(オクチルチオメチル)−o−クレゾール、4,6−ビス(ドデシルチオメチル)−o−クレゾール、エチレンビス(オキシエチレン)ビス[3−(5−tert−ブチル−4−ヒドロキシ−m−トリル)プロピオネート、ヘキサメチレンビス[3−(3,5−ジ−tert−ブチル−4−ヒドロキシフェニル)プロピオネート]、1,3,5−トリス[(4−tert−ブチル−3−ヒドロキシ−2,6−キシリル)メチル]−1,3,5−トリアジン−2,4,6(1H,3H,5H)−トリオン、2,6−ジ−tert−ブチル−4−(4,6−ビス(オクチルチオ)−1,3,5−トリアジン−2−イルアミン)フェノール、1,3,5−トリメチル−2,4,6−トリス(3,5−ジ−t−ブチル−4−ヒドロキシベンジル)ベンゼン、2,6−ジ−t−ブチル−4−クレゾール等が挙げられる。 Examples of the compound having a hindered phenol structure include pentaerythritol tetrakis [3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionate] and thiodiethylenebis [3- (3,5-di-). tert-butyl-4-hydroxyphenyl) propionate], octadecyl-3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionate, tris- (3,5-di-t-butyl-4-hydroxy) Benzyl) -isocyanurate, 1,3,5-trimethyl-2,4,6-tris (3,5-di-tert-butyl-4-hydroxybenzyl) benzene, N, N'-hexane-1,6 -Diylbis [3- (3,5-di-tert-butyl-4-hydroxyphenylpropionamide), 3,3', 3', 5', 5'-hexa-tert-butyl-a, a', a '-(Mesitylen-2,4,6-triyl) tri-p-cresol, 4,6-bis (octylthiomethyl) -o-cresol, 4,6-bis (dodecylthiomethyl) -o-cresol, ethylene Bis (oxyethylene) bis [3- (5-tert-butyl-4-hydroxy-m-tolyl) propionate, hexamethylene bis [3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionate] , 1,3,5-Tris [(4-tert-butyl-3-hydroxy-2,6-kisilyl) methyl] -1,3,5-triazine-2,4,6 (1H, 3H, 5H)- Trion, 2,6-di-tert-butyl-4- (4,6-bis (octylthio) -1,3,5-triazine-2-ylamine) phenol, 1,3,5-trimethyl-2,4 Examples thereof include 6-tris (3,5-di-t-butyl-4-hydroxybenzyl) benzene and 2,6-di-t-butyl-4-cresol.
上記ヒンダードフェノール構造を有する化合物の市販品としては、例えばアデカスタブAO−20、同AO−30、同AO−40、同AO−50、同AO−60、同AO−70、同AO−80、同AO−330(以上、ADEKA社)、sumilizerGM、同GS、同MDP−S、同BBM−S、同WX−R、同GA−80(以上、住友化学社)、IRGANOX1010、同1035、同1076、同1098、同1135、同1330、同1726、同1425WL、同1520L、同245、同259、同3114、同565、IRGAMOD295(以上、BASF社)、ヨシノックスBHT、同BB、同2246G、同425、同250、同930、同SS、同TT、同917、同314(以上、エーピーアイコーポレーション社)等が挙げられる。 Commercially available products of the compound having the hindered phenol structure include, for example, ADEKA STUB AO-20, AO-30, AO-40, AO-50, AO-60, AO-70, and AO-80. AO-330 (above, ADEKA), sumilizerGM, GS, MDP-S, BBM-S, WX-R, GA-80 (above, Sumitomo Chemical), IRGANOX1010, 1035, 1076 , 1098, 1135, 1330, 1726, 1425WL, 1520L, 245, 259, 3114, 565, IRGAMOD295 (above, BASF), Yoshinox BHT, BB, 2246G, 425. , 250, 930, SS, TT, 917, 314 (above, API Corporation) and the like.
ヒンダードフェノール構造を有する化合物の中でも、ペンタエリスリトールテトラキス[3−(3,5−ジ−tert−ブチル−4−ヒドロキシフェニル)プロピオネート]、1,3,5−トリメチル−2,4,6−トリス(3,5−ジ−t−ブチル−4−ヒドロキシベンジル)ベンゼン及び2,6−ジ−t−ブチル−4−クレゾールがより好ましい。 Among the compounds having a hindered phenol structure, pentaerythritol tetrakis [3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionate], 1,3,5-trimethyl-2,4,6-tris (3,5-Di-t-Butyl-4-hydroxybenzyl) benzene and 2,6-di-t-butyl-4-cresol are more preferred.
[D]酸化防止剤の含有量としては、[A]重合体100質量部に対して、0.001質量部以上5質量部以下が好ましい。[D]酸化防止剤の含有量を上記範囲とすることで、得られる硬化膜の経時的な酸化劣化を効果的に抑制することなどができる。 The content of the [D] antioxidant is preferably 0.001 part by mass or more and 5 parts by mass or less with respect to 100 parts by mass of the [A] polymer. [D] By setting the content of the antioxidant in the above range, it is possible to effectively suppress the oxidative deterioration of the obtained cured film over time.
<その他の成分>
当該硬化膜形成用樹脂材料(1)が含有してもよいその他の成分としては、例えば後述の溶媒の他、[E]界面活性剤、[F]接着助剤等が挙げられる。なお、当該硬化膜形成用樹脂材料(1)は、上記各成分を単独で又は2種以上を組み合わせて用いてもよい。
<Other ingredients>
Examples of other components that the cured film-forming resin material (1) may contain include, for example, [E] surfactant, [F] adhesive aid, and the like, in addition to the solvent described below. In the resin material (1) for forming a cured film, each of the above components may be used alone or in combination of two or more.
<[E]界面活性剤>
[E]界面活性剤は、膜形成性を向上させる成分である。[E]界面活性剤としては、例えばフッ素系界面活性剤、シリコーン系界面活性剤、及びその他の界面活性剤が挙げられる。
<[E] Surfactant>
[E] The surfactant is a component that improves the film-forming property. [E] Examples of the surfactant include a fluorine-based surfactant, a silicone-based surfactant, and other surfactants.
上記フッ素系界面活性剤としては、末端、主鎖及び側鎖の少なくともいずれかの部位にフルオロアルキル基及び/又はフルオロアルキレン基を有する化合物が好ましく、例えば1,1,2,2−テトラフロロ−n−オクチル(1,1,2,2−テトラフロロ−n−プロピル)エーテル、1,1,2,2−テトラフロロ−n−オクチル(n−ヘキシル)エーテル、ヘキサエチレングリコールジ(1,1,2,2,3,3−ヘキサフロロ−n−ペンチル)エーテル、オクタエチレングリコールジ(1,1,2,2−テトラフロロ−n−ブチル)エーテル、ヘキサプロピレングリコールジ(1,1,2,2,3,3−ヘキサフロロ−n−ペンチル)エーテル、オクタプロピレングリコールジ(1,1,2,2−テトラフロロ−n−ブチル)エーテル、パーフロロ−n−ドデカンスルホン酸ナトリウム、1,1,2,2,3,3−ヘキサフロロ−n−デカン、1,1,2,2,8,8,9,9,10,10−デカフロロ−n−ドデカンや、フロロアルキルベンゼンスルホン酸ナトリウム、フロロアルキルリン酸ナトリウム、フロロアルキルカルボン酸ナトリウム、ジグリセリンテトラキス(フロロアルキルポリオキシエチレンエーテル)、フロロアルキルアンモニウムヨージド、フロロアルキルベタイン、他のフロロアルキルポリオキシエチレンエーテル、パーフロロアルキルポリオキシエタノール、パーフロロアルキルアルコキシレート、カルボン酸フロロアルキルエステル等が挙げられる。 As the fluorine-based surfactant, a compound having a fluoroalkyl group and / or a fluoroalkylene group at at least one of the terminal, main chain and side chain is preferable, and for example, 1,1,2,2-tetrafluoro-n. -Octyl (1,1,2,2-tetrafluoro-n-propyl) ether, 1,1,2,2-tetrafluoro-n-octyl (n-hexyl) ether, hexaethylene glycol di (1,1,2,2, 2,3,3-hexafluoro-n-pentyl) ether, octaethylene glycol di (1,1,2,2-tetrafluoro-n-butyl) ether, hexapropylene glycol di (1,1,2,2,3) 3-Hexafluoro-n-pentyl) ether, octapropylene glycol di (1,1,2,2-tetrafluoro-n-butyl) ether, sodium perfluoro-n-dodecanesulfonate, 1,1,2,2,3 3-Hexafluoro-n-decane, 1,1,2,2,8,8,9,9,10,10-decafluoro-n-dodecane, sodium fluoroalkylbenzenesulfonate, sodium fluoroalkylphosphate, fluoroalkylcarboxylic acid Sodium acid, diglycerin tetrakis (fluoroalkyl polyoxyethylene ether), fluoroalkyl ammonium iodide, fluoroalkyl betaine, other fluoroalkyl polyoxyethylene ethers, perfluoroalkyl polyoxyethanol, perfluoroalkyl alkoxylate, fluorocarboxylic acid Alkyl esters and the like can be mentioned.
上記フッ素系界面活性剤の市販品としては、例えばBM−1000、BM−1100(以上、BM CHEMIE社)、メガファックF142D、同F172、同F173、同F183、同F178、同F191、同F471、同F476(以上、大日本インキ化学工業社)、フロラードFC−170C、同−171、同−430、同−431(以上、住友スリーエム社)、サーフロンS−112、同−113、同−131、同−141、同−145、同−382、サーフロンSC−101、同−102、同−103、同−104、同−105、同−106(以上、旭硝子社)、エフトップEF301、同303、同352(以上、新秋田化成社)、フタージェントFT−100、同−110、同−140A、同−150、同−250、同−251、同−300、同−310、同−400S、FTX−218、同−251(以上、ネオス社)等が挙げられる。 Commercially available products of the above-mentioned fluorine-based surfactant include, for example, BM-1000, BM-1100 (above, BM CHEMIE), Megafuck F142D, F172, F173, F183, F178, F191, F471, F476 (above, Dainippon Ink and Chemicals), Florard FC-170C, -171, -430, A-431 (above, Sumitomo 3M Ltd.), Surfron S-112, -113, -131, -141, -145, -382, Surflon SC-101, -102, -103, -104, -105, -106 (above, Asahi Glass Co., Ltd.), Ftop EF301, 303, 352 (above, Shin-Akita Kaseisha), Surfactant FT-100, -110, -140A, -150, -250, -251, -300, -310, -400S, FTX -218, -251 (above, Neos) and the like.
上記シリコーン系界面活性剤の市販品としては、例えばトーレシリコーンDC3PA、同DC7PA、同SH11PA、同SH21PA、同SH28PA、同SH29PA、同SH30PA、同SH−190、同SH−193、同SZ−6032、同SF−8428、同DC−57、同DC−190(以上、東レ・ダウコーニング・シリコーン社)、TSF−4440、TSF−4300、TSF−4445、TSF−4446、TSF−4460、TSF−4452(以上、GE東芝シリコーン社)、オルガノシロキサンポリマーKP341(信越化学工業社)等が挙げられる。 Examples of commercially available silicone-based surfactants include Torre Silicone DC3PA, DC7PA, SH11PA, SH21PA, SH28PA, SH29PA, SH30PA, SH-190, SH-193, and SZ-6032. SF-8428, DC-57, DC-190 (above, Toray Dow Corning Silicone), TSF-4440, TSF-4300, TSF-4445, TSF-4446, TSF-4460, TSF-4452 ( As mentioned above, GE Toshiba Silicone Co., Ltd.), Organosiloxane Polymer KP341 (Shin-Etsu Chemical Co., Ltd.) and the like can be mentioned.
上記その他の界面活性剤としては、例えばポリオキシエチレンラウリルエーテル、ポリオキシエチレンステアリルエーテル、ポリオキシエチレンオレイルエーテル等のポリオキシエチレンアルキルエーテル;ポリオキシエチレン−n−オクチルフェニルエーテル、ポリオキシエチレン−n−ノニルフェニルエーテル等のポリオキシエチレンアリールエーテル;ポリオキシエチレンジラウレート、ポリオキシエチレンジステアレート等のポリオキシエチレンジアルキルエステルなどのノニオン系界面活性剤等が挙げられる。 Examples of the other surfactant include polyoxyethylene alkyl ethers such as polyoxyethylene lauryl ether, polyoxyethylene stearyl ether, and polyoxyethylene oleyl ether; polyoxyethylene-n-octylphenyl ether, and polyoxyethylene-n. -Polyoxyethylene aryl ethers such as nonylphenyl ether; nonionic surfactants such as polyoxyethylene dialkyl esters such as polyoxyethylene dilaurate and polyoxyethylene distearate can be mentioned.
上記その他の界面活性剤の市販品としては、例えば(メタ)アクリル酸系共重合体ポリフローNo.57、同No.95(以上、共栄社化学社)等が挙げられる。 Examples of commercially available products of the above other surfactants include (meth) acrylic acid-based copolymer Polyflow No. 57, No. 95 (above, Kyoeisha Chemical Co., Ltd.) and the like can be mentioned.
[E]界面活性剤の含有量としては、[A]重合体100質量部に対して、0.01質量部以上3質量部以下が好ましい。[E]界面活性剤の含有量を上記範囲とすることで、効果的に膜形成性を向上させることができる。 The content of the [E] surfactant is preferably 0.01 parts by mass or more and 3 parts by mass or less with respect to 100 parts by mass of the [A] polymer. [E] By setting the content of the surfactant in the above range, the film-forming property can be effectively improved.
<[F]接着助剤>
[F]接着助剤は、得られる硬化膜と基板との接着性を向上させる成分である。[F]接着助剤としては、カルボキシ基、メタクリロイル基、ビニル基、イソシアネート基、オキシラニル基等の反応性官能基を有する官能性シランカップリング剤が好ましい。
<[F] Adhesive aid>
[F] The adhesive aid is a component that improves the adhesiveness between the obtained cured film and the substrate. [F] As the adhesion aid, a functional silane coupling agent having a reactive functional group such as a carboxy group, a methacryloyl group, a vinyl group, an isocyanate group, and an oxylanyl group is preferable.
上記官能性シランカップリング剤としては、例えばトリメトキシシリル安息香酸、γ−メタクリロキシプロピルトリメトキシシラン、ビニルトリアセトキシシラン、ビニルトリメトキシシラン、γ−イソシアナートプロピルトリエトキシシラン、γ−グリシドキシプロピルトリメトキシシラン、β−(3,4−エポキシシクロヘキシル)エチルトリメトキシシラン等が挙げられる。 Examples of the functional silane coupling agent include trimethoxysilyl benzoic acid, γ-methacryloxypropyltrimethoxysilane, vinyltriacetoxysilane, vinyltrimethoxysilane, γ-isocyanatopropyltriethoxysilane, and γ-glycidoxy. Examples thereof include propyltrimethoxysilane and β- (3,4-epoxycyclohexyl) ethyltrimethoxysilane.
[F]接着助剤の含有量としては、[A]重合体100質量部に対して、0.01質量部以上20質量部以下が好ましい。 The content of the [F] adhesive aid is preferably 0.01 parts by mass or more and 20 parts by mass or less with respect to 100 parts by mass of the [A] polymer.
<硬化膜形成用樹脂材料(1)の調製方法>
当該硬化膜形成用樹脂材料(1)は、[A]重合体及び必要に応じてその他の成分を所定の割合で混合し、好ましくは適当な溶媒に溶解して調製できる。調製した硬化膜形成用樹脂材料(1)は、例えば孔径0.2μm程度のフィルタでろ過することが好ましい。
<Preparation method of resin material (1) for forming a cured film>
The cured film-forming resin material (1) can be prepared by mixing the polymer [A] and, if necessary, other components in a predetermined ratio, and preferably dissolving it in an appropriate solvent. The prepared resin material (1) for forming a cured film is preferably filtered through, for example, a filter having a pore size of about 0.2 μm.
当該硬化膜形成用樹脂材料(1)の調製に用いられる溶媒としては、当該硬化膜形成用樹脂材料(1)が含有する各成分を均一に溶解又は分散し、上記各成分と反応しないものが用いられる。このような溶媒としては、例えばアルコール系溶媒、エーテル系溶媒、ケトン系溶媒、アミド系溶媒、エステル系溶媒、炭化水素系溶媒等が挙げられる。 As the solvent used for preparing the cured film-forming resin material (1), a solvent in which each component contained in the cured film-forming resin material (1) is uniformly dissolved or dispersed and does not react with the above-mentioned components is used. Used. Examples of such a solvent include alcohol solvents, ether solvents, ketone solvents, amide solvents, ester solvents, hydrocarbon solvents and the like.
上記アルコール系溶媒としては、例えば
モノアルコール系溶媒として、メタノール、エタノール、n−プロパノール、i−プロパノール、n−ブタノール、i−ブタノール、sec−ブタノール、tert−ブタノール、n−ペンタノール、i−ペンタノール、2−メチルブタノール、sec−ペンタノール、tert−ペンタノール、3−メトキシブタノール、n−ヘキサノール、2−メチルペンタノール、sec−ヘキサノール、2−エチルブタノール、sec−ヘプタノール、3−ヘプタノール、n−オクタノール、2−エチルヘキサノール、sec−オクタノール、n−ノニルアルコール、2,6−ジメチル−4−ヘプタノール、n−デカノール、sec−ウンデシルアルコール、トリメチルノニルアルコール、sec−テトラデシルアルコール、sec−ヘプタデシルアルコール、フルフリルアルコール、フェノール、シクロヘキサノール、メチルシクロヘキサノール、3,3,5−トリメチルシクロヘキサノール、ベンジルアルコール、ジアセトンアルコール等;
多価アルコール系溶媒として、エチレングリコール、1,2−プロピレングリコール、1,3−ブチレングリコール、2,4−ペンタンジオール、2−メチル−2,4−ペンタンジオール、2,5−ヘキサンジオール、2,4−ヘプタンジオール、2−エチル−1,3−ヘキサンジオール、ジエチレングリコール、ジプロピレングリコール、トリエチレングリコール、トリプロピレングリコール等;
多価アルコール部分エーテル系溶媒として、エチレングリコールモノメチルエーテル、エチレングリコールモノエチルエーテル、エチレングリコールモノプロピルエーテル、エチレングリコールモノブチルエーテル、エチレングリコールモノヘキシルエーテル、エチレングリコールモノフェニルエーテル、エチレングリコールモノ−2−エチルブチルエーテル、ジエチレングリコールモノメチルエーテル、ジエチレングリコールモノエチルエーテル、ジエチレングリコールモノプロピルエーテル、ジエチレングリコールモノブチルエーテル、ジエチレングリコールモノヘキシルエーテル、プロピレングリコールモノメチルエーテル、プロピレングリコールモノエチルエーテル、プロピレングリコールモノプロピルエーテル、プロピレングリコールモノブチルエーテル、ジプロピレングリコールモノメチルエーテル、ジプロピレングリコールモノエチルエーテル、ジプロピレングリコールモノプロピルエーテル等が挙げられる。
Examples of the alcohol-based solvent include methanol, ethanol, n-propanol, i-propanol, n-butanol, i-butanol, sec-butanol, tert-butanol, n-pentanol, and i-pen as monoalcohol-based solvents. Tanol, 2-methylbutanol, sec-pentanol, tert-pentanol, 3-methoxybutanol, n-hexanol, 2-methylpentanol, sec-hexanol, 2-ethylbutanol, sec-heptanol, 3-heptanol, n -Octanol, 2-ethylhexanol, sec-octanol, n-nonyl alcohol, 2,6-dimethyl-4-heptanol, n-decanol, sec-undecyl alcohol, trimethylnonyl alcohol, sec-tetradecyl alcohol, sec-hepta Decyl alcohol, furfuryl alcohol, phenol, cyclohexanol, methylcyclohexanol, 3,3,5-trimethylcyclohexanol, benzyl alcohol, diacetone alcohol, etc .;
As polyhydric alcohol-based solvents, ethylene glycol, 1,2-propylene glycol, 1,3-butylene glycol, 2,4-pentanediol, 2-methyl-2,4-pentanediol, 2,5-hexanediol, 2 , 4-Heptanediol, 2-ethyl-1,3-hexanediol, Diethylene glycol, Dipropylene glycol, Triethylene glycol, Tripropylene glycol, etc .;
As a polyhydric alcohol partially ether-based solvent, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, ethylene glycol monobutyl ether, ethylene glycol monohexyl ether, ethylene glycol monophenyl ether, ethylene glycol mono-2-ethyl Butyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monopropyl ether, diethylene glycol monobutyl ether, diethylene glycol monohexyl ether, propylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, propylene glycol monobutyl ether, dipropylene glycol Examples thereof include monomethyl ether, dipropylene glycol monoethyl ether and dipropylene glycol monopropyl ether.
上記エーテル系溶媒としては、例えばジエチルエーテル、ジプロピルエーテル、ジブチルエーテル、ジフェニルエーテル、ジエチレングリコールジメチルエーテル、ジエチレングリコールメチルエチルエーテル、ジエチレングリコールジエチルエーテル、テトラヒドロフラン等が挙げられる。 Examples of the ether solvent include diethyl ether, dipropyl ether, dibutyl ether, diphenyl ether, diethylene glycol dimethyl ether, diethylene glycol methyl ethyl ether, diethylene glycol diethyl ether, tetrahydrofuran and the like.
上記ケトン系溶媒としては、例えばアセトン、メチルエチルケトン、メチル−n−プロピルケトン、メチル−n−ブチルケトン、ジエチルケトン、メチル−i−ブチルケトン、メチル−n−ペンチルケトン、エチル−n−ブチルケトン、メチル−n−ヘキシルケトン、ジ−i−ブチルケトン、トリメチルノナノン、シクロペンタノン、シクロヘキサノン、シクロヘプタノン、シクロオクタノン、メチルシクロヘキサノン、2,4−ペンタンジオン、アセトニルアセトン、アセトフェノン等が挙げられる。 Examples of the ketone solvent include acetone, methyl ethyl ketone, methyl-n-propyl ketone, methyl-n-butyl ketone, diethyl ketone, methyl-i-butyl ketone, methyl-n-pentyl ketone, ethyl-n-butyl ketone, and methyl-n. Examples thereof include -hexyl ketone, di-i-butyl ketone, trimethylnonanone, cyclopentanone, cyclohexanone, cycloheptanone, cyclooctanone, methylcyclohexanone, 2,4-pentandione, acetonylacetone and acetophenone.
上記アミド系溶媒としては、例えばN,N’−ジメチルイミダゾリジノン、N−メチルホルムアミド、N,N−ジメチルホルムアミド、N,N−ジエチルホルムアミド、アセトアミド、N−メチルアセトアミド、N,N−ジメチルアセトアミド、N−メチルプロピオンアミド、N−メチルピロリドン等が挙げられる。 Examples of the amide solvent include N, N'-dimethylimidazolidinone, N-methylformamide, N, N-dimethylformamide, N, N-diethylformamide, acetamide, N-methylacetamide, N, N-dimethylacetamide. , N-methylpropionamide, N-methylpyrrolidone and the like.
上記エステル系溶媒としては、例えば酢酸メチル、酢酸エチル、酢酸n−プロピル、酢酸i−プロピル、酢酸n−ブチル、酢酸i−ブチル、酢酸sec−ブチル、酢酸n−ペンチル、酢酸sec−ペンチル、酢酸3−メトキシブチル、酢酸3−メチル−3−メトキシブチル、酢酸メチルペンチル、酢酸2−エチルブチル、酢酸2−エチルヘキシル、酢酸ベンジル、酢酸シクロヘキシル、酢酸メチルシクロヘキシル、酢酸n−ノニル、アセト酢酸メチル、アセト酢酸エチル、酢酸エチレングリコールモノメチルエーテル、酢酸エチレングリコールモノエチルエーテル、酢酸エチレングリコールモノ−n−プロピルエーテル、酢酸エチレングリコールモノ−n−ブチルエーテル、酢酸ジエチレングリコールモノメチルエーテル、酢酸ジエチレングリコールモノエチルエーテル、酢酸ジエチレングリコールモノ−n−プロピルエーテル、酢酸ジエチレングリコールモノ−n−ブチルエーテル、酢酸プロピレングリコールモノメチルエーテル、酢酸プロピレングリコールモノエチルエーテル、酢酸プロピレングリコールモノプロピルエーテル、酢酸プロピレングリコールモノブチルエーテル、酢酸ジプロピレングリコールモノメチルエーテル、酢酸ジプロピレングリコールモノエチルエーテル、ジ酢酸グリコール、酢酸メトキシトリグリコール、プロピオン酸エチル、プロピオン酸n−ブチル、プロピオン酸i−アミル、シュウ酸ジエチル、シュウ酸ジ−n−ブチル、乳酸メチル、乳酸エチル、乳酸n−ブチル、乳酸n−アミル、マロン酸ジエチル、フタル酸ジメチル、フタル酸ジエチル等が挙げられる。 Examples of the ester solvent include methyl acetate, ethyl acetate, n-propyl acetate, i-propyl acetate, n-butyl acetate, i-butyl acetate, sec-butyl acetate, n-pentyl acetate, sec-pentyl acetate and acetic acid. 3-methoxybutyl, 3-methyl-3-methoxybutyl acetate, methylpentyl acetate, 2-ethylbutyl acetate, 2-ethylhexyl acetate, benzyl acetate, cyclohexyl acetate, methylcyclohexyl acetate, n-nonyl acetate, methyl acetoacetate, acetoacetate Ethyl, ethylene glycol monomethyl ether acetate, ethylene glycol monoethyl ether acetate, ethylene glycol mono-n-propyl acetate ether, ethylene glycol mono-n-butyl acetate ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, diethylene glycol mono-n acetate -Propyl ether, diethylene glycol mono-n-butyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, propylene glycol monopropyl acetate ether, propylene glycol monobutyl acetate ether, dipropylene glycol monomethyl ether acetate, dipropylene glycol monoacetate Ethyl ether, glycol diacetate, methoxytriglycol acetate, ethyl propionate, n-butyl propionate, i-amyl propionate, diethyl oxalate, di-n-butyl oxalate, methyl lactate, ethyl lactate, n-butyl lactate , N-amyl lactate, diethyl malonate, dimethyl phthalate, diethyl phthalate and the like.
上記炭化水素系溶媒としては、例えば
脂肪族炭化水素系溶媒として、n−ペンタン、i−ペンタン、n−ヘキサン、i−ヘキサン、n−ヘプタン、i−ヘプタン、2,2,4−トリメチルペンタン、n−オクタン、i−オクタン、シクロヘキサン、メチルシクロヘキサン等;
芳香族炭化水素系溶媒として、ベンゼン、トルエン、キシレン、メシチレン、エチルベンゼン、トリメチルベンゼン、メチルエチルベンゼン、n−プロピルベンゼン、i−プロピルベンゼン、ジエチルベンゼン、i−ブチルベンゼン、トリエチルベンゼン、ジ−i−プロピルベンセン、n−アミルナフタレン等が挙げられる。
Examples of the above-mentioned hydrocarbon-based solvent include n-pentane, i-pentane, n-hexane, i-hexane, n-heptane, i-heptane, 2,2,4-trimethylpentane, as aliphatic hydrocarbon-based solvents. n-octane, i-octane, cyclohexane, methylcyclohexane, etc .;
Aromatic hydrocarbon solvents include benzene, toluene, xylene, mesitylene, ethylbenzene, trimethylbenzene, methylethylbenzene, n-propylbenzene, i-propylbenzene, diethylbenzene, i-butylbenzene, triethylbenzene, di-i-propylbenzene. , N-amylnaphthalene and the like.
また、上記溶媒は、カプロン酸、カプリル酸、炭酸エチレン、炭酸プロピレン等の高沸点溶媒をさらに含有してもよい。 Further, the solvent may further contain a high boiling point solvent such as caproic acid, caprylic acid, ethylene carbonate and propylene carbonate.
<硬化膜の形成方法(1)>
本発明の一実施形態に係る硬化膜の形成方法(1)は、
(1)当該硬化膜形成用樹脂材料(1)を用い、基板上に塗膜を形成する工程(以下、「工程(A1)」ともいう)、及び
(2)上記塗膜を加熱する工程(以下、「工程(A2)」ともいう)
を備える。
<Method of forming a cured film (1)>
The method (1) for forming a cured film according to an embodiment of the present invention is
(1) A step of forming a coating film on a substrate using the resin material (1) for forming a cured film (hereinafter, also referred to as "step (A1)"), and (2) a step of heating the coating film (2) Hereinafter, it is also referred to as "process (A2)")
To be equipped.
当該硬化膜形成用樹脂材料(1)は上述の性質を有しているため、当該硬化膜の形成方法(1)によれば、耐熱性、耐薬品性、透過率、比誘電率等の一般的特性を十分満足し、かつ優れた表面硬度を有する硬化膜を形成することができる。以下、各工程について詳述する。 Since the cured film forming resin material (1) has the above-mentioned properties, according to the cured film forming method (1), general heat resistance, chemical resistance, transmittance, relative permittivity, etc. are generally used. It is possible to form a cured film that sufficiently satisfies the above-mentioned characteristics and has excellent surface hardness. Hereinafter, each step will be described in detail.
[工程(A1)]
本工程では、当該硬化膜形成用樹脂材料(1)を用い、基板上に塗膜を形成する。具体的には、溶液状の当該硬化膜形成用樹脂材料(1)を基板表面に塗布し、好ましくはプレベークを行うことにより溶媒を除去して塗膜を形成する。上記基板としては、例えばガラス基板、シリコン基板、プラスチック基板、及びこれらの表面に各種金属薄膜が形成された基板等が挙げられる。上記プラスチック基板としては、例えばポリエチレンテレフタレート(PET)、ポリブチレンテレフタレート(PBT)、ポリエーテルスルホン、ポリカーボネート、ポリイミド等のプラスチックからなる樹脂基板が挙げられる。
[Step (A1)]
In this step, a coating film is formed on the substrate by using the cured film forming resin material (1). Specifically, the resin material (1) for forming the cured film in the form of a solution is applied to the surface of the substrate, and preferably prebaking is performed to remove the solvent to form a coating film. Examples of the substrate include a glass substrate, a silicon substrate, a plastic substrate, and a substrate on which various metal thin films are formed on the surface thereof. Examples of the plastic substrate include resin substrates made of plastics such as polyethylene terephthalate (PET), polybutylene terephthalate (PBT), polyether sulfone, polycarbonate, and polyimide.
塗布方法としては、例えばスプレー法、ロールコート法、回転塗布法(スピンコート法)、スリットダイ塗布法、バー塗布法、インクジェット法等の適宜の方法を採用することができる。これらの中で、塗布方法としては、スピンコート法、バー塗布法及びスリットダイ塗布法が好ましい。上記プレベークの条件としては、各成分の種類、使用割合等によっても異なるが、例えば60℃〜130℃で30秒間〜10分間程度とすることができる。形成される塗膜の膜厚は、プレベーク後の値として、0.1μm以上8μm以下が好ましい。 As the coating method, for example, an appropriate method such as a spray method, a roll coating method, a rotary coating method (spin coating method), a slit die coating method, a bar coating method, and an inkjet method can be adopted. Among these, as the coating method, a spin coating method, a bar coating method and a slit die coating method are preferable. The pre-baking conditions vary depending on the type of each component, the usage ratio, and the like, but can be, for example, about 30 seconds to 10 minutes at 60 ° C to 130 ° C. The film thickness of the coating film to be formed is preferably 0.1 μm or more and 8 μm or less as a value after prebaking.
[工程(A2)]
本工程では、上記塗膜を加熱により硬化させる。加熱方法としては特に限定されないが、例えばオーブンやホットプレート等の加熱装置を用いて加熱することができる。本工程における加熱温度としては、200℃以下が好ましい。このように低い温度での加熱が可能であることにより、当該硬化膜の形成方法(1)は、フレキシブルディスプレイのプラスチック基板上における層間絶縁膜等の硬化膜形成に好適に使用することができる。加熱温度としては、120℃以上180℃以下がより好ましい。加熱時間としては、加熱機器の種類により異なるが、例えばホットプレート上で加熱処理を行う場合には5分以上40分以下、オーブン中で加熱処理を行う場合には30分以上80分以下とすることができる。このようにして、目的とする層間絶縁膜等の硬化膜を基板上に形成することができる。
[Process (A2)]
In this step, the coating film is cured by heating. The heating method is not particularly limited, but heating can be performed using a heating device such as an oven or a hot plate. The heating temperature in this step is preferably 200 ° C. or lower. Since heating at such a low temperature is possible, the method (1) for forming the cured film can be suitably used for forming a cured film such as an interlayer insulating film on a plastic substrate of a flexible display. The heating temperature is more preferably 120 ° C. or higher and 180 ° C. or lower. The heating time varies depending on the type of heating equipment, but is, for example, 5 minutes or more and 40 minutes or less when heat treatment is performed on a hot plate, and 30 minutes or more and 80 minutes or less when heat treatment is performed in an oven. be able to. In this way, a cured film such as a target interlayer insulating film can be formed on the substrate.
<硬化膜形成用樹脂材料(2)>
当該硬化膜形成用樹脂材料(2)は、[A]重合体、[B]重合性化合物及び[C]感放射線性重合開始剤を含有する。また、当該硬化膜形成用樹脂材料(2)は、好適成分として[D]酸化防止剤を含有してもよい。さらに、当該硬化膜形成用樹脂材料(2)は、本発明の効果を損なわない範囲でその他の成分を含有してもよい。
<Resin material for forming a cured film (2)>
The cured film-forming resin material (2) contains a [A] polymer, a [B] polymerizable compound, and a [C] radiation-sensitive polymerization initiator. Further, the resin material (2) for forming a cured film may contain a [D] antioxidant as a suitable component. Further, the cured film-forming resin material (2) may contain other components as long as the effects of the present invention are not impaired.
当該硬化膜形成用樹脂材料(2)は、[A]重合体、[B]重合性化合物及び[C]感放射線性重合開始剤を含有しているため、放射線が照射された部位(露光部)が重合により硬化し、アルカリ現像液による現像により上記露光部以外の部位(未露光部)が溶解除去されてパターンを形成できる、いわゆるネガ型の特性を有するネガ型感放射線性樹脂組成物である。そのため、当該硬化膜形成用樹脂材料(2)は、パターン状の硬化膜を形成することができる。以下、各成分について詳述する。 Since the resin material (2) for forming a cured film contains the [A] polymer, the [B] polymerizable compound, and the [C] radiation-sensitive polymerization initiator, the portion irradiated with radiation (exposed portion). ) Is cured by polymerization, and parts other than the exposed part (unexposed part) can be dissolved and removed by development with an alkaline developer to form a pattern, which is a negative type radiation-sensitive resin composition having so-called negative type characteristics. is there. Therefore, the cured film-forming resin material (2) can form a patterned cured film. Hereinafter, each component will be described in detail.
<[A]重合体>
[A]重合体は、構造単位(I)及び構造単位(II)を含む重合体である。また、[A]重合体は、構造単位(III)を含むことが好ましく、構造単位(IV)及び構造単位(V)を含んでいてもよい。当該硬化膜形成用樹脂材料(2)における[A]重合体は、上述した硬化膜形成用樹脂材料(1)における[A]重合体と同様のものとすることができる。
<[A] Polymer>
[A] The polymer is a polymer containing a structural unit (I) and a structural unit (II). Further, the [A] polymer preferably contains a structural unit (III), and may contain a structural unit (IV) and a structural unit (V). The [A] polymer in the cured film-forming resin material (2) can be the same as the [A] polymer in the above-mentioned cured film-forming resin material (1).
[A]重合体が構造単位(I)及び構造単位(II)を有することで、上述の硬化膜形成用樹脂材料(1)と同様に、当該硬化膜形成用樹脂材料(2)は、優れた表面硬度を有すると共に耐薬品性、耐熱性、透明性、低誘電性等の一般的特性を十分満足可能な硬化膜を形成でき、かつ保存安定性に優れる。加えて、当該硬化膜形成用樹脂材料(2)は、構造単位(I)の酸性基の存在により、未露光部においてアルカリ現像液に対する良好な溶解性を発揮できる。なお、[A]重合体は、各構造単位を2種以上有していてもよい。 [A] Since the polymer has the structural unit (I) and the structural unit (II), the cured film-forming resin material (2) is excellent in the same manner as the cured film-forming resin material (1) described above. It has a surface hardness, can form a cured film that can sufficiently satisfy general properties such as chemical resistance, heat resistance, transparency, and low dielectric property, and is excellent in storage stability. In addition, the cured film-forming resin material (2) can exhibit good solubility in an alkaline developer in an unexposed portion due to the presence of the acidic group of the structural unit (I). The polymer [A] may have two or more types of each structural unit.
[構造単位(I)]
構造単位(I)は、酸性基を有する構造単位である。この構造単位(I)は、上述の硬化膜形成用樹脂材料(1)の[A]重合体おける構造単位(I)と同様であるため、その詳細な説明は省略する。
[Structural unit (I)]
The structural unit (I) is a structural unit having an acidic group. Since this structural unit (I) is the same as the structural unit (I) in the polymer [A] of the above-mentioned resin material for forming a cured film (1), detailed description thereof will be omitted.
当該硬化膜形成用樹脂材料(2)の[A]重合体における構造単位(I)の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、10質量%が好ましく、20質量%がより好ましく、30質量%がさらに好ましく、40質量%が特に好ましい。一方、構造単位(I)の含有割合の上限としては、80質量%が好ましく、70質量%がより好ましく、60質量%がさらに好ましい。構造単位(I)の含有割合を上記範囲とすることにより、保存安定性や、得られる硬化膜の諸特性等をより高めることができる。また、構造単位(I)の含有割合を上記範囲とすることにより、良好な現像性等を発揮することもできる。 The lower limit of the content ratio of the structural unit (I) in the [A] polymer of the cured film forming resin material (2) is preferably 10% by mass with respect to all the structural units constituting the [A] polymer. , 20% by mass is more preferable, 30% by mass is further preferable, and 40% by mass is particularly preferable. On the other hand, as the upper limit of the content ratio of the structural unit (I), 80% by mass is preferable, 70% by mass is more preferable, and 60% by mass is further preferable. By setting the content ratio of the structural unit (I) in the above range, the storage stability and various properties of the obtained cured film can be further improved. Further, by setting the content ratio of the structural unit (I) in the above range, good developability and the like can be exhibited.
当該硬化膜形成用樹脂材料(2)の[A]重合体における上記式(3−1)及び式(3−2)で表される構造単位等の、フッ素含有アルコール性水酸基を有する構造単位の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、10質量%が好ましく、20質量%がより好ましくい。一方、この上限としては、60質量%が好ましく、50質量%がより好ましく、40質量%がさらに好ましい。 A structural unit having a fluorine-containing alcoholic hydroxyl group, such as the structural units represented by the above formulas (3-1) and (3-2) in the [A] polymer of the cured film-forming resin material (2). As the lower limit of the content ratio, 10% by mass is preferable, and 20% by mass is more preferable with respect to all the structural units constituting the polymer [A]. On the other hand, as the upper limit, 60% by mass is preferable, 50% by mass is more preferable, and 40% by mass is further preferable.
当該硬化膜形成用樹脂材料(2)の[A]重合体における(メタ)アクリル酸に由来する構造単位等、カルボキシ基を有する構造単位の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、5質量%が好ましく、10質量%がより好ましく、15質量%がさらに好ましく、20質量%が特に好ましい。一方、この上限としては、50質量%が好ましく、30質量%がより好ましい。 The lower limit of the content ratio of the structural unit having a carboxy group such as the structural unit derived from (meth) acrylic acid in the [A] polymer of the resin material for forming a cured film (2) is the [A] polymer. 5% by mass is preferable, 10% by mass is more preferable, 15% by mass is further preferable, and 20% by mass is particularly preferable with respect to all the structural units. On the other hand, as the upper limit, 50% by mass is preferable, and 30% by mass is more preferable.
[構造単位(II)]
構造単位(II)は、上記式(1−1)で表される基及び上記式(1−2)で表される基から選ばれる少なくとも1種の基を有する構造単位である。この構造単位(II)は、上述の硬化膜形成用樹脂材料(1)の[A]重合体おける構造単位(II)と同様であるため、その詳細な説明は省略する。
[Structural unit (II)]
The structural unit (II) is a structural unit having at least one group selected from the group represented by the above formula (1-1) and the group represented by the above formula (1-2). Since this structural unit (II) is the same as the structural unit (II) in the [A] polymer of the above-mentioned resin material for forming a cured film (1), detailed description thereof will be omitted.
当該硬化膜形成用樹脂材料(2)の[A]重合体における構造単位(II)の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、10質量%が好ましく、20質量%がより好ましい。一方、この上限としては、70質量%が好ましく、50質量%がより好ましい。構造単位(II)の含有割合を上記範囲とすることで、得られる硬化膜の諸特性や保存安定性等をより高めることができる。また、構造単位(II)の含有割合を上記範囲とすることで、[A]重合体において構造単位(I)と構造単位(II)との間で十分な架橋反応が生じることなどにより、現像密着性を高めることなどができる。 The lower limit of the content ratio of the structural unit (II) in the [A] polymer of the cured film forming resin material (2) is preferably 10% by mass with respect to all the structural units constituting the [A] polymer. , 20% by mass is more preferable. On the other hand, as the upper limit, 70% by mass is preferable, and 50% by mass is more preferable. By setting the content ratio of the structural unit (II) within the above range, various properties and storage stability of the obtained cured film can be further enhanced. Further, by setting the content ratio of the structural unit (II) in the above range, a sufficient cross-linking reaction occurs between the structural unit (I) and the structural unit (II) in the [A] polymer, and thus development is performed. Adhesion can be improved.
[構造単位(III)]
構造単位(III)は、架橋性基を有する構造単位である。[A]重合体が構造単位(III)を有することで、得られる硬化膜の表面硬度や、現像密着性等を高めることができる。この構造単位(III)は、上述の硬化膜形成用樹脂材料(1)の[A]重合体おける構造単位(III)と同様であるため、その詳細な説明は省略する。
[Structural unit (III)]
The structural unit (III) is a structural unit having a crosslinkable group. [A] When the polymer has the structural unit (III), the surface hardness of the obtained cured film, the development adhesion, and the like can be improved. Since this structural unit (III) is the same as the structural unit (III) in the [A] polymer of the above-mentioned resin material for forming a cured film (1), detailed description thereof will be omitted.
当該硬化膜形成用樹脂材料(2)の[A]重合体における構造単位(III)の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、1質量%が好ましく、5質量%がより好ましく、10質量%がさらに好ましい。一方、この上限としては、70質量%が好ましく、50質量%がより好ましく、30質量%がさらに好ましく、25質量%が特に好ましい。構造単位(III)の含有割合を上記範囲とすることで、高い保存安定性を維持したまま、得られる硬化膜の硬度や現像密着性等の諸特性をより高めることなどができる。 The lower limit of the content ratio of the structural unit (III) in the [A] polymer of the cured film forming resin material (2) is preferably 1% by mass with respect to all the structural units constituting the [A] polymer. 5, 5% by mass is more preferable, and 10% by mass is further preferable. On the other hand, as the upper limit, 70% by mass is preferable, 50% by mass is more preferable, 30% by mass is further preferable, and 25% by mass is particularly preferable. By setting the content ratio of the structural unit (III) in the above range, it is possible to further enhance various properties such as hardness and development adhesion of the obtained cured film while maintaining high storage stability.
[構造単位(IV)]
構造単位(IV)は、構造単位(I)〜(III)以外の構造単位であって、ヒドロキシ基を有する(メタ)アクリル酸エステル由来の構造単位である。[A]重合体が構造単位(IV)を有することで、アルカリ現像性の制御及び残渣抑制を図ることができる。この構造単位(IV)は、上述の硬化膜形成用樹脂材料(1)の[A]重合体おける構造単位(IV)と同様であるため、その詳細な説明は省略する。
[Structural unit (IV)]
The structural unit (IV) is a structural unit other than the structural units (I) to (III) and is a structural unit derived from a (meth) acrylic acid ester having a hydroxy group. [A] When the polymer has the structural unit (IV), the alkali developability can be controlled and the residue can be suppressed. Since this structural unit (IV) is the same as the structural unit (IV) in the polymer [A] of the above-mentioned resin material for forming a cured film (1), detailed description thereof will be omitted.
当該硬化膜形成用樹脂材料(2)の[A]重合体における構造単位(IV)の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、1質量%が好ましく、5質量%がより好ましい。一方、この上限としては、50質量%が好ましく、20質量%がより好ましい。構造単位(IV)の含有割合を上記範囲とすることで、高い保存安定性を維持したまま、アルカリ現像性等をより良好なものとすることができる。 The lower limit of the content ratio of the structural unit (IV) in the [A] polymer of the cured film forming resin material (2) is preferably 1% by mass with respect to all the structural units constituting the [A] polymer. 5, 5% by mass is more preferable. On the other hand, as the upper limit, 50% by mass is preferable, and 20% by mass is more preferable. By setting the content ratio of the structural unit (IV) in the above range, it is possible to improve the alkali developability and the like while maintaining high storage stability.
[構造単位(V)]
構造単位(V)は、上記構造単位(I)〜(IV)以外の構造単位である。[A]重合体が構造単位(V)を有することで、当該硬化膜形成用樹脂材料(2)は、樹脂のガラス転移温度を調整し、アルカリ現像性、熱硬化時のメルトフロー性や硬化膜の機械的強度、耐薬品性を向上することができる。この構造単位(V)は、上述の硬化膜形成用樹脂材料(1)の[A]重合体おける構造単位(V)と同様であるため、その詳細な説明は省略する。
[Structural unit (V)]
The structural unit (V) is a structural unit other than the structural units (I) to (IV). [A] Since the polymer has a structural unit (V), the cured film-forming resin material (2) adjusts the glass transition temperature of the resin, and has alkali developability, melt flow property during thermosetting, and curing. The mechanical strength and chemical resistance of the film can be improved. Since this structural unit (V) is the same as the structural unit (V) in the polymer [A] of the above-mentioned resin material for forming a cured film (1), detailed description thereof will be omitted.
当該硬化膜形成用樹脂材料(2)の[A]重合体における構造単位(V)の含有割合の下限としては、[A]重合体を構成する全構造単位に対して、1質量%が好ましく、3質量%がより好ましい。一方、この上限としては、50質量%が好ましく、30質量%がより好ましい。構造単位(V)の含有割合を上記範囲とすることで、耐薬品性等を効果的に向上させることができる。 The lower limit of the content ratio of the structural unit (V) in the [A] polymer of the cured film forming resin material (2) is preferably 1% by mass with respect to all the structural units constituting the [A] polymer. 3, 3% by mass is more preferable. On the other hand, as the upper limit, 50% by mass is preferable, and 30% by mass is more preferable. By setting the content ratio of the structural unit (V) within the above range, chemical resistance and the like can be effectively improved.
<[A]重合体の合成方法>
当該硬化膜形成用樹脂材料(2)の[A]重合体は、上述した硬化膜形成用樹脂材料(1)における[A]重合体の合成方法と同様の方法等を適用することができる。
<[A] Polymer synthesis method>
As the [A] polymer of the cured film-forming resin material (2), the same method as the method for synthesizing the [A] polymer in the cured film-forming resin material (1) described above can be applied.
当該硬化膜形成用樹脂材料(2)における[A]重合体のゲルパーミエーションクロマトグラフィ(GPC)によるポリスチレン換算重量平均分子量(Mw)としては、特に限定されないが、1,000以上30,000以下が好ましい。また、[A]重合体のMwとGPCによるポリスチレン換算数平均分子量(Mn)との比(Mw/Mn)としては、1以上3以下が好ましい。 The polystyrene-equivalent weight average molecular weight (Mw) of the polymer [A] in the cured film-forming resin material (2) by gel permeation chromatography (GPC) is not particularly limited, but is 1,000 or more and 30,000 or less. preferable. The ratio (Mw / Mn) of the Mw of the polymer [A] to the polystyrene-equivalent number average molecular weight (Mn) by GPC is preferably 1 or more and 3 or less.
当該硬化膜形成用樹脂材料(2)における[A]重合体の含有量としては特に限定されないが、全固形分に占める[A]重合体の含有量の下限としては、40質量%が好ましく、50質量%がより好ましく、60質量%がさらに好ましい。一方、この上限は、90質量%が好ましく、80質量%がより好ましい。当該硬化膜形成用樹脂材料(2)における[A]重合体の含有量を上記範囲とすることにより、良好な感度等を有しつつ、得られる硬化膜の諸特性をより効果的に高めることなどができる。 The content of the [A] polymer in the resin material (2) for forming a cured film is not particularly limited, but the lower limit of the content of the [A] polymer in the total solid content is preferably 40% by mass. 50% by mass is more preferable, and 60% by mass is further preferable. On the other hand, this upper limit is preferably 90% by mass, more preferably 80% by mass. By setting the content of the [A] polymer in the resin material (2) for forming a cured film within the above range, various properties of the obtained cured film can be more effectively enhanced while having good sensitivity and the like. And so on.
<[B]重合性化合物>
[B]重合性化合物は、エチレン性不飽和結合を有する化合物である。なお、[B]重合性化合物は、単独で又は2種以上を組み合わせて用いてもよい。
<[B] Polymerizable compound>
[B] The polymerizable compound is a compound having an ethylenically unsaturated bond. The [B] polymerizable compound may be used alone or in combination of two or more.
[B]重合性化合物としては、エチレン性不飽和結合を有する重合性化合物であれば特に限定されないが、例えばω−カルボキシポリカプロラクトンモノ(メタ)アクリレート、2−(2’−ビニロキシエトキシ)エチル(メタ)アクリレート等の単官能(メタ)アクリレート化合物;エチレングリコールジ(メタ)アクリレート、1,6−ヘキサンジオールジ(メタ)アクリレート、1,9−ノナンジオールジ(メタ)アクリレート、テトラエチレングリコールジ(メタ)アクリレート、ポリエチレングリコールジ(メタ)アクリレート、ポリプロピレングリコールジ(メタ)アクリレート、ビスフェノキシエタノールフルオレンジ(メタ)アクリレート、ジメチロールトリシクロデカンジ(メタ)アクリレート、2−ヒドロキシ−3−(メタ)アクリロイロキシプロピルメタクリレート、トリメチロールプロパントリ(メタ)アクリレート、ペンタエリスリトールトリ(メタ)アクリレート、ペンタエリスリトールテトラ(メタ)アクリレート、ジペンタエリスリトールペンタ(メタ)アクリレート、ジペンタエリスリトールヘキサ(メタ)アクリレート、トリ(2−(メタ)アクリロイロキシエチル)フォスフェート、エチレンオキサイド変性ジペンタエリスリトールヘキサアクリレート、コハク酸変性ペンタエリスリトールトリアクリレート、直鎖アルキレン基及び脂環式構造を有し、かつ2個以上のイソシアネート基を有する化合物と、分子内に1個以上の水酸基を有し、かつ3個〜5個の(メタ)アクリロイロキシ基を有する化合物とを反応させて得られるウレタン(メタ)アクリレート化合物等の多官能(メタ)アクリレート化合物等が挙げられる。 The [B] polymerizable compound is not particularly limited as long as it is a polymerizable compound having an ethylenically unsaturated bond, and is, for example, ω-carboxypolycaprolactone mono (meth) acrylate, 2- (2'-vinyloxyethoxy) ethyl. Monofunctional (meth) acrylate compounds such as (meth) acrylate; ethylene glycol di (meth) acrylate, 1,6-hexanediol di (meth) acrylate, 1,9-nonanediol di (meth) acrylate, tetraethylene glycol di (Meta) acrylate, Polyethylene glycol di (meth) acrylate, Polypropylene glycol di (meth) acrylate, Bisphenoxyethanol full orange (meth) acrylate, Dimethylol tricyclodecandi (meth) acrylate, 2-Hydroxy-3- (meth) Acryloyloxypropyl methacrylate, trimethylolpropane tri (meth) acrylate, pentaerythritol tri (meth) acrylate, pentaerythritol tetra (meth) acrylate, dipentaerythritol penta (meth) acrylate, dipentaerythritol hexa (meth) acrylate, tri (2- (Meta) acryloyloxyethyl) phosphate, ethylene oxide-modified dipentaerythritol hexaacrylate, succinic acid-modified pentaerythritol triacrylate, linear alkylene group and alicyclic structure, and two or more isocyanates. A polyfunctional compound such as a urethane (meth) acrylate compound obtained by reacting a compound having a group with a compound having one or more hydroxyl groups in the molecule and having 3 to 5 (meth) acrylate groups. Examples thereof include (meth) acrylate compounds.
[B]重合性化合物の市販品としては、例えば
アロニックスM−400、同M−402、同M−405、同M−450、同M−1310、同M−1600、同M−1960、同M−7100、同M−8030、同M−8060、同M−8100、同M−8530、同M−8560、同M−9050、アロニックスTO−1450、同TO−1382(以上、東亞合成社);
KAYARAD DPHA、同DPCA−20、同DPCA−30、同DPCA−60、同DPCA−120、同MAX−3510(以上、日本化薬社);
ビスコート295、同300、同360、同GPT、同3PA、同400(以上、大阪有機化学工業社);
ウレタンアクリレート系化合物として、ニューフロンティア R−1150(第一工業製薬社);
KAYARAD DPHA−40H、UX−5000(以上、日本化薬社);
UN−9000H(根上工業社);
アロニックスM−5300、同M−5600、同M−5700、M−210、同M−220、同M−240、同M−270、同M−6200、同M−305、同M−309、同M−310、同M−315(以上、東亞合成社);
KAYARAD HDDA、KAYARAD HX−220、同HX−620、同R−526、同R−167、同R−604、同R−684、同R−551、同R−712、UX−2201、UX−2301、UX−3204、UX−3301、UX−4101、UX−6101、UX−7101、UX−8101、UX−0937、MU−2100、MU−4001(以上、日本化薬社);
アートレジンUN−9000PEP、同UN−9200A、同UN−7600、同UN−333、同UN−1003、同UN−1255、同UN−6060PTM、同UN−6060P(以上、根上工業社);
SH−500Bビスコート260、同312、同335HP(以上、大阪有機化学工業社)等が挙げられる。
[B] Commercially available products of the polymerizable compound include, for example, Aronix M-400, M-402, M-405, M-450, M-1310, M-1600, M-1960, and M. -7100, M-8030, M-8060, M-8100, M-8530, M-8560, M-9050, Aronix TO-1450, TO-1382 (above, Toagosei Co., Ltd.);
KAYARAD DPHA, DPCA-20, DPCA-30, DPCA-60, DPCA-120, MAX-3510 (above, Nippon Kayaku Co., Ltd.);
Viscoat 295, 300, 360, GPT, 3PA, 400 (above, Osaka Organic Chemical Industry Co., Ltd.);
As a urethane acrylate compound, New Frontier R-1150 (Daiichi Kogyo Seiyaku Co., Ltd.);
KAYARAD DPHA-40H, UX-5000 (above, Nippon Kayaku Co., Ltd.);
UN-9000H (Negami Kogyo Co., Ltd.);
Aronix M-5300, M-5600, M-5700, M-210, M-220, M-240, M-270, M-6200, M-305, M-309, same M-310, M-315 (above, Toagosei);
KAYARAD HDDA, KAYARAD HX-220, HX-620, R-526, R-167, R-604, R-684, R-551, R-712, UX-2201, UX-2301 , UX-3204, UX-3301, UX-4101, UX-6101, UX-7101, UX-8101, UX-0937, MU-2100, MU-4001 (above, Nippon Kayaku Co., Ltd.);
Art Resin UN-99000PEP, UN-9200A, UN-7600, UN-333, UN-1003, UN-1255, UN-6060PTM, UN-6060P (above, Negami Kogyo Co., Ltd.);
SH-500B Viscoat 260, 312, 335HP (above, Osaka Organic Chemical Industry Co., Ltd.) and the like can be mentioned.
[B]重合性化合物は、同一分子内にカルボキシ基を少なくとも1つ有することが好ましい。これにより、架橋性の向上及び未露光部における現像残渣の低減を図ることができる。同一分子内にカルボキシ基を少なくとも1つ有する[B]重合性化合物としては、ω−カルボキシポリカプロラクトンモノ(メタ)アクリレート、コハク酸変性ペンタエリスリトールトリアクリレート等を挙げることができる。 [B] The polymerizable compound preferably has at least one carboxy group in the same molecule. As a result, it is possible to improve the crosslinkability and reduce the development residue in the unexposed portion. Examples of the [B] polymerizable compound having at least one carboxy group in the same molecule include ω-carboxypolycaprolactone mono (meth) acrylate and succinic acid-modified pentaerythritol triacrylate.
[B]重合性化合物の含有量の下限としては、[A]重合体100質量部に対して、10質量部が好ましく、30質量部がより好ましい。一方、この上限としては、200質量部が好ましく、100質量部がより好ましい。[B]重合性化合物の含有量を上記範囲とすることで、当該硬化膜形成用樹脂材料(2)は、密着性に優れ、かつ低露光量においても十分な表面硬度を有する硬化膜を形成することができる。 The lower limit of the content of the [B] polymerizable compound is preferably 10 parts by mass and more preferably 30 parts by mass with respect to 100 parts by mass of the [A] polymer. On the other hand, as the upper limit, 200 parts by mass is preferable, and 100 parts by mass is more preferable. [B] By setting the content of the polymerizable compound in the above range, the cured film-forming resin material (2) forms a cured film having excellent adhesion and sufficient surface hardness even at a low exposure amount. can do.
<[C]感放射線性重合開始剤>
[C]感放射線性重合開始剤は、放射線に感応して[B]重合性化合物の重合を開始しうる活性種を生じる成分である。[C]感放射線性重合開始剤としては、例えばオキシムエステル化合物、アセトフェノン化合物、ビイミダゾール化合物等が挙げられる。なお、[C]感放射線性重合開始剤は、単独で又は2種以上を組み合わせて用いてもよい。
<[C] Radiation Sensitive Polymerization Initiator>
The [C] radiation-sensitive polymerization initiator is a component that produces an active species capable of initiating the polymerization of the [B] polymerizable compound in response to radiation. [C] Examples of the radiation-sensitive polymerization initiator include an oxime ester compound, an acetophenone compound, and a biimidazole compound. The [C] radiation-sensitive polymerization initiator may be used alone or in combination of two or more.
上記オキシムエステル化合物としては、例えばエタノン−1−〔9−エチル−6−(2−メチルベンゾイル)−9H−カルバゾール−3−イル〕−1−(O−アセチルオキシム)、1,2−オクタンジオン−1−[4−(フェニルチオ)−2−(O−ベンゾイルオキシム)]、1−〔9−エチル−6−ベンゾイル−9H−カルバゾール−3−イル〕−オクタン−1−オンオキシム−O−アセテート、1−〔9−エチル−6−(2−メチルベンゾイル)−9H−カルバゾール−3−イル〕−エタン−1−オンオキシム−O−ベンゾエート、1−〔9−n−ブチル−6−(2−エチルベンゾイル)−9H−カルバゾール−3−イル〕−エタン−1−オンオキシム−O−ベンゾエート、エタノン−1−[9−エチル−6−(2−メチル−4−テトラヒドロフラニルベンゾイル)−9H−カルバゾール−3−イル]−1−(O−アセチルオキシム)、エタノン−1−〔9−エチル−6−(2−メチル−4−テトラヒドロピラニルベンゾイル)−9H−カルバゾール−3−イル〕−1−(O−アセチルオキシム)、エタノン−1−〔9−エチル−6−(2−メチル−5−テトラヒドロフラニルベンゾイル)−9H−カルバゾール−3−イル〕−1−(O−アセチルオキシム)、エタノン−1−〔9−エチル−6−{2−メチル−4−(2,2−ジメチル−1,3−ジオキソラニル)メトキシベンゾイル}−9H−カルバゾール−3−イル〕−1−(O−アセチルオキシム)などのO−アシルオキシム化合物等が挙げられる。これらの中で、オキシムエステル化合物としては、エタノン−1−〔9−エチル−6−(2−メチルベンゾイル)−9H−カルバゾール−3−イル〕−1−(O−アセチルオキシム)、1,2−オクタンジオン−1−[4−(フェニルチオ)−2−(O−ベンゾイルオキシム)]、エタノン−1−〔9−エチル−6−(2−メチル−4−テトラヒドロフラニルメトキシベンゾイル)−9H−カルバゾール−3−イル〕−1−(O−アセチルオキシム)、及びエタノン−1−〔9−エチル−6−{2−メチル−4−(2,2−ジメチル−1,3−ジオキソラニル)メトキシベンゾイル}−9H−カルバゾール−3−イル〕−1−(O−アセチルオキシム)が好ましい。 Examples of the oxime ester compound include ethanone-1- [9-ethyl-6- (2-methylbenzoyl) -9H-carbazole-3-yl] -1- (O-acetyloxime) and 1,2-octanedione. -1- [4- (Phenylthio) -2- (O-benzoyloxime)], 1- [9-ethyl-6-benzoyl-9H-carbazole-3-yl] -octane-1-one oxime-O-acetate, 1- [9-ethyl-6- (2-methylbenzoyl) -9H-carbazole-3-yl] -ethane-1-one oxime-O-benzoate, 1- [9-n-butyl-6- (2-ethyl) Benzoyl) -9H-carbazole-3-yl] -ethane-1-one oxime-O-benzoate, etanone-1- [9-ethyl-6- (2-methyl-4-tetrahydrofuranylbenzoyl) -9H-carbazole-3 -Il] -1- (O-acetyloxime), Etanone-1- [9-ethyl-6- (2-methyl-4-tetrahydropyranylbenzoyl) -9H-carbazole-3-yl] -1- (O) -Acetyloxime), Etanone-1- [9-ethyl-6- (2-methyl-5-tetrahydrofuranylbenzoyl) -9H-carbazole-3-yl] -1- (O-acetyloxime), Etanone-1- [9-Ethyl-6- {2-methyl-4- (2,2-dimethyl-1,3-dioxolanyl) methoxybenzoyl} -9H-carbazole-3-yl] -1- (O-acetyloxime) and the like Examples thereof include O-acyloxime compounds. Among these, as the oxime ester compound, etanone-1- [9-ethyl-6- (2-methylbenzoyl) -9H-carbazole-3-yl] -1- (O-acetyloxime), 1, 2 − Octandion-1- [4- (phenylthio) -2- (O-benzoyloxime)], Etanone-1- [9-ethyl-6- (2-methyl-4-tetrahydrofuranylmethoxybenzoyl) -9H-carbazole) -3-yl] -1- (O-acetyloxime) and ethanone-1- [9-ethyl-6- {2-methyl-4- (2,2-dimethyl-1,3-dioxolanyl) methoxybenzoyl} -9H-carbazole-3-yl] -1- (O-acetyloxime) is preferred.
上記アセトフェノン化合物としては、例えばα−アミノケトン化合物、α−ヒドロキシケトン化合物等が挙げられる。 Examples of the acetophenone compound include an α-aminoketone compound and an α-hydroxyketone compound.
上記α−アミノケトン化合物としては、例えば2−ベンジル−2−ジメチルアミノ−1−(4−モルホリノフェニル)−ブタン−1−オン、2−ジメチルアミノ−2−(4−メチルベンジル)−1−(4−モルフォリン−4−イル−フェニル)−ブタン−1−オン、2−メチル−1−(4−メチルチオフェニル)−2−モルフォリノプロパン−1−オン等が挙げられる。 Examples of the α-aminoketone compound include 2-benzyl-2-dimethylamino-1- (4-morpholinophenyl) -butane-1-one and 2-dimethylamino-2- (4-methylbenzyl) -1-(. Examples thereof include 4-morpholin-4-yl-phenyl) -butane-1-one, 2-methyl-1- (4-methylthiophenyl) -2-morpholinopropane-1-one and the like.
上記α−ヒドロキシケトン化合物としては、例えば1−フェニル−2−ヒドロキシ−2−メチルプロパン−1−オン、1−(4−i−プロピルフェニル)−2−ヒドロキシ−2−メチルプロパン−1−オン、4−(2−ヒドロキシエトキシ)フェニル−(2−ヒドロキシ−2−プロピル)ケトン、1−ヒドロキシシクロヘキシルフェニルケトン等が挙げられる Examples of the α-hydroxyketone compound include 1-phenyl-2-hydroxy-2-methylpropane-1-one and 1- (4-i-propylphenyl) -2-hydroxy-2-methylpropane-1-one. , 4- (2-Hydroxyethoxy) phenyl- (2-hydroxy-2-propyl) ketone, 1-hydroxycyclohexylphenyl ketone and the like.
上記アセトフェノン化合物としては、α−アミノケトン化合物が好ましく、2−ジメチルアミノ−2−(4−メチルベンジル)−1−(4−モルフォリン−4−イル−フェニル)−ブタン−1−オン、及び2−メチル−1−(4−メチルチオフェニル)−2−モルフォリノプロパン−1−オンがより好ましい。 As the acetophenone compound, an α-aminoketone compound is preferable, 2-dimethylamino-2- (4-methylbenzyl) -1- (4-morpholin-4-yl-phenyl) -butane-1-one, and 2 -Methyl-1- (4-methylthiophenyl) -2-morpholinopropane-1-one is more preferable.
上記ビイミダゾール化合物としては、例えば2,2’−ビス(2−クロロフェニル)−4,4’,5,5’−テトラキス(4−エトキシカルボニルフェニル)−1,2’−ビイミダゾール、2,2’−ビス(2−クロロフェニル)−4,4’,5,5’−テトラフェニル−1,2’−ビイミダゾール、2,2’−ビス(2,4−ジクロロフェニル)−4,4’,5,5’−テトラフェニル−1,2’−ビイミダゾール、2,2’−ビス(2,4,6−トリクロロフェニル)−4,4’,5,5’−テトラフェニル−1,2’−ビイミダゾール等が挙げられる。これらの中で、2,2’−ビス(2−クロロフェニル)−4,4’,5,5’−テトラフェニル−1,2’−ビイミダゾール、2,2’−ビス(2,4−ジクロロフェニル)−4,4’,5,5’−テトラフェニル−1,2’−ビイミダゾール、及び2,2’−ビス(2,4,6−トリクロロフェニル)−4,4’,5,5’−テトラフェニル−1,2’−ビイミダゾールが好ましく、2,2’−ビス(2,4−ジクロロフェニル)−4,4’,5,5’−テトラフェニル−1,2’−ビイミダゾールがより好ましい。 Examples of the biimidazole compound include 2,2'-bis (2-chlorophenyl) -4,4', 5,5'-tetrakis (4-ethoxycarbonylphenyl) -1,2'-biimidazole, 2,2. '-Bis (2-chlorophenyl) -4,4', 5,5'-Tetraphenyl-1,2'-biimidazole, 2,2'-bis (2,4-dichlorophenyl) -4,4', 5 , 5'-Tetraphenyl-1,2'-biimidazole, 2,2'-bis (2,4,6-trichlorophenyl) -4,4', 5,5'-tetraphenyl-1,2'- Examples thereof include biimidazole. Among these, 2,2'-bis (2-chlorophenyl) -4,4', 5,5'-tetraphenyl-1,2'-biimidazole, 2,2'-bis (2,4-dichlorophenyl) ) -4,4', 5,5'-tetraphenyl-1,2'-biimidazole, and 2,2'-bis (2,4,56-trichlorophenyl) -4,4', 5,5' -Tetraphenyl-1,2'-biimidazole is preferred, 2,2'-bis (2,4-dichlorophenyl) -4,4', 5,5'-tetraphenyl-1,2'-biimidazole is more preferred. preferable.
[C]感放射線性重合開始剤の市販品としては、例えば2−メチル−1−(4−メチルチオフェニル)−2−モルフォリノプロパン−1−オン(イルガキュア907)、2−ジメチルアミノ−2−(4−メチルベンジル)−1−(4−モルフォリン−4−イル−フェニル)−ブタン−1−オン(イルガキュア379)、1,2−オクタンジオン−1−[4−(フェニルチオ)−2−(O−ベンゾイルオキシム)](イルガキュアOXE01)、エタノン−1−〔9−エチル−6−(2−メチルベンゾイル)−9H−カルバゾール−3−イル〕−1−(O−アセチルオキシム)(イルガキュアOXE02)(以上、チバ・スペシャルティー・ケミカルズ社)等が挙げられる。 [C] Commercially available products of the radiosensitizing polymerization initiator include, for example, 2-methyl-1- (4-methylthiophenyl) -2-morpholinopropane-1-one (Irgacure 907), 2-dimethylamino-2-. (4-Methylbenzyl) -1- (4-morpholin-4-yl-phenyl) -butane-1-one (Irgacure 379), 1,2-octanedione-1- [4- (phenylthio) -2- (O-Benzyl oxime)] (Irgacure OXE01), Etanone-1- [9-ethyl-6- (2-methylbenzoyl) -9H-carbazole-3-yl] -1- (O-acetyloxime) (Irgacure OXE02) ) (The above is Ciba Specialty Chemicals Co., Ltd.) and the like.
[C]感放射線性重合開始剤の含有量の下限としては、[A]重合体100質量部に対して、0.1質量部が好ましく、0.5質量部がより好ましく、2質量部がさらに好ましい。一方、この上限としては、40質量部が好ましく、20質量部がより好ましく、10質量部がさらに好ましい。[C]感放射線性重合開始剤の含有量を上記範囲とすることで、当該硬化膜形成用樹脂材料(2)は、低露光量の場合でも十分な表面硬度及び密着性を有する硬化膜を形成することなどができる。 The lower limit of the content of the [C] radiation-sensitive polymerization initiator is preferably 0.1 part by mass, more preferably 0.5 part by mass, and 2 parts by mass with respect to 100 parts by mass of the [A] polymer. More preferred. On the other hand, as the upper limit, 40 parts by mass is preferable, 20 parts by mass is more preferable, and 10 parts by mass is further preferable. [C] By setting the content of the radiation-sensitive polymerization initiator within the above range, the cured film-forming resin material (2) can be a cured film having sufficient surface hardness and adhesion even at a low exposure amount. It can be formed and so on.
さらに、[C]感放射線性重合開始剤がオキシムエステル化合物であり、このオキシムエステル化合物の含有量の下限が[A]重合体100質量部に対して0.1質量部であることが好ましく、0.5質量部であることがより好ましく、2質量部であることがさらに好ましい。また、オキシムエステル化合物の含有量の上限は[A]重合体100質量部に対して20質量部であることが好ましく、10質量部であることがより好ましく、5質量部であることがさらに好ましい。これにより、低露光量の場合でも十分な表面硬度及び密着性を有する硬化膜を効率良く形成することなどができる。 Further, it is preferable that the [C] radiation-sensitive polymerization initiator is an oxime ester compound, and the lower limit of the content of the oxime ester compound is 0.1 part by mass with respect to 100 parts by mass of the [A] polymer. It is more preferably 0.5 parts by mass, and even more preferably 2 parts by mass. The upper limit of the content of the oxime ester compound is preferably 20 parts by mass, more preferably 10 parts by mass, and even more preferably 5 parts by mass with respect to 100 parts by mass of the polymer [A]. .. As a result, it is possible to efficiently form a cured film having sufficient surface hardness and adhesion even at a low exposure amount.
<[D]酸化防止剤>
[D]酸化防止剤は、露光や加熱により発生したラジカル、又は酸化によって生成した過酸化物を分解し、重合体分子の結合の解裂を防止することができる成分である。硬化膜形成用樹脂材料(2)における[D]酸化防止剤は、上述した硬化膜形成用樹脂材料(1)における[D]酸化防止剤を適用することができる。当該硬化膜形成用樹脂材料(2)は、[D]酸化防止剤を含有することで、得られる硬化膜は経時的な酸化劣化が防止され、例えば硬化膜の膜厚変化を抑制することができる。なお、[D]酸化防止剤は、単独で又は2種以上を組み合わせて用いてもよい。
<[D] Antioxidant>
[D] The antioxidant is a component capable of decomposing radicals generated by exposure or heating or peroxides generated by oxidation to prevent the bond of polymer molecules from breaking. As the [D] antioxidant in the cured film-forming resin material (2), the [D] antioxidant in the cured film-forming resin material (1) described above can be applied. By containing the [D] antioxidant in the cured film-forming resin material (2), the obtained cured film can be prevented from oxidative deterioration over time, and for example, changes in the film thickness of the cured film can be suppressed. it can. The [D] antioxidant may be used alone or in combination of two or more.
当該硬化膜形成用樹脂材料(2)における[D]酸化防止剤の含有量としては、[A]重合体100質量部に対して、0.001質量部以上5質量部以下が好ましい。[D]酸化防止剤の含有量を上記範囲とすることで、得られる硬化膜の経時的な酸化劣化を効果的に抑制することなどができる。 The content of the [D] antioxidant in the cured film-forming resin material (2) is preferably 0.001 part by mass or more and 5 parts by mass or less with respect to 100 parts by mass of the [A] polymer. [D] By setting the content of the antioxidant in the above range, it is possible to effectively suppress the oxidative deterioration of the obtained cured film over time.
<その他の成分>
当該硬化膜形成用樹脂材料(2)が含有してもよいその他の成分としては、例えば溶媒の他、[E]界面活性剤、[F]接着助剤等が挙げられる。なお、各その他の成分については、上述の硬化膜形成用樹脂材料(1)に含まれる成分として説明したものを適用することができる。
<Other ingredients>
Examples of other components that the cured film-forming resin material (2) may contain include, in addition to solvents, [E] surfactants, [F] adhesive aids, and the like. As each of the other components, those described as the components contained in the above-mentioned resin material for forming a cured film (1) can be applied.
<硬化膜形成用樹脂材料(2)の調製方法>
当該硬化膜形成用樹脂材料(2)は、[A]重合体、[B]重合性化合物及び[C]感放射線性重合開始剤、並びに必要に応じてその他の成分を所定の割合で混合し、好ましくは適当な溶媒に溶解して調製できる。硬化膜形成用樹脂材料(2)の調製に用いられる溶媒としては、例えば上述の硬化膜形成用樹脂材料(1)の調製方法の説明において例示した溶媒と同様の溶媒等を適用することができる。調製した硬化膜形成用樹脂材料(2)は、例えば孔径0.2μm程度のフィルタでろ過することが好ましい。
<Preparation method of resin material (2) for forming a cured film>
In the cured film-forming resin material (2), the [A] polymer, the [B] polymerizable compound, the [C] radiation-sensitive polymerization initiator, and other components, if necessary, are mixed in a predetermined ratio. , Preferably can be prepared by dissolving in a suitable solvent. As the solvent used for preparing the cured film-forming resin material (2), for example, the same solvent as the solvent exemplified in the above-mentioned description of the method for preparing the cured film-forming resin material (1) can be applied. .. The prepared resin material (2) for forming a cured film is preferably filtered through, for example, a filter having a pore size of about 0.2 μm.
<硬化膜の形成方法(2)>
本発明の一実施形態に係る硬化膜の形成方法(2)は、
(1)当該硬化膜形成用樹脂材料(2)を用い、基板上に塗膜を形成する工程(以下、「工程(B1)」ともいう)、
(2)上記塗膜の一部に放射線を照射する工程(以下、「工程(B2)」ともいう)、
(3)上記放射線が照射された塗膜を現像する工程(以下、「工程(B3)」ともいう)、及び
(4)上記現像された塗膜を加熱する工程(以下、「工程(B4)」ともいう)
を備える。
<Method of forming a cured film (2)>
The method (2) for forming a cured film according to an embodiment of the present invention is
(1) A step of forming a coating film on a substrate using the cured film forming resin material (2) (hereinafter, also referred to as "step (B1)").
(2) A step of irradiating a part of the coating film with radiation (hereinafter, also referred to as "step (B2)").
(3) A step of developing the coating film irradiated with the radiation (hereinafter, also referred to as "step (B3)"), and (4) a step of heating the developed coating film (hereinafter, "step (B4)"). Also called)
To be equipped.
当該硬化膜形成用樹脂材料(2)は、上述の性質を有しているため、当該硬化膜の形成方法(2)によれば、耐熱性、耐薬品性、透過率、比誘電率等の一般的特性を十分満足し、かつ優れた表面硬度を有する硬化膜を形成することができる。また、当該硬化膜の形成方法(2)によれば、良好な感度で現像することができ、現像密着性に優れる硬化膜を得ることもできる。以下、各工程について詳述する。 Since the cured film forming resin material (2) has the above-mentioned properties, according to the cured film forming method (2), heat resistance, chemical resistance, transmittance, relative permittivity, etc. It is possible to form a cured film that sufficiently satisfies general properties and has excellent surface hardness. Further, according to the cured film forming method (2), it is possible to develop with good sensitivity and to obtain a cured film having excellent development adhesion. Hereinafter, each step will be described in detail.
[工程(B1)]
本工程では、当該硬化膜形成用樹脂材料(2)を用い、基板上に塗膜を形成する。具体的には、当該硬化膜形成用樹脂材料(2)の溶液を基板表面に塗布し、好ましくはプレベークを行うことにより溶媒を除去して塗膜を形成する。上記基板や塗布方法は、硬化膜の形成方法(1)の工程(A1)において説明したものと同様とすることができる。
[Step (B1)]
In this step, a coating film is formed on the substrate by using the cured film forming resin material (2). Specifically, the solution of the cured film-forming resin material (2) is applied to the surface of the substrate, and the solvent is preferably removed by prebaking to form a coating film. The substrate and coating method can be the same as those described in the step (A1) of the cured film forming method (1).
[工程(B2)]
本工程では、上記塗膜の一部に放射線を照射する。具体的には、工程(B1)で形成した塗膜に所定のパターンを有するマスクを介して放射線を照射する。このとき用いられる放射線としては、例えば紫外線、遠紫外線、X線、荷電粒子線等が挙げられる。
[Process (B2)]
In this step, a part of the coating film is irradiated with radiation. Specifically, the coating film formed in the step (B1) is irradiated with radiation through a mask having a predetermined pattern. Examples of the radiation used at this time include ultraviolet rays, far ultraviolet rays, X-rays, charged particle beams, and the like.
上記紫外線としては、例えばg線(波長436nm)、i線(波長365nm)等が挙げられる。遠紫外線としては、例えばKrFエキシマレーザー光等が挙げられる。X線としては、例えばシンクロトロン放射線等が挙げられる。荷電粒子線としては、例えば電子線等が挙げられる。これらの放射線のうち、紫外線が好ましく、紫外線の中でもg線、h線及び/又はi線を含む放射線がより好ましい。放射線の露光量としては、0.1J/m2以上10,000J/m2以下が好ましい。 Examples of the ultraviolet rays include g-line (wavelength 436 nm) and i-line (wavelength 365 nm). Examples of far ultraviolet rays include KrF excimer laser light and the like. Examples of X-rays include synchrotron radiation and the like. Examples of the charged particle beam include an electron beam and the like. Among these radiations, ultraviolet rays are preferable, and among the ultraviolet rays, radiation containing g-rays, h-rays and / or i-rays is more preferable. The exposure amount of radiation, 0.1 J / m 2 or more 10,000 J / m 2 or less.
[工程(B3)]
本工程では、上記放射線が照射された塗膜を現像する。具体的には、工程(B2)で放射線が照射された塗膜に対し、現像液により現像を行って放射線の照射部分を除去する。上記現像液としては、例えば水酸化ナトリウム、水酸化カリウム、炭酸ナトリウム、ケイ酸ナトリウム、メタケイ酸ナトリウム、アンモニア、エチルアミン、n−プロピルアミン、ジエチルアミン、ジエチルアミノエタノール、ジ−n−プロピルアミン、トリエチルアミン、メチルジエチルアミン、ジメチルエタノールアミン、トリエタノールアミン、テトラメチルアンモニウムヒドロキシド(TMAH)、テトラエチルアンモニウムヒドロキシド、ピロール、ピペリジン、1,8−ジアザビシクロ〔5,4,0〕−7−ウンデセン、1,5−ジアザビシクロ〔4,3,0〕−5−ノナンなどのアルカリ(塩基性化合物)の水溶液等が挙げられる。また、上記アルカリの水溶液にメタノール、エタノール等の水溶性有機溶媒や界面活性剤を適当量添加した水溶液、又は当該硬化膜形成用樹脂材料(2)を溶解可能な各種有機溶媒を少量含むアルカリ水溶液を現像液として用いてもよい。
[Step (B3)]
In this step, the coating film irradiated with the above radiation is developed. Specifically, the coating film irradiated with radiation in the step (B2) is developed with a developing solution to remove the irradiated portion of the radiation. Examples of the developer include sodium hydroxide, potassium hydroxide, sodium carbonate, sodium silicate, sodium metasilicate, ammonia, ethylamine, n-propylamine, diethylamine, diethylaminoethanol, di-n-propylamine, triethylamine, and methyl. Diethylamine, dimethylethanolamine, triethanolamine, tetramethylammonium hydroxide (TMAH), tetraethylammonium hydroxide, pyrrole, piperidine, 1,8-diazabicyclo [5,4,0] -7-undecene, 1,5-diazabicyclo Examples thereof include an aqueous solution of an alkali (basic compound) such as [4,5,0] -5-nonane. Further, an aqueous solution obtained by adding an appropriate amount of a water-soluble organic solvent such as methanol or ethanol or a surfactant to the alkaline aqueous solution, or an alkaline aqueous solution containing a small amount of various organic solvents capable of dissolving the cured film-forming resin material (2). May be used as a developing solution.
現像方法としては、例えば液盛り法、ディッピング法、揺動浸漬法、シャワー法等の適宜の方法を採用することができる。現像時間としては、当該硬化膜形成用樹脂材料(2)の組成によって異なるが、例えば30秒以上120秒以下とすることができる。なお、現像工程の後、パターニングされた塗膜に対して流水洗浄によるリンス処理を行い、次いで、高圧水銀灯等による放射線を全面に照射(後露光)することにより、塗膜中に残存する[C]感放射線性重合開始剤の分解処理を行うことが好ましい。この後露光における露光量としては、2,000J/m2以上5,000J/m2以下が好ましい。 As the developing method, for example, an appropriate method such as a liquid filling method, a dipping method, a rocking dipping method, and a shower method can be adopted. The developing time varies depending on the composition of the cured film-forming resin material (2), but can be, for example, 30 seconds or more and 120 seconds or less. After the developing step, the patterned coating film is rinsed by washing with running water, and then the entire surface is irradiated with radiation (post-exposure) from a high-pressure mercury lamp or the like to remain in the coating film [C. ] It is preferable to perform a decomposition treatment of the radiation-sensitive polymerization initiator. The exposure amount in the post-exposure is preferably 2,000 J / m 2 or more and 5,000 J / m 2 or less.
[工程(B4)]
本工程では、上記現像された塗膜を加熱する。具体的には、工程(B3)で現像された塗膜を加熱するホットプレート、オーブン等の加熱装置を用い、この塗膜を加熱処理(ポストベーク)することによって塗膜の硬化を行う。本工程における加熱温度や加熱時間は、硬化膜の形成方法(1)の工程(A2)において説明したものと同様とすることができる。このようにして、目的とする層間絶縁膜等の硬化膜に対応するパターン状塗膜を基板上に形成することができる。
[Process (B4)]
In this step, the developed coating film is heated. Specifically, the coating film is cured by heat-treating (post-baking) the coating film using a heating device such as a hot plate or an oven that heats the coating film developed in the step (B3). The heating temperature and heating time in this step can be the same as those described in step (A2) of the cured film forming method (1). In this way, a patterned coating film corresponding to the desired cured film such as an interlayer insulating film can be formed on the substrate.
<硬化膜>
本発明の一実施形態に係る硬化膜は、当該硬化膜形成用樹脂材料(硬化膜形成用樹脂材料(1)又は硬化膜形成用樹脂材料(2))から形成される。当該硬化膜の形成方法としては、特に限定されないが、好ましくは上述の当該硬化膜の形成方法(1)又は当該硬化膜の形成方法(2)を用いて形成することができる。当該硬化膜は、当該硬化膜形成用樹脂材料から形成されているため、優れた表面硬度を有すると共に耐薬品性、耐熱性、透過率及び比誘電率等の一般的特性を十分満足できる。当該硬化膜は上記特性を有しているため、例えば表示素子の層間絶縁膜、スペーサー、保護膜、カラーフィルタ用着色パターン等として好適である。
<Cured film>
The cured film according to one embodiment of the present invention is formed from the cured film-forming resin material (cured film-forming resin material (1) or cured film-forming resin material (2)). The method for forming the cured film is not particularly limited, but it can be preferably formed by using the above-mentioned method for forming the cured film (1) or the method for forming the cured film (2). Since the cured film is formed from the resin material for forming the cured film, it has excellent surface hardness and can sufficiently satisfy general properties such as chemical resistance, heat resistance, transmittance and relative permittivity. Since the cured film has the above characteristics, it is suitable as, for example, an interlayer insulating film for a display element, a spacer, a protective film, a coloring pattern for a color filter, and the like.
<半導体素子>
本発明の一実施形態に係る半導体素子は、当該硬化膜を備えている。この硬化膜は、例えば当該半導体素子中の配線間を絶縁する層間絶縁膜、スペーサー、保護膜、カラーフィルタ用着色パターン等として用いられる。当該半導体素子は、公知の方法を用いて形成することができる。当該半導体素子は、当該硬化膜を備えているため、表示素子、LED、太陽電池等の電子デバイスに好適に用いることができる。
<Semiconductor element>
The semiconductor device according to the embodiment of the present invention includes the cured film. This cured film is used, for example, as an interlayer insulating film, a spacer, a protective film, a coloring pattern for a color filter, or the like that insulates wiring between wirings in the semiconductor element. The semiconductor device can be formed by using a known method. Since the semiconductor element includes the cured film, it can be suitably used for electronic devices such as display elements, LEDs, and solar cells.
<表示素子>
本発明の一実施形態に係る表示素子は、当該半導体素子を備えている。当該表示素子は、当該硬化膜を有する半導体素子を備えているため、表示素子として実用面で要求される一般的特性を満足する。当該表示素子としては、例えば液晶表示素子等が挙げられる。上記液晶表示素子においては、例えば液晶配向膜が表面に形成された2枚のTFTアレイ基板が、TFTアレイ基板の周辺部に設けられたシール剤を介して液晶配向膜側で対向して配置されており、これら2枚のTFTアレイ基板間に液晶が充填されている。上記TFTアレイ基板は、層状に配置される配線を有し、この配線間を層間絶縁膜としての当該硬化膜により絶縁しているものである。
<Display element>
The display element according to the embodiment of the present invention includes the semiconductor element. Since the display element includes a semiconductor element having the cured film, it satisfies the general characteristics required for practical use as a display element. Examples of the display element include a liquid crystal display element and the like. In the liquid crystal display element, for example, two TFT array substrates having a liquid crystal alignment film formed on the surface are arranged so as to face each other on the liquid crystal alignment film side via a sealant provided on the periphery of the TFT array substrate. A liquid crystal is filled between these two TFT array substrates. The TFT array substrate has wirings arranged in layers, and the wirings are insulated by the cured film as an interlayer insulating film.
以下、本発明を実施例に基づいて具体的に説明するが、本発明は、これらの実施例に限定されるものではない。各物性値の測定方法を下記に示す。 Hereinafter, the present invention will be specifically described based on examples, but the present invention is not limited to these examples. The measurement method of each physical property value is shown below.
[重量平均分子量(Mw)及び数平均分子量(Mn)]
下記条件によるゲルパーミエーションクロマトグラフィー(GPC)によりMw及びMnを測定した。また、分子量分布(Mw/Mn)は得られたMw及びMnより算出した。
装置:昭和電工社のGPC−101
GPCカラム:島津ジーエルシー社のGPC−KF−801、GPC−KF−802、GPC−KF−803及びGPC−KF−804を結合
移動相:テトラヒドロフラン
カラム温度:40℃
流速:1.0mL/分
試料濃度:1.0質量%
試料注入量:100μL
検出器:示差屈折計
標準物質:単分散ポリスチレン
[Weight average molecular weight (Mw) and number average molecular weight (Mn)]
Mw and Mn were measured by gel permeation chromatography (GPC) under the following conditions. The molecular weight distribution (Mw / Mn) was calculated from the obtained Mw and Mn.
Equipment: Showa Denko GPC-101
GPC column: GPC-KF-801, GPC-KF-802, GPC-KF-803 and GPC-KF-804 of Shimadzu GLC Co., Ltd. are combined. Mobile phase: tetrahydrofuran Column temperature: 40 ° C.
Flow velocity: 1.0 mL / min Sample concentration: 1.0 mass%
Sample injection volume: 100 μL
Detector: Differential Refractometer Standard Material: Monodisperse Polystyrene
<[A]重合体の合成>
各実施例及び比較例の重合体の合成で用いた単量体化合物を以下に示す。
<[A] Synthesis of polymer>
The monomer compounds used in the synthesis of the polymers of each example and comparative example are shown below.
[構造単位(I)を与える単量体化合物]
下記式(I−1)〜(I−8)でそれぞれ表される単量体化合物(I〜1)〜(I−8)、並びに単量体化合物(I−9)〜(I−11)
[Monomer compound giving structural unit (I)]
Monomer compounds (I-1) to (I-8) represented by the following formulas (I-1) to (I-8), and monomer compounds (I-9) to (I-11), respectively.
(I−10):α−メチル−p−ヒドロキシスチレン
(I−11):メタクリル酸
(I-10): α-methyl-p-hydroxystyrene (I-11): methacrylic acid
[構造単位(II)を与える単量体化合物]
下記式(II−1)〜(II−4)でそれぞれ表される単量体化合物(II〜1)〜(II−4)。
[Monomer compound giving structural unit (II)]
Monomer compounds (II-1) to (II-4) represented by the following formulas (II-1) to (II-4), respectively.
また、比較合成例において、構造単位(II)を与える単量体化合物に対応する単量体化合物として、下記(ii−1)で表される単量体化合物(ii−1)を用いた。 Further, in the comparative synthesis example, the monomer compound (ii-1) represented by the following (ii-1) was used as the monomer compound corresponding to the monomer compound giving the structural unit (II).
[構造単位(III)を与える単量体化合物]
下記式(III−1)〜(III−15)で表される単量体化合物(III−1)〜(III−15)
[Monomer compound giving structural unit (III)]
Monomer compounds (III-1) to (III-15) represented by the following formulas (III-1) to (III-15)
[構造単位(IV)を与える単量体化合物]
(IV−1):メタクリル酸ヒドロキシエチル(2−ヒドロキシエチルメタクリレート)
[Monomer compound giving structural unit (IV)]
(IV-1): Hydroxyethyl methacrylate (2-hydroxyethyl methacrylate)
[構造単位(V)を与える単量体化合物]
(V−1):スチレン
(V−2):メタクリル酸メチル
(V−3):N−シクロヘキシルマレイミド
(V−4):メタクリル酸テトラヒドロフルフリル
(V−5):メタクリル酸トリシクロ[5.2.1.02,6]デカン−8−イル
[Monomer compound giving structural unit (V)]
(V-1): Styrene (V-2): Methyl methacrylate (V-3): N-cyclohexylmaleimide (V-4): Tetrahydrofurfuryl methacrylate (V-5): Tricyclo methacrylate [5.2] .1.0 2,6 ] Decane-8-il
[合成例1](重合体(A−1)の合成)
冷却管及び撹拌機を備えたフラスコに、2,2’−アゾビス(2,4−ジメチルバレロニトリル)7質量部及びジエチレングリコールメチルエチルエーテル220質量部を仕込んだ。次いで、構造単位(I)を与える単量体化合物(I−1)30質量部、及び(I−11)22質量部、構造単位(II)を与える単量体化合物(II−1)30質量部、並びに構造単位(III)を与える単量体化合物(III−1)18質量部を仕込んだ。その後、窒素置換し、緩やかに攪拌しつつ、溶液の温度を70℃に上昇させ、この温度を4時間保持して重合することにより重合体(A−1)を含有する重合体溶液を得た。この重合体溶液の固形分濃度は30.4質量%であり、重合体(A−1)のMwは8,000、分子量分布(Mw/Mn)は2.3であった。
[Synthesis Example 1] (Synthesis of Polymer (A-1))
A flask equipped with a cooling tube and a stirrer was charged with 7 parts by mass of 2,2'-azobis (2,4-dimethylvaleronitrile) and 220 parts by mass of diethylene glycol methyl ethyl ether. Next, 30 parts by mass of the monomer compound (I-1) giving the structural unit (I), 22 parts by mass of (I-11), and 30 parts by mass of the monomer compound (II-1) giving the structural unit (II). 18 parts by mass of the monomer compound (III-1) giving the structural unit (III) as well as the parts were charged. Then, nitrogen substitution was performed, the temperature of the solution was raised to 70 ° C. while gently stirring, and the temperature was maintained for 4 hours for polymerization to obtain a polymer solution containing the polymer (A-1). .. The solid content concentration of this polymer solution was 30.4% by mass, the Mw of the polymer (A-1) was 8,000, and the molecular weight distribution (Mw / Mn) was 2.3.
[合成例2〜47及び比較合成例1〜4](重合体(A−2)〜(A−47)及び(a−1)〜(a−4)の合成)
下記表1に示す種類及び配合量の単量体化合物を用いた以外は、合成例1と同様に操作し、重合体(A−2)〜(A−47)及び(a−1)〜(a−4)を合成した。得られた各重合体溶液の固形分濃度、並びに各重合体のMw及びMw/Mnは、上記重合体(A−1)の値と同等であった。なお、表1中の空欄は、該当する単量体化合物を配合しなかったことを示す。
[Synthesis Examples 2 to 47 and Comparative Synthesis Examples 1 to 4] (Synthesis of Polymers (A-2) to (A-47) and (a-1) to (a-4))
The same procedure as in Synthesis Example 1 was carried out except that the monomer compounds of the types and amounts shown in Table 1 below were used, and the polymers (A-2) to (A-47) and (a-1) to ( a-4) was synthesized. The solid content concentration of each of the obtained polymer solutions and the Mw and Mw / Mn of each polymer were equivalent to the values of the above-mentioned polymer (A-1). The blanks in Table 1 indicate that the corresponding monomer compound was not blended.
<硬化膜形成用樹脂材料(1)の調製>
[実施例1]
[A]重合体としての(A−6)100質量部(固形分)を含有する重合体溶液に、固形分濃度が30質量%となるように溶媒としてのジエチレングリコールメチルエチルエーテルを添加した後、孔径0.2μmのメンブランフィルタでろ過することにより、実施例1の硬化膜形成用樹脂材料(1)を調製した。
<Preparation of resin material (1) for forming a cured film>
[Example 1]
[A] After adding diethylene glycol methyl ethyl ether as a solvent to a polymer solution containing 100 parts by mass (solid content) of (A-6) as a polymer so that the solid content concentration becomes 30% by mass, The resin material (1) for forming a cured film of Example 1 was prepared by filtering with a polymer filter having a pore size of 0.2 μm.
[実施例2〜3及び比較例1〜4]
[A]成分を表2に示す種類及び配合量とした以外は、実施例1と同様に操作し、実施例2〜3及び比較例1〜4の各硬化膜形成用樹脂材料(1)を調製した。なお、表2中の「−」は、後述の評価を行わなかったことを示す。
[Examples 2 to 3 and Comparative Examples 1 to 4]
The same operation as in Example 1 was carried out except that the component [A] was the type and blending amount shown in Table 2, and each of the cured film-forming resin materials (1) of Examples 2 to 3 and Comparative Examples 1 to 4 was used. Prepared. In addition, "-" in Table 2 indicates that the evaluation described later was not performed.
<硬化膜形成用樹脂材料(2)の調製>
各硬化膜形成用樹脂材料(2)の調製に用いた[B]重合性化合物、[C]感放射線性重合開始剤及び[D]酸化防止剤を以下に示す。
<Preparation of resin material (2) for forming a cured film>
The [B] polymerizable compound, [C] radiation-sensitive polymerization initiator, and [D] antioxidant used in the preparation of each cured film-forming resin material (2) are shown below.
[[B]重合性化合物]
(B−1):ジペンタエリスリトールヘキサアクリレート
[[B] Polymerizable compound]
(B-1): Dipentaerythritol hexaacrylate
[[C]感放射線性重合開始剤]
(C−1):エタノン−1−〔9−エチル−6−(2−メチルベンゾイル)−9H−カルバゾール−3−イル〕−1−(O−アセチルオキシム)(イルガキュアOXE02、チバ・スペシャルティー・ケミカルズ社)
[[C] Radiation Sensitive Polymerization Initiator]
(C-1): Etanone-1- [9-ethyl-6- (2-methylbenzoyl) -9H-carbazole-3-yl] -1- (O-acetyloxime) (Irgacure OXE02, Ciba Specialty. Chemicals)
[[D]酸化防止剤]
(D−1):ペンタエリスリトールテトラキス[3−(3,5−ジ−tert−ブチル−4−ヒドロキシフェニル)プロピオナート], (ADEKA社の「アデカスタブAO−60」)
[[D] Antioxidant]
(D-1): Pentaerythritol tetrakis [3- (3,5-di-tert-butyl-4-hydroxyphenyl) propionate], (ADEKA's "ADEKA STAB AO-60")
[実施例4]
[A]重合体としての(A−1)100質量部(固形分)を含有する重合体溶液、[B]重合性化合物としての(B−1)50質量部、[C]感放射線性重合開始剤としての(C−1)5質量部、及び[D]酸化防止剤としての(D−1)0.5質量部を加えて混合し、さらに固形分濃度が30質量%となるように溶媒としてのジエチレングリコールメチルエチルエーテルを添加した後、孔径0.2μmのメンブランフィルタでろ過することにより、実施例4の硬化膜形成用樹脂材料(2)を調製した。
[Example 4]
[A] Polymer solution containing 100 parts by mass (solid content) of (A-1) as a polymer, [B] 50 parts by mass of (B-1) as a polymerizable compound, [C] Radiation-sensitive polymerization Add 5 parts by mass of (C-1) as an initiator and 0.5 parts by mass of (D-1) as an antioxidant and mix them so that the solid content concentration becomes 30% by mass. After adding diethylene glycol methyl ethyl ether as a solvent, the resin material (2) for forming a cured film of Example 4 was prepared by filtering with a polymer filter having a pore size of 0.2 μm.
[実施例5〜50及び比較例5〜8]
[A]成分を表3に示す種類及び配合量とした以外は、実施例4と同様に操作し、実施例5〜50及び比較例5〜8の各硬化膜形成用樹脂材料(2)を調製した。
[Examples 5 to 50 and Comparative Examples 5 to 8]
The same operation as in Example 4 was carried out except that the component [A] was the type and blending amount shown in Table 3, and each of the cured film forming resin materials (2) of Examples 5 to 50 and Comparative Examples 5 to 8 was used. Prepared.
<評価>
調製した各硬化膜形成用樹脂材料(1)及び(2)を用い、下記評価方法に従い評価した。その評価結果を表2及び表3に合わせて示す。
<Evaluation>
The prepared resin materials (1) and (2) for forming a cured film were used and evaluated according to the following evaluation method. The evaluation results are shown in Tables 2 and 3.
[保存安定性]
各硬化膜形成用樹脂材料の粘度(V1)を測定し、各硬化膜形成用樹脂材料を40℃のオーブン中で1週間放置した。加温後の粘度(V2)を測定し、粘度変化率(%)を下記式から算出し、保存安定性の指標とした。
粘度変化率(%)={(V2−V1)/V1}×100(%)
粘度変化率を、A:粘度変化率5%未満、B:粘度変化率5%以上10%未満、C:粘度変化率10%以上15%未満、D:粘度変化率15%以上で区分し、A又はBの場合、保存安定性は良好と、C又はDの場合、不良と評価した。粘度は、E型粘度計(東機産業の「VISCONIC ELD.R」)を用いて25℃で測定した。
[Storage stability]
The viscosity (V 1 ) of each cured film-forming resin material was measured, and each cured film-forming resin material was left in an oven at 40 ° C. for 1 week. The viscosity (V 2 ) after heating was measured, and the viscosity change rate (%) was calculated from the following formula and used as an index of storage stability.
Viscosity change rate (%) = {(V 2- V 1 ) / V 1 } x 100 (%)
The viscosity change rate is classified into A: viscosity change rate of less than 5%, B: viscosity change rate of 5% or more and less than 10%, C: viscosity change rate of 10% or more and less than 15%, and D: viscosity change rate of 15% or more. In the case of A or B, the storage stability was evaluated as good, and in the case of C or D, it was evaluated as poor. The viscosity was measured at 25 ° C. using an E-type viscometer (“VISCONIC ELD.R” manufactured by Toki Sangyo).
[感度]
スピンナーを用い、シリコン基板上に各硬化膜形成用樹脂材料を塗布した後、90℃にて2分間ホットプレート上でプレベークして膜厚3.0μmの塗膜を形成した。得られた塗膜に幅10μmのライン・アンド・スペースパターンを有するパターンマスクを介して、水銀ランプによって所定量の紫外線を照射した。次いでテトラメチルアンモニウムヒドロキシド2.38質量%水溶液よりなる現像液を用い、25℃で60秒現像処理を行った後、超純水で1分間流水洗浄を行った。このとき、幅10μmのライン・アンド・スペースパターンを形成可能な最小紫外線照射量を測定した。この測定値が700J/m2未満の場合、感度は良好と、700J/m2以上の場合、不良と評価できる。
[sensitivity]
After applying each cured film-forming resin material on a silicon substrate using a spinner, it was prebaked on a hot plate at 90 ° C. for 2 minutes to form a coating film having a film thickness of 3.0 μm. The obtained coating film was irradiated with a predetermined amount of ultraviolet rays by a mercury lamp through a pattern mask having a line-and-space pattern having a width of 10 μm. Next, a developing solution consisting of a 2.38% by mass aqueous solution of tetramethylammonium hydroxide was used to develop the product at 25 ° C. for 60 seconds, and then washed with ultrapure water for 1 minute. At this time, the minimum ultraviolet irradiation amount capable of forming a line-and-space pattern having a width of 10 μm was measured. When this measured value is less than 700 J / m 2 , the sensitivity can be evaluated as good, and when it is 700 J / m 2 or more, it can be evaluated as defective.
[現像密着性]
スピンナーを用い、シリコン基板上に各硬化膜形成用樹脂材料を塗布した後、90℃にて2分間ホットプレート上でプレベークして膜厚3.0μmの塗膜を形成した。得られた塗膜に幅10μmのライン・アンド・スペースパターンを有するパターンマスクを介して、水銀ランプによって1,000J/m2の紫外線を照射した。次いでテトラメチルアンモニウムヒドロキシド2.38質量%水溶液よりなる現像液を用い、25℃で60秒現像処理を行った後、超純水で1分間流水洗浄を行った。そして幅10μmのライン・アンド・スペースパターンの剥離の有無を顕微鏡で観察して現像密着性とした。このとき、剥離の度合いにより、A:剥離無し、B:わずかに剥離有り、C:一部剥離有り、D:全面剥離有りと区分し、A又はBの場合、現像密着性は良好と、C又はDの場合、不良と評価した。
[Development adhesion]
After applying each cured film-forming resin material on a silicon substrate using a spinner, it was prebaked on a hot plate at 90 ° C. for 2 minutes to form a coating film having a film thickness of 3.0 μm. The obtained coating film was irradiated with ultraviolet rays of 1,000 J / m 2 by a mercury lamp through a pattern mask having a line-and-space pattern having a width of 10 μm. Next, a developing solution consisting of a 2.38% by mass aqueous solution of tetramethylammonium hydroxide was used to develop the product at 25 ° C. for 60 seconds, and then washed with ultrapure water for 1 minute under running water. Then, the presence or absence of peeling of the line-and-space pattern having a width of 10 μm was observed with a microscope to determine the development adhesion. At this time, depending on the degree of peeling, A: no peeling, B: slightly peeled, C: partially peeled, D: fully peeled, and in the case of A or B, the development adhesion is good, C. Or, in the case of D, it was evaluated as defective.
[耐薬品性]
スピンナーを用い、シリコン基板上に各硬化膜形成用樹脂材料を塗布した後、90℃にて2分間ホットプレート上でプレベークして膜厚3.0μmの塗膜を形成した。得られた塗膜に水銀ランプによって積算照射量が1,000J/m2となるように紫外線を照射した。次いで、このシリコン基板をホットプレート上で、200℃で30分加熱し、得られた硬化膜の膜厚(T1)を測定した。そして、この硬化膜が形成されたシリコン基板を、70℃に温度制御されたジメチルスルホキシド中に20分間浸漬させた後、上記浸漬後の硬化膜の膜厚(t1)を測定し、膜厚変化率を下記式から算出し、これを耐薬品性の指標とした。
膜厚変化率={(t1−T1)/T1}×100(%)
この値の絶対値が5%未満の場合、耐薬品性は良好と、5%以上の場合、不良と評価できる。さらに、絶対値が2%未満の場合、耐薬品性は特に良好と評価できる。
[chemical resistance]
After applying each cured film-forming resin material on a silicon substrate using a spinner, it was prebaked on a hot plate at 90 ° C. for 2 minutes to form a coating film having a film thickness of 3.0 μm. The obtained coating film was irradiated with ultraviolet rays by a mercury lamp so that the integrated irradiation amount was 1,000 J / m 2 . Next, this silicon substrate was heated at 200 ° C. for 30 minutes on a hot plate, and the film thickness (T1) of the obtained cured film was measured. Then, the silicon substrate on which the cured film was formed was immersed in dimethyl sulfoxide whose temperature was controlled at 70 ° C. for 20 minutes, and then the film thickness (t1) of the cured film after the immersion was measured to change the film thickness. The rate was calculated from the following formula and used as an index of chemical resistance.
Film thickness change rate = {(t1-T1) / T1} x 100 (%)
When the absolute value of this value is less than 5%, it can be evaluated as good chemical resistance, and when it is 5% or more, it can be evaluated as defective. Further, when the absolute value is less than 2%, the chemical resistance can be evaluated as particularly good.
[耐熱性]
スピンナーを用い、シリコン基板上に各硬化膜形成用樹脂材料を塗布した後、90℃にて2分間ホットプレート上でプレベークして膜厚3.0μmの塗膜を形成した。得られた塗膜に水銀ランプによって積算照射量が1,000J/m2となるように紫外線を照射した。次いで、このシリコン基板をホットプレート上にて200℃で30分間加熱して硬化膜を得た。得られた硬化膜の5%重量減少温度を測定器(エスアイアイ・ナノテクノロジー社の「TG/DTA220U」)を用いて空気下で測定し、耐熱性の指標とした。このとき、5%重量減少温度が300℃以上の場合、耐熱性は良好と、300℃未満の場合、耐熱性は不良と評価できる。さらに、5%重量減少温度が320℃以上の場合、耐熱性はより良好と、340℃以上の場合、耐熱性は特に良好と評価できる。
[Heat-resistant]
After applying each cured film-forming resin material on a silicon substrate using a spinner, it was prebaked on a hot plate at 90 ° C. for 2 minutes to form a coating film having a film thickness of 3.0 μm. The obtained coating film was irradiated with ultraviolet rays by a mercury lamp so that the integrated irradiation amount was 1,000 J / m 2 . Next, this silicon substrate was heated on a hot plate at 200 ° C. for 30 minutes to obtain a cured film. The 5% weight loss temperature of the obtained cured film was measured in air using a measuring device (“TG / DTA220U” manufactured by SII Nanotechnology Co., Ltd.) and used as an index of heat resistance. At this time, if the 5% weight loss temperature is 300 ° C. or higher, the heat resistance can be evaluated as good, and if it is less than 300 ° C., the heat resistance can be evaluated as poor. Further, when the 5% weight loss temperature is 320 ° C. or higher, the heat resistance is more good, and when the temperature is 340 ° C. or higher, the heat resistance is particularly good.
[透過率(透明性)]
スピンナーを用い、ガラス基板上に各硬化膜形成用樹脂材料を塗布した後、90℃にて2分間ホットプレート上でプレベークして膜厚3.0μmの塗膜を形成した。得られた塗膜に水銀ランプによって積算照射量が1,000J/m2となるように紫外線を照射した。次いで、このガラス基板をホットプレート上にて200℃で30分間加熱して硬化膜を得た。得られた硬化膜の透過率を紫外可視分光光度計(日本分光社の「V−630」)を用いて測定した。このとき、波長400nmの光の透過率が95%以上の場合を良好(透明性が良い)と、95%未満の場合を不良(透明性が悪い)と評価できる。さらに、透過率が97%以上の場合、透明性がより良好と、98%以上の場合、透明性は特に良好と評価できる。
[Transmittance (transparency)]
Each resin material for forming a cured film was applied onto a glass substrate using a spinner, and then prebaked on a hot plate at 90 ° C. for 2 minutes to form a coating film having a film thickness of 3.0 μm. The obtained coating film was irradiated with ultraviolet rays by a mercury lamp so that the integrated irradiation amount was 1,000 J / m 2 . Next, this glass substrate was heated on a hot plate at 200 ° C. for 30 minutes to obtain a cured film. The transmittance of the obtained cured film was measured using an ultraviolet-visible spectrophotometer (“V-630” manufactured by JASCO Corporation). At this time, a case where the transmittance of light having a wavelength of 400 nm is 95% or more can be evaluated as good (transparency is good), and a case where the transmittance is less than 95% can be evaluated as poor (poor transparency). Further, when the transmittance is 97% or more, the transparency can be evaluated as better, and when the transmittance is 98% or more, the transparency can be evaluated as particularly good.
[鉛筆硬度(表面硬度)]
スピンナーを用い、シリコン基板上に各硬化膜形成用樹脂材料を塗布した後、90℃にて2分間ホットプレート上でプレベークして膜厚3.0μmの塗膜を形成した。得られた塗膜に水銀ランプによって積算照射量が1,000J/m2となるように紫外線を照射した。次いで、このシリコン基板をホットプレート上で、200℃で30分加熱して硬化膜を得た。そして、硬化膜が形成された基板について、JIS−K−5400(1990)の8.4.1鉛筆引っかき試験により、硬化膜の鉛筆硬度を測定し、これを表面硬度の指標とした。鉛筆硬度が3H以上の場合、硬化膜の表面硬度は良好(硬化膜形成用樹脂材料は十分な硬化性を有する)と、2H以下の場合、不良と評価できる。
[Pencil hardness (surface hardness)]
After applying each cured film-forming resin material on a silicon substrate using a spinner, it was prebaked on a hot plate at 90 ° C. for 2 minutes to form a coating film having a film thickness of 3.0 μm. The obtained coating film was irradiated with ultraviolet rays by a mercury lamp so that the integrated irradiation amount was 1,000 J / m 2 . Next, this silicon substrate was heated at 200 ° C. for 30 minutes on a hot plate to obtain a cured film. Then, the pencil hardness of the cured film was measured by the 8.4.1 pencil scratch test of JIS-K-5400 (1990) on the substrate on which the cured film was formed, and this was used as an index of the surface hardness. When the pencil hardness is 3H or more, the surface hardness of the cured film is good (the resin material for forming the cured film has sufficient curability), and when it is 2H or less, it can be evaluated as poor.
[比誘電率(低誘電性)]
スピンナーを用い、SUS基板上に各硬化膜形成用樹脂材料を塗布した後、90℃にて2分間ホットプレート上でプレベークして膜厚3.0μmの塗膜を形成した。露光機(キヤノン社の「MPA−600FA」)を用い、積算照射量が1,000J/m2となるように上記塗膜を露光した。その後、露光した基板をクリーンオーブン内にて200℃で30分加熱することにより、SUS基板上に硬化膜を形成した。次いで、蒸着法により、上記硬化膜上にPt/Pd電極パターンを形成して誘電率測定用サンプルを作製した。この電極パターンを有する基板について、電極(横河・ヒューレットパッカード社の「HP16451B」)及びプレシジョンLCRメーター(横河・ヒューレットパッカード社の「HP4284A」)を用い、周波数10kHzでCV法により比誘電率の測定を行った。このとき、比誘電率が3.9以下の場合を良好と、3.9を超える場合を不良と評価できる。さらに、比誘電率が3.4以下の場合をより良好と、3.3以下の場合を特に良好と評価できる。
[Relative permittivity (low dielectric constant)]
Each resin material for forming a cured film was applied onto a SUS substrate using a spinner, and then prebaked on a hot plate at 90 ° C. for 2 minutes to form a coating film having a film thickness of 3.0 μm. The coating film was exposed using an exposure machine (“MPA-600FA” manufactured by Canon Inc.) so that the integrated irradiation dose was 1,000 J / m 2 . Then, the exposed substrate was heated at 200 ° C. for 30 minutes in a clean oven to form a cured film on the SUS substrate. Next, a Pt / Pd electrode pattern was formed on the cured film by a thin-film deposition method to prepare a sample for measuring the dielectric constant. For a substrate having this electrode pattern, an electrode ("HP16451B" by Yokogawa Hewlett-Packard) and a precision LCR meter ("HP4284A" by Yokogawa Hewlett-Packard) were used to determine the relative permittivity by the CV method at a frequency of 10 kHz. The measurement was performed. At this time, a case where the relative permittivity is 3.9 or less can be evaluated as good, and a case where the relative permittivity exceeds 3.9 can be evaluated as defective. Further, the case where the relative permittivity is 3.4 or less can be evaluated as better, and the case where the relative permittivity is 3.3 or less can be evaluated as particularly good.
表2及び表3の評価結果から分かるように、実施例ではいずれの特性も良好であった。特に、表2に示されるように、実施例1〜3の硬化膜形成用樹脂材料(1)は、比較例1〜4の硬化膜形成用樹脂材料(1)と比べて、耐熱性、透過率(透明性)及び鉛筆硬度(表面硬度)がいずれも優れていることがわかる。また、表3に示されるように、実施例4〜50の硬化膜形成用樹脂材料(2)は、比較例5〜8の硬化膜形成用樹脂材料(2)と比べ、耐薬品性、耐熱性、透過率(透明性)及び比誘電率(低誘電性)がいずれも優れていることがわかる。 As can be seen from the evaluation results in Tables 2 and 3, both characteristics were good in the examples. In particular, as shown in Table 2, the cured film-forming resin materials (1) of Examples 1 to 3 have higher heat resistance and permeability than the cured film-forming resin materials (1) of Comparative Examples 1 to 4. It can be seen that both the rate (transparency) and the pencil hardness (surface hardness) are excellent. Further, as shown in Table 3, the cured film-forming resin materials (2) of Examples 4 to 50 have higher chemical resistance and heat resistance than the cured film-forming resin materials (2) of Comparative Examples 5 to 8. It can be seen that the properties, transmittance (transparency) and relative permittivity (low dielectric constant) are all excellent.
特に、表3に示されるように、実施例11、12、20〜25及び35は、耐熱性、透明性、表面硬度及び低誘電性について、いずれも優れている。これらは、[A]重合体が、構造単位(I)が上記式(3−1)又は(3−2)で表される構造単位と、カルボキシ基を有する構造単位とを含み、構造単位(II)が上記式(5−2)で表される構造単位であり、構造単位(III)がオキシラニル基又はメチロール基を有する構造単位であり、上記式(3−1)及び(3−2)中のR4及びR5がパーフルオロアルキル基であり、カルボキシ基を有する構造単位の含有割合が比較的高いことによると推察される。 In particular, as shown in Table 3, Examples 11, 12, 20 to 25 and 35 are all excellent in heat resistance, transparency, surface hardness and low dielectric property. In these, the [A] polymer contains a structural unit in which the structural unit (I) is represented by the above formula (3-1) or (3-2) and a structural unit having a carboxy group, and the structural unit ( II) is a structural unit represented by the above formula (5-2), and structural unit (III) is a structural unit having an oxylanyl group or a methylol group, and the above formulas (3-1) and (3-2). It is presumed that R 4 and R 5 in the group are perfluoroalkyl groups, and the content ratio of the structural unit having a carboxy group is relatively high.
本発明は、優れた表面硬度を有すると共に耐薬品性、耐熱性、透明性及び低誘電性等の一般的特性を十分満足可能な硬化膜を形成でき、かつ保存安定性に優れる硬化膜形成用樹脂材料を提供することができる。従って、当該硬化膜形成用樹脂材料、この硬化膜形成用樹脂材料から形成される硬化膜、半導体素子及び表示素子、並びに当該硬化膜の形成方法は、フレキシブルディスプレイなどの電子デバイス等の製造プロセスに好適に使用することができる。 The present invention is for forming a cured film having excellent surface hardness, capable of forming a cured film that can sufficiently satisfy general properties such as chemical resistance, heat resistance, transparency, and low dielectric property, and having excellent storage stability. A resin material can be provided. Therefore, the resin material for forming the cured film, the cured film formed from the resin material for forming the cured film, the semiconductor element and the display element, and the method for forming the cured film are used in the manufacturing process of electronic devices such as flexible displays. It can be preferably used.
Claims (9)
酸化防止剤、
エチレン性不飽和結合を有する重合性化合物、並びに
感放射線性重合開始剤
を含有し、
上記架橋性基が、オキシラニル基、オキセタニル基、メチロール基又はこれらの組み合わせである硬化膜形成用樹脂材料。
上記式(1−2)中、R1、R2及びR3は、上記式(1−1)と同義である。A2は、ハロゲン原子、ヒドロキシ基、炭素数1〜6のアルコキシ基又は炭素数1〜6のアルキル基である。A2が複数の場合、複数のA2はそれぞれ独立して上記定義を満たす。n2は、0〜6の整数である。*は結合部位を示す。) A structural unit having an acidic group, a structural unit having a crosslinkable group, and at least one group selected from a group represented by the following formula (1-1) and a group represented by the following formula (1-2). co-polymer containing a structural unit having,
Antioxidant,
It contains a polymerizable compound having an ethylenically unsaturated bond and a radiation-sensitive polymerization initiator.
A resin material for forming a cured film, wherein the crosslinkable group is an oxylanyl group, an oxetanyl group, a methylol group, or a combination thereof.
In the above formula (1-2), R 1 , R 2 and R 3 are synonymous with the above formula (1-1). A 2 is a halogen atom, a hydroxy group, an alkoxy group having 1 to 6 carbon atoms, or an alkyl group having 1 to 6 carbon atoms. If A 2 is plural, each independently plurality of A 2 satisfy the above definition. n2 is an integer from 0 to 6. * Indicates the binding site. )
酸化防止剤、
エチレン性不飽和結合を有する重合性化合物、並びに
感放射線性重合開始剤
を含有し、
上記酸性基が下記式(2)で表される基である硬化膜形成用樹脂材料。
上記式(1−2)中、R1、R2及びR3は、上記式(1−1)と同義である。A2は、ハロゲン原子、ヒドロキシ基、炭素数1〜6のアルコキシ基又は炭素数1〜6のアルキル基である。A2が複数の場合、複数のA2はそれぞれ独立して上記定義を満たす。n2は、0〜6の整数である。*は結合部位を示す。)
Antioxidant,
It contains a polymerizable compound having an ethylenically unsaturated bond and a radiation-sensitive polymerization initiator.
A resin material for forming a cured film, wherein the acidic group is a group represented by the following formula (2).
In the above formula (1-2), R 1 , R 2 and R 3 are synonymous with the above formula (1-1). A 2 is a halogen atom, a hydroxy group, an alkoxy group having 1 to 6 carbon atoms, or an alkyl group having 1 to 6 carbon atoms. If A 2 is plural, each independently plurality of A 2 satisfy the above definition. n2 is an integer from 0 to 6. * Indicates the binding site. )
酸化防止剤、
エチレン性不飽和結合を有する重合性化合物、並びに
感放射線性重合開始剤
を含有し、
上記感放射線性重合開始剤がオキシムエステル化合物であり、
このオキシムエステル化合物の含有量が、上記重合体100質量部に対して0.1質量部以上20質量部以下である硬化膜形成用樹脂材料。
上記式(1−2)中、R1、R2及びR3は、上記式(1−1)と同義である。A2は、ハロゲン原子、ヒドロキシ基、炭素数1〜6のアルコキシ基又は炭素数1〜6のアルキル基である。A2が複数の場合、複数のA2はそれぞれ独立して上記定義を満たす。n2は、0〜6の整数である。*は結合部位を示す。) Structural unit having an acidic group, and a co-polymer comprising a structural unit having at least one group selected from the groups represented by groups and the following formula represented by the following formula (1-1) (1-2) ,
Antioxidant,
It contains a polymerizable compound having an ethylenically unsaturated bond and a radiation-sensitive polymerization initiator.
The radiation-sensitive polymerization initiator is an oxime ester compound.
A resin material for forming a cured film in which the content of the oxime ester compound is 0.1 part by mass or more and 20 parts by mass or less with respect to 100 parts by mass of the polymer.
In the above formula (1-2), R 1 , R 2 and R 3 are synonymous with the above formula (1-1). A 2 is a halogen atom, a hydroxy group, an alkoxy group having 1 to 6 carbon atoms, or an alkyl group having 1 to 6 carbon atoms. If A 2 is plural, each independently plurality of A 2 satisfy the above definition. n2 is an integer from 0 to 6. * Indicates the binding site. )
エチレン性不飽和結合を有する重合性化合物、並びに
感放射線性重合開始剤
を含有し、
上記架橋性基が、オキシラニル基、オキセタニル基、メチロール基又はこれらの組み合わせである硬化膜形成用樹脂材料。
上記式(1−2)中、R1、R2及びR3は、上記式(1−1)と同義である。A2は、ハロゲン原子、ヒドロキシ基、炭素数1〜6のアルコキシ基又は炭素数1〜6のアルキル基である。A2が複数の場合、複数のA2はそれぞれ独立して上記定義を満たす。n2は、0〜6の整数である。*は結合部位を示す。) A structural unit having an acidic group, a structural unit having a crosslinkable group, and at least one group selected from a group represented by the following formula (1-1) and a group represented by the following formula (1-2). co-polymer containing a structural unit having,
It contains a polymerizable compound having an ethylenically unsaturated bond and a radiation-sensitive polymerization initiator.
A resin material for forming a cured film, wherein the crosslinkable group is an oxylanyl group, an oxetanyl group, a methylol group, or a combination thereof.
In the above formula (1-2), R 1 , R 2 and R 3 are synonymous with the above formula (1-1). A 2 is a halogen atom, a hydroxy group, an alkoxy group having 1 to 6 carbon atoms, or an alkyl group having 1 to 6 carbon atoms. If A 2 is plural, each independently plurality of A 2 satisfy the above definition. n2 is an integer from 0 to 6. * Indicates the binding site. )
エチレン性不飽和結合を有する重合性化合物、並びに
感放射線性重合開始剤
を含有し、
上記酸性基が下記式(2)で表される基である硬化膜形成用樹脂材料。
上記式(1−2)中、R1、R2及びR3は、上記式(1−1)と同義である。A2は、ハロゲン原子、ヒドロキシ基、炭素数1〜6のアルコキシ基又は炭素数1〜6のアルキル基である。A2が複数の場合、複数のA2はそれぞれ独立して上記定義を満たす。n2は、0〜6の整数である。*は結合部位を示す。)
It contains a polymerizable compound having an ethylenically unsaturated bond and a radiation-sensitive polymerization initiator.
A resin material for forming a cured film, wherein the acidic group is a group represented by the following formula (2).
In the above formula (1-2), R 1 , R 2 and R 3 are synonymous with the above formula (1-1). A 2 is a halogen atom, a hydroxy group, an alkoxy group having 1 to 6 carbon atoms, or an alkyl group having 1 to 6 carbon atoms. If A 2 is plural, each independently plurality of A 2 satisfy the above definition. n2 is an integer from 0 to 6. * Indicates the binding site. )
上記塗膜の一部に放射線を照射する工程、
上記放射線が照射された塗膜を現像する工程、及び
上記現像された塗膜を加熱する工程
を備える硬化膜の形成方法。 A step of forming a coating film on a substrate by using the resin material for forming a cured film according to any one of claims 1 to 5 .
The process of irradiating a part of the coating film with radiation,
A method for forming a cured film, comprising a step of developing the coating film irradiated with radiation and a step of heating the developed coating film.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015214790A JP6795753B2 (en) | 2015-10-30 | 2015-10-30 | Resin material for forming a cured film, method for forming a cured film, cured film, semiconductor element and display element |
KR1020160138953A KR102464649B1 (en) | 2015-10-30 | 2016-10-25 | Resin material for forming cured film, method for forming the cured film, the cured film, semiconductor device, and display device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015214790A JP6795753B2 (en) | 2015-10-30 | 2015-10-30 | Resin material for forming a cured film, method for forming a cured film, cured film, semiconductor element and display element |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017082173A JP2017082173A (en) | 2017-05-18 |
JP6795753B2 true JP6795753B2 (en) | 2020-12-02 |
Family
ID=58710692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015214790A Active JP6795753B2 (en) | 2015-10-30 | 2015-10-30 | Resin material for forming a cured film, method for forming a cured film, cured film, semiconductor element and display element |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6795753B2 (en) |
KR (1) | KR102464649B1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6603115B2 (en) * | 2015-11-27 | 2019-11-06 | 信越化学工業株式会社 | Silicon-containing condensate, silicon-containing resist underlayer film forming composition, and pattern forming method |
WO2019031114A1 (en) * | 2017-08-10 | 2019-02-14 | Jsr株式会社 | Polymer, resin composition, resin film, method for producing patterned resin film, and electronic component |
CN108303851B (en) * | 2018-01-05 | 2019-09-10 | 湖北固润科技股份有限公司 | Photoetching compositions comprising poly(4-hydroxystyrene) class oxetane resin as film-forming resin |
JPWO2023100736A1 (en) * | 2021-12-02 | 2023-06-08 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3965868B2 (en) | 2000-06-12 | 2007-08-29 | Jsr株式会社 | Interlayer insulation film and microlens |
JP2012113227A (en) * | 2010-11-26 | 2012-06-14 | Jnc Corp | Photosensitive resin composition, patterned transparent film and display element |
JP2013020103A (en) * | 2011-07-12 | 2013-01-31 | Mitsubishi Paper Mills Ltd | Negative photosensitive lithographic printing plate |
JP2014062978A (en) * | 2012-09-20 | 2014-04-10 | Jnc Corp | Positive photosensitive composition |
KR102115817B1 (en) * | 2013-01-16 | 2020-05-27 | 제이에스알 가부시끼가이샤 | Thermosetting resin composition for forming cured film, negative radiation-sensitive resin composition, positive radiation-sensitive resin composition, cured film, method for forming the same, semiconductor device and display device |
JP6089743B2 (en) | 2013-02-05 | 2017-03-08 | Jsr株式会社 | Radiation-sensitive resin composition for forming cured film, cured film, method for forming the same, semiconductor element and display element |
JP6089931B2 (en) * | 2013-04-26 | 2017-03-08 | 大日本印刷株式会社 | Color material dispersion, colored resin composition for color filter, color filter, liquid crystal display device, and organic light emitting display device |
JP6171573B2 (en) * | 2013-05-29 | 2017-08-02 | 東洋インキScホールディングス株式会社 | Photosensitive resin composition and cured film |
WO2015033901A1 (en) * | 2013-09-06 | 2015-03-12 | 日本ゼオン株式会社 | Radiation-sensitive resin composition, and electronic component |
WO2015037695A1 (en) * | 2013-09-13 | 2015-03-19 | 富士フイルム株式会社 | Photosensitive resin composition, method for producing cured film, cured film, liquid crystal display device and organic el display device |
JP2015145927A (en) * | 2014-01-31 | 2015-08-13 | Jsr株式会社 | Production method of cured film of display element, radiation-sensitive resin composition, cured film of display element, display element, and heating device |
-
2015
- 2015-10-30 JP JP2015214790A patent/JP6795753B2/en active Active
-
2016
- 2016-10-25 KR KR1020160138953A patent/KR102464649B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2017082173A (en) | 2017-05-18 |
KR20170051285A (en) | 2017-05-11 |
KR102464649B1 (en) | 2022-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102720666B1 (en) | Radiation-sensitive resin composition, method for forming cured film, cured film, semiconductor device, and display device | |
JP6089743B2 (en) | Radiation-sensitive resin composition for forming cured film, cured film, method for forming the same, semiconductor element and display element | |
JP6070203B2 (en) | Semiconductor element and display element | |
JP5636918B2 (en) | Radiation sensitive resin composition, cured film for display element, method for forming cured film for display element, and display element | |
TWI667540B (en) | Negative-type photosensitive resin composition, photo-curable pattern and image display device using the same | |
KR102115817B1 (en) | Thermosetting resin composition for forming cured film, negative radiation-sensitive resin composition, positive radiation-sensitive resin composition, cured film, method for forming the same, semiconductor device and display device | |
CN105388705B (en) | Colored photosensitive resin composition | |
KR102252030B1 (en) | Curable resin composition, cured film for display device, method for forming the same, and display device | |
JP6606055B2 (en) | Colored photosensitive resin composition, color filter produced using the same, and image display device | |
JP6795753B2 (en) | Resin material for forming a cured film, method for forming a cured film, cured film, semiconductor element and display element | |
JP7201034B2 (en) | Radiation sensitive composition | |
JP5708313B2 (en) | Radiation sensitive resin composition, cured film, method for forming cured film, color filter, and method for forming color filter | |
KR102654596B1 (en) | Negative-type Photosensitive Resin Composition | |
JP6168212B2 (en) | Positive radiation-sensitive resin composition, cured film and method for forming the same, semiconductor element, and display element | |
CN104950570B (en) | Resin composition for forming cured film, cured film and method for forming same, and display element | |
KR20160020300A (en) | Negative-type photosensitive resin comopsition | |
CN115202152A (en) | Composition, cured film and method for producing same, semiconductor element, and display element | |
KR20120059352A (en) | Radiation-sensitive resin composition, cured film for display device, method for forming the cured film for display device, and the display device | |
JP2013231106A (en) | Polymer, method of manufacturing polymer, curable resin composition, and cured film | |
JP2015092233A (en) | Radiation-sensitive resin composition, interlayer insulator for display element, method for forming the same and display element | |
JP2024060600A (en) | Negative photosensitive resin composition for formation of high refractive index pattern | |
KR20130110439A (en) | Negative-type photosensitive resin composition and insulating film prepared therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180730 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190417 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190423 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190610 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191105 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191223 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20200526 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200803 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20200803 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20200811 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20200818 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201013 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201026 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6795753 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |